Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3012336	p-haptog	g/l (g/l)	9499	15067	0.00%
3012336	s-haptog	g/l (g/l)	5756	9092	0.89%
3012336	p-haptog	— (—)	2392	4019	100.00%	Distribution not available
3012336	s-haptog	— (—)	1583	2497	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormalities of breathing

3213

8689

2.21

323.31

1.9

1.7

1.55

1.49

g/l

2.36

2761

7446

Gout, idiopatic and unspecified

1489

5232

3.13

320.18

1.8

1.6

1.64

1.55

g/l

3.10

1317

4430

Type 2 diabetes

3555

10131

2.11

318.77

1.8

1.7

1.64

1.47

g/l

19.60

3070

8560

Medical observation and evaluation for suspected diseases and conditions

2489

5242

2.51

317.87

1.8

1.6

1.51

1.52

g/l

0.23

2135

4415

Other diseases of intestines

3713

10466

2.07

316.18

1.8

1.53

1.48

g/l

2.48

3210

8899

Ischemic heart diseases

3014

8337

2.25

315.58

1.8

1.7

1.58

1.57

g/l

0.13

2580

7098

Diabetes, insulin treatment (Kela reimbursement)

3737

11312

2.06

314.83

1.8

1.7

1.65

1.49

g/l

18.14

3247

9559

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1255

2291

3.58

314.42

2.0

1.6

1.47

1.40

g/l

1.28

1102

1932

Major coronary heart disease event

3123

8859

2.20

311.80

1.8

1.7

1.58

1.57

g/l

0.05

2671

7533

Other disorders of skin and subcutaneous tissue

2863

11998

2.21

310.26

1.9

1.7

1.60

1.53

g/l

2.98

2483

10177

Other diseases of the digestive system

1717

6569

2.81

310.20

1.8

1.6

1.47

1.56

g/l

3.67

1491

5556

Any reimbursement code in KELA

1573

2532

3.20

308.54

1.9

1.8

1.50

1.26

g/l

14.05

1369

2126

Other CVD (FINNGEN)

595

783

6.48

307.74

1.8

1.5

1.56

1.52

g/l

0.32

511

651

Disorders of lipoprotein metabolism and other lipidaemias

3265

8678

2.42

307.65

1.7

1.62

1.54

g/l

4.64

2809

7309

Insulin, fast-acting

1709

6326

2.87

307.65

1.9

1.7

1.60

1.50

g/l

4.04

1515

5352

Type 2 diabetes, wide definition

3469

8966

2.60

307.65

1.7

1.67

1.49

g/l

19.56

3007

7555

Insulin medication

2826

9299

2.70

307.65

1.9

1.7

1.65

1.48

g/l

14.29

2494

7842

Viral Sepsis

1297

3049

4.75

307.65

2.2

1.6

1.58

1.49

g/l

2.54

1144

2562

Covid-19 confirmed case

1981

6985

3.06

307.65

2.1

1.6

1.58

1.52

g/l

2.25

1762

5914

Non-rheumatic valve diseases

2489

4932

3.93

307.65

1.8

1.6

1.43

1.59

g/l

11.67

2019

4190

ILD medications

5034

10146

2.81

307.65

2.0

1.6

1.54

1.47

g/l

3.89

4376

8587

Heart failure and coronary heart disease

2685

5867

3.57

307.65

1.8

1.6

1.58

1.59

g/l

0.24

2289

4962

Inflammatory bowel disease treatment related agents

4721

11495

2.38

307.65

2.0

1.6

1.57

1.47

g/l

7.37

4097

9761

Oedema, not elsewhere classified

1545

4789

3.40

307.65

1.9

1.6

1.57

1.53

g/l

0.90

1357

4045

Oxycodone

1816

6016

2.90

307.65

1.8

1.6

1.74

1.51

g/l

15.44

1544

5092

Septicaemia

2964

6627

4.67

307.65

2.1

1.5

1.63

1.48

g/l

10.82

2571

5574

Hypertension

2853

5600

2.99

307.65

2.0

1.7

1.53

1.47

g/l

2.36

2488

4684

Malaise and fatigue

2617

6470

3.47

307.65

1.8

1.6

1.58

1.51

g/l

3.12

2264

5455

Tramadol

3277

7862

2.67

307.65

1.8

1.7

1.62

1.47

g/l

13.38

2835

6667

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3503

9981

2.18

307.65

1.8

1.7

1.64

1.47

g/l

18.74

3041

8430

Anaemias

2449

609

31.53

307.65

2.3

1.7

1.42

1.11

g/l

13.89

2096

526

Hard cardiovascular diseases

2998

7989

2.32

307.65

1.8

1.7

1.57

1.56

g/l

0.25

2565

6793

Diabetic nephropathy

1197

3501

3.94

307.65

2.1

1.7

1.65

1.62

g/l

0.69

1115

2961

Diabetic nephropathy, excluding more controls

1188

2173

5.33

307.65

2.1

1.7

1.66

1.61

g/l

0.78

1106

1821

Implicit viral Sepsis

1700

4592

4.06

307.65

2.0

1.6

1.59

1.51

g/l

2.22

1487

3867

Hypertension, essential

2785

5479

2.99

307.65

1.9

1.7

1.55

1.47

g/l

3.56

2417

4581

ILD medications: azathioprine

762

1628

5.12

307.65

2.3

1.5

1.48

1.49

g/l

0.10

685

1378

Infections, IBD-co-morbidities

1022

978

8.27

307.65

2.2

1.6

1.54

1.44

g/l

1.65

907

825

Percutaneous Coronary Intervention

3031

8153

2.37

307.65

1.8

1.7

1.55

1.58

g/l

0.62

2587

6935

Insulin, intermediate and long-acting

2554

10489

2.50

307.65

1.9

1.6

1.64

1.52

g/l

8.44

2253

8876

Bacterial Sepsis

3474

6917

4.82

307.65

2.0

1.5

1.65

1.53

g/l

7.85

3004

5811

Erysipelas

2604

8050

3.03

307.65

1.8

1.5

1.67

1.48

g/l

16.37

2219

6783

Insulin, combination of fast acting with intermediate-acting or long-acting

2828

11198

2.42

307.65

1.9

1.6

1.65

1.52

g/l

9.72

2496

9459

Liquid cancers, helper endpoint

2834

5643

4.96

307.65

2.1

1.6

1.39

1.58

g/l

16.02

2416

4801

L04AA Selective immunosuppressants

1580

3134

5.76

307.65

2.3

1.6

1.49

1.55

g/l

1.43

1435

2671

Explicit Sepsis

3016

6888

4.54

307.65

2.1

1.6

1.63

1.52

g/l

5.88

2617

5798

ILD medications: prednisolone, methylprednisolone, prednisone

4913

10044

2.86

307.65

2.0

1.6

1.56

1.48

g/l

5.74

4275

8499

Heart failure,strict

3520

5712

4.85

307.65

1.8

1.5

1.58

g/l

0.04

3028

4769

Provisional assignment of new diseases of uncertain etiology

2422

9697

2.63

307.65

2.0

1.7

1.58

1.49

g/l

3.96

2153

8241

Codes for special purposes

2425

9716

2.63

307.65

2.0

1.7

1.58

1.49

g/l

3.92

2156

8252

Acute renal failure

2243

3426

8.15

307.65

2.2

1.6

1.65

1.54

g/l

4.74

2002

2834

Pneumonia, organism unspecified

4321

10455

3.06

307.65

1.9

1.6

1.66

1.46

g/l

26.66

3744

8867

ILD medications: immunosuppressive drugs

3523

8493

4.15

307.65

2.1

1.6

1.51

1.50

g/l

0.24

3103

7198

Gout

1815

4675

3.78

307.65

1.8

1.6

1.61

1.55

g/l

1.92

1607

3973

Dialysis

582

424

21.49

307.65

2.6

1.8

1.49

1.51

g/l

0.17

553

365

Oral corticosteroids

4383

11268

2.40

307.65

1.9

1.6

1.60

1.48

g/l

11.25

3778

9565

Heart failure and antihypertensive medication

1729

1387

9.24

307.65

1.9

1.7

1.58

1.50

g/l

1.43

1493

1167

Secondary hypertension

821

572

17.96

307.65

2.4

1.5

1.46

1.48

g/l

0.21

749

477

Acute tubulo-interstitial nephritis

2869

8236

3.18

307.65

1.9

1.6

1.68

1.47

g/l

22.87

2492

6849

Caries of dentine

1424

3303

4.64

307.65

2.3

1.6

1.53

g/l

0.04

1252

2824

Extracorporeal dialysis

1027

927

18.94

307.65

2.8

1.8

1.53

1.50

g/l

0.32

957

809

Iron deficiency anaemia secondary to blood loss (chronic)

1302

2442

6.25

307.65

1.8

1.7

1.50

1.54

g/l

0.68

1138

2071

Other and unspecified iron deficiency

3092

5403

6.77

307.65

1.7

1.6

1.58

1.53

g/l

1.94

2641

4581

Preparatory care for dialysis

899

652

29.87

307.65

2.6

1.9

1.53

1.54

g/l

0.05

866

568

Other and unspecified anaemias

5587

6226

11.16

307.65

1.9

1.5

1.53

1.58

g/l

1.92

4805

5223

Other dialysis

491

414

20.28

307.65

2.6

1.9

1.49

1.53

g/l

0.29

471

361

Emergency coronary revascularization (for ACS)

3375

9409

2.27

307.65

1.8

1.7

1.56

1.58

g/l

0.77

2876

7991

Autoimmune diseases excluding thyroid diseases, strict definition

4393

9753

2.57

307.65

2.1

1.6

1.50

1.51

g/l

0.18

3793

8304

Other septicaemia

2661

6108

4.69

307.65

2.1

1.5

1.62

1.48

g/l

8.78

2308

5142

Anaemia in chronic diseases classified elsewhere

373

257

24.28

307.65

2.5

2.0

1.53

1.52

g/l

0.07

332

228

Examination and observation for other reasons

2669

5164

3.14

307.65

1.8

1.6

1.47

1.52

g/l

1.69

2311

4358

Presence of cardiac and vascular implants and grafts

2405

6640

2.89

307.65

1.8

1.6

1.49

1.60

g/l

5.27

1977

5642

Intestinal infectious diseases

3610

13615

2.08

307.65

2.0

1.7

1.54

1.50

g/l

1.45

3120

11579

Heart failure, not strict

4943

7218

5.15

307.65

2.0

1.5

1.56

1.57

g/l

0.16

4335

6046

Cardiovascular diseases

1720

2852

3.34

307.65

2.2

1.8

1.45

1.27

g/l

9.13

1502

2450

Kidney transplant status

803

609

21.04

307.65

2.8

1.8

1.42

1.49

g/l

0.73

764

524

Persons encountering health services for specific procedures and health care

4814

10713

2.82

307.65

2.0

1.6

1.56

1.48

g/l

5.57

4204

9033

GASTRO-related operations

2848

4378

3.38

307.65

1.9

1.6

1.49

1.39

g/l

4.77

2443

3736

Other bacterial diseases

5562

9843

4.10

307.65

1.9

1.6

1.66

1.45

g/l

35.97

4819

8314

All kidney diseases

5986

9619

4.60

307.65

2.0

1.6

1.59

1.45

g/l

19.11

5282

8027

Erysipelas

3296

8610

3.08

307.65

1.8

1.5

1.65

1.47

g/l

18.55

2829

7237

All pneumoniae

4638

11134

2.92

307.65

1.9

1.7

1.65

1.45

g/l

29.68

4029

9463

L04AX Other immunosuppressants

2295

9463

2.54

307.65

1.8

1.7

1.55

1.52

g/l

0.66

1982

8112

Transplanted organ and tissue status

1260

1180

14.93

307.65

2.5

1.6

1.39

1.54

g/l

3.95

1181

1007

Implicit Sepsis

4423

9173

3.93

307.65

1.9

1.6

1.61

1.50

g/l

8.45

3820

7740

Condition for Implicit Sepsis (Organ dysfunction codes)

4367

9402

3.39

307.65

1.9

1.6

1.56

1.49

g/l

4.28

3780

7963

All chronic kidney diseases

5078

6693

7.27

307.65

2.0

1.5

1.60

1.49

g/l

8.86

4570

5535

Myelodysplastic syndrome, including Hilmo

399

453

13.01

307.65

2.3

1.6

1.13

1.51

g/l

9.74

345

385

Dyspnoea

3781

12480

2.33

307.65

1.9

1.7

1.56

1.52

g/l

1.79

3236

10647

Diseases of arteries, arterioles and capillaries

3306

9943

2.60

307.65

1.8

1.6

1.63

1.55

g/l

3.97

2844

8411

Care involving dialysis

1491

1072

24.67

307.65

2.7

1.7

1.52

1.49

g/l

0.38

1403

922

Dental caries

1599

3741

4.53

307.65

2.4

1.6

1.51

1.54

g/l

0.45

1416

3207

Diverticular disease of intestine

3029

8249

2.45

307.65

1.7

1.6

1.60

1.56

g/l

1.59

2608

6976

Bacterial infection, other or unspecified

4121

7917

4.91

307.65

1.9

1.5

1.72

1.47

g/l

36.20

3562

6664

Implicit bacterial Sepsis

3309

6740

4.77

307.65

2.0

1.5

1.64

1.54

g/l

6.19

2874

5656

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4173

8842

3.00

307.65

1.9

1.7

1.64

1.44

g/l

25.25

3628

7529

Condition for Implicit Sepsis (Organ dysfunction codes)

4458

9460

3.54

307.65

1.9

1.6

1.58

1.50

g/l

5.20

3855

8009

Other disorders of fluid, electrolyte and acid-base balance

1897

5112

3.88

307.65

1.8

1.6

1.62

1.55

g/l

2.09

1656

4303

Nutritional anaemias

4164

8252

5.59

307.65

1.7

1.56

1.54

g/l

0.69

3553

6981

Implicit bacterial Sepsis

3125

6389

4.90

307.65

2.0

1.5

1.65

1.54

g/l

7.36

2716

5364

Unspecified kidney failure

1100

1566

9.02

307.65

2.2

1.6

1.60

1.54

g/l

1.16

993

1282

Other anaemias

5610

6255

11.11

307.65

1.9

1.5

1.53

1.57

g/l

1.97

4826

5249

Atrial fibrillation and flutter with reimbursement

1062

1329

5.42

307.65

1.8

1.5

1.58

1.53

g/l

0.64

948

1104

Cerebrovascular diseases (FINNGEN)

1095

1702

4.79

307.65

1.9

1.5

1.60

1.47

g/l

2.91

938

1423

Heart failure, strict

3783

7770

3.78

307.65

1.8

1.6

1.58

g/l

0.14

3246

6559

Complications of surgical and medical care, not elsewhere classified

4059

12833

2.25

307.65

1.9

1.7

1.58

1.51

g/l

4.17

3477

10930

Disorders resulting from impaired renal tubular function

526

507

16.34

307.65

2.4

2.0

1.57

1.56

g/l

0.07

489

444

Other autoimmune haemolytic anaemias

267

175

36.41

307.65

8.6

1.5

0.86

1.55

g/l

12.66

202

156

Purpura and other haemorrhagic conditions

960

2135

5.17

307.65

2.3

1.7

1.30

1.55

g/l

10.37

815

1838

Diabetes, varying definitions

3696

10463

2.13

307.65

1.9

1.7

1.62

1.45

g/l

17.89

3204

8847

Fever of other and unknown origin

3110

7424

4.00

307.65

2.1

1.6

1.63

1.49

g/l

9.53

2694

6275

Continuous positive airway pressure

939

1500

5.72

307.65

1.9

1.6

1.64

1.50

g/l

3.07

818

1269

Pneumonias (Asthma/COPD co-morbidities)

4631

11069

2.95

307.65

1.9

1.6

1.65

1.45

g/l

29.89

4022

9405

Peripheral artery disease

2302

7549

2.59

307.65

1.8

1.6

1.72

1.55

g/l

13.54

2000

6356

Hypertensive heart and/or renal disease

1508

2953

4.16

307.65

1.8

1.6

1.62

1.51

g/l

3.78

1306

2456

Atrial fibrillation and flutter

1276

1580

5.56

307.65

1.9

1.5

1.53

1.51

g/l

0.25

1101

1319

Metabolic disorders

4131

9527

2.77

307.65

1.8

1.7

1.56

1.51

g/l

2.79

3570

8045

4173

8842

3.00

307.65

1.9

1.7

1.64

1.44

g/l

25.25

3628

7529

Pure hypercholesterolaemia

2940

8344

2.40

307.65

1.6

1.7

1.63

1.54

g/l

5.25

2531

7034

Hypertensive diseases

2855

5603

2.99

307.65

2.0

1.7

1.53

1.47

g/l

2.38

2489

4687

Nephropathy related operations

1873

1894

15.08

307.65

2.7

1.6

1.50

1.55

g/l

1.00

1745

1610

L04AD Calcineurin inhibitors

1236

1328

12.40

307.65

2.6

1.7

1.39

1.56

g/l

5.33

1150

1137

Implicit Sepsis

4483

9480

3.70

307.65

1.9

1.6

1.59

1.50

g/l

6.99

3868

8017

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4221

10640

2.70

307.65

2.0

1.7

1.49

1.53

g/l

1.85

3633

9088

Valvular heart disease excluding rheumatic fever

2510

4951

3.95

307.65

1.8

1.6

1.43

1.59

g/l

11.17

2036

4207

Other heart diseases

1937

2487

5.37

307.65

2.0

1.6

1.53

1.39

g/l

6.20

1660

2099

Haemolytic anaemias

581

458

21.49

307.65

7.1

1.5

0.89

1.52

g/l

24.80

424

403

Iron deficiency anaemia

3765

6991

6.19

307.65

1.7

1.6

1.57

1.54

g/l

1.07

3224

5915

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

8765

7532

9.22

307.65

2.0

1.4

1.50

1.55

g/l

2.60

7497

6419

Implicit viral Sepsis

1297

3045

4.76

307.65

2.2

1.6

1.58

1.49

g/l

2.55

1144

2559

Certain infectious and parasitic diseases

3657

7260

2.61

307.65

1.9

1.6

1.57

1.41

g/l

14.60

3173

6124

Cardiovascular diseases (excluding rheumatic etc)

1987

3243

3.65

307.65

2.1

1.7

1.48

1.30

g/l

9.48

1731

2767

Autoimmune diseases

4176

10051

2.18

307.65

2.0

1.6

1.48

1.51

g/l

0.93

3606

8562

Cardiac arrhythmias

1844

4245

2.92

307.65

1.9

1.7

1.46

1.42

g/l

1.04

1575

3628

All-cause Heart Failure

3704

7683

3.75

307.65

1.8

1.6

1.57

1.58

g/l

0.21

3178

6482

Influenza and pneumonia

4706

10990

2.85

307.65

1.9

1.7

1.63

1.44

g/l

27.89

4091

9342

Acquired haemolytic anaemia

470

329

28.57

307.65

8.0

1.6

0.88

1.48

g/l

17.92

336

287

Autoimmune diseases excluding thyroid diseases

4553

10009

2.58

307.65

2.1

1.6

1.50

1.51

g/l

0.23

3932

8527

Glomerular diseases

1779

2925

7.51

307.65

2.5

1.6

1.59

1.52

g/l

2.00

1641

2486

Bleeding

3756

11186

2.51

307.65

1.8

1.6

1.49

1.58

g/l

6.89

3241

9471

Coronary revascularization (ANGIO or CABG)

2998

8154

2.34

307.65

1.8

1.7

1.56

1.58

g/l

0.41

2562

6936

First line medication for Crohn's disease

4746

9860

2.71

307.65

2.0

1.6

1.55

1.46

g/l

7.30

4122

8331

Coagulation defects, purpura and other haemorrhagic conditions

1214

3125

4.33

307.65

2.3

1.7

1.32

1.55

g/l

11.26

1041

2676

Diseases of liver

1696

6013

3.02

307.65

1.9

1.7

1.29

1.58

g/l

28.05

1435

5141

Used for control exclusion in common control thyroid runs

3830

9439

2.11

307.65

2.0

1.6

1.49

1.51

g/l

0.74

3303

8029

Second line medication for Crohn's disease

2351

9697

2.54

307.65

1.8

1.7

1.55

1.52

g/l

0.60

2034

8321

Benign neoplasm of colon, rectum, anus and anal canal

2835

11068

2.34

307.65

1.7

1.6

1.58

1.57

g/l

0.10

2454

9369

Gout, FINNGEN

1815

5971

3.34

307.65

1.8

1.6

1.61

1.54

g/l

2.78

1607

5016

Diseases of the digestive system

2229

9170

2.56

307.65

1.8

1.6

1.47

1.55

g/l

3.72

1929

7759

Diabetes mellitus

3713

10466

2.14

307.65

1.9

1.7

1.62

1.45

g/l

18.04

3216

8853

Glomerular disorders in diseases classified elsewhere

1364

1870

9.70

307.65

2.6

1.6

1.59

1.52

g/l

1.59

1267

1593

Non-ischemic cardiomyopathy

1810

4065

3.94

307.65

1.9

1.6

1.53

1.59

g/l

1.29

1556

3406

Bacterial infection, other or unspecified

3911

7665

4.96

307.65

1.9

1.5

1.72

1.48

g/l

33.59

3382

6442

Diseases of oesophagus, stomach and duodenum

4350

11394

2.37

307.65

1.8

1.7

1.51

1.53

g/l

0.52

3766

9675

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4538

11213

2.90

307.65

1.9

1.7

1.65

1.45

g/l

28.55

3935

9534

Other bacterial diseases

5455

9638

3.83

307.65

2.0

1.6

1.65

1.43

g/l

36.51

4716

8146

Primary_lymphoid and hematopoietic malignant neoplasms

1793

4497

4.57

307.65

2.3

1.5

1.44

1.57

g/l

5.94

1541

3817

Dialysis, with operation codes

2041

1645

19.36

307.65

2.7

1.6

1.50

1.52

g/l

0.20

1900

1373

Renal tubulo-interstitial diseases

6077

9626

5.19

307.65

2.0

1.6

1.62

1.46

g/l

24.63

5366

8038

Aplastic and other anaemias

5952

6561

10.96

307.65

1.9

1.5

1.53

1.58

g/l

2.66

5133

5499

Thrombocytopenia, unspecified

621

1093

6.96

307.65

2.5

1.7

1.20

1.53

g/l

11.21

527

947

Valvular operations

866

1976

4.90

307.65

2.0

1.5

1.19

1.59

g/l

22.53

622

1675

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2531

8854

2.41

307.65

1.7

1.72

1.51

g/l

22.15

2173

7483

Complications of medical and surgical care

3055

12786

2.29

307.65

2.0

1.7

1.58

1.52

g/l

2.48

2623

10883

Ulcer of lower limb, not elsewhere classified

1114

2668

4.87

307.65

1.9

1.6

1.70

1.56

g/l

4.67

989

2267

Any gastric operation

2848

4378

3.38

307.65

1.9

1.6

1.49

1.39

g/l

4.77

2443

3736

Hypertensive diseases (excluding secondary)

1861

2408

4.70

307.65

2.1

1.6

1.52

1.41

g/l

3.31

1640

2027

Any death

2839

8795

2.44

307.65

1.8

1.6

1.69

1.54

g/l

9.41

2416

7553

Diseases of arteries, arterioles and capillaries (FINNGEN)

1330

7.60

307.65

1.9

1.5

1.65

1.52

g/l

3.23

1154

1108

Other heart diseases, wide

3412

7815

2.77

307.65

1.9

1.7

1.53

1.51

g/l

0.82

2901

6708

Other diseases of blood and blood-forming organs, wide

1281

3669

3.86

307.65

2.2

1.6

1.38

1.57

g/l

8.17

1089

3133

Chronic kidney disease

3897

5113

9.77

307.65

2.2

1.5

1.59

1.54

g/l

1.73

3548

4228

Heart failure and bmi 25plus

2106

3977

3.95

307.65

1.8

1.6

1.64

1.63

g/l

0.22

1807

3333

Polyarthropathies

3317

7588

3.01

307.65

1.7

1.60

1.49

g/l

6.50

2888

6448

General symptoms and signs

4184

8382

2.59

307.65

1.9

1.7

1.53

1.47

g/l

2.75

3599

7118

Renal failure

5175

6987

8.13

307.65

2.1

1.5

1.60

1.54

g/l

3.26

4637

5776

Antihypertensive medication - note that there are other indications

1707

3106

2.99

307.35

2.1

1.8

1.43

1.30

g/l

4.95

1485

2674

Gout, unspecified

1270

4181

3.37

307.32

1.8

1.6

1.63

1.55

g/l

2.48

1128

3539

GI-bleeding

1717

6603

2.79

306.85

1.8

1.6

1.47

1.56

g/l

3.63

1489

5580

Glomerulonephritis

695

1517

5.30

305.46

2.4

1.7

1.55

1.52

g/l

0.38

627

1298

COPD/asthma related infections

3603

8843

2.10

305.26

1.9

1.7

1.60

1.44

g/l

14.35

3130

7530

COPD/asthma/ILD related infections

3603

8843

2.10

305.26

1.9

1.7

1.60

1.44

g/l

14.35

3130

7530

Complications of procedures, not elsewhere classified

3097

12464

2.13

303.99

1.9

1.7

1.57

1.51

g/l

2.67

2656

10620

Atherosclerosis, excluding cerebral and coronary sclerosis

2151

7179

2.53

301.74

1.8

1.6

1.70

1.55

g/l

9.76

1866

6050

Asthma, unspecified (mode), excluding more controls

1726

4833

2.77

297.29

1.7

1.60

1.44

g/l

8.96

1474

4119

Type 1 diabetes

1124

3458

3.45

296.70

2.1

1.7

1.53

1.42

g/l

3.18

1012

2911

Azathioprine

762

1808

4.60

296.11

2.3

1.6

1.48

g/l

0.07

685

1544

Gout, strict definition

1164

3728

3.50

296.05

1.8

1.6

1.67

1.55

g/l

4.03

1026

3169

Hypertensive Heart Disease

1174

2810

3.52

295.89

1.8

1.6

1.62

1.50

g/l

3.28

993

2332

Calcific aortic valvular stenosis, including rheumatic fever

1688

6408

2.76

290.55

1.8

1.6

1.44

1.58

g/l

6.87

1356

5449

Insulin, fast-acting or short human

1714

6742

2.69

290.22

1.9

1.7

1.60

1.51

g/l

3.15

1519

5713

Calcific aortic valvular stenosis

1685

6403

2.76

290.12

1.8

1.6

1.44

1.58

g/l

6.62

1353

5444

Calcific aortic valvular stenosis, operated

1685

6403

2.76

290.12

1.8

1.6

1.44

1.58

g/l

6.62

1353

5444

Operations 2 for CAVS

1683

6396

2.76

289.69

1.8

1.6

1.44

1.58

g/l

6.59

1352

5437

Calcific aortic valvular stenosis, diagnosis (helper)

1683

6396

2.76

289.69

1.8

1.6

1.44

1.58

g/l

6.59

1352

5437

Diabetes medication

3689

11233

2.00

288.43

1.8

1.7

1.64

1.46

g/l

21.90

3211

9507

Lymphoid leukaemia

525

959

6.92

288.29

2.9

1.7

1.23

1.52

g/l

8.67

457

829

Other medical care

1974

7403

2.52

288.01

1.8

1.6

1.67

1.54

g/l

6.30

1697

6208

STROKE

1884

5054

2.63

286.05

1.8

1.7

1.57

1.53

g/l

0.82

1605

4260

Hernia of abdominal wall, postoperative

737

1741

4.51

285.63

1.7

1.4

1.58

1.46

g/l

2.41

634

1480

Other disorders of kidney and ureter

841

2247

4.24

282.68

2.2

1.7

1.58

1.56

g/l

0.25

756

1930

Chronic lymphocytic leukaemia

346

419

11.80

281.68

3.3

1.6

1.22

1.54

g/l

6.02

306

360

Chronic lymphocytic leukaemia, helper endpoint

346

419

11.80

281.68

3.3

1.6

1.22

1.54

g/l

6.02

306

360

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

346

419

11.80

281.68

3.3

1.6

1.22

1.54

g/l

6.02

306

360

Certain infectious and parasitic diseases

2473

5382

2.36

278.97

1.8

1.6

1.58

1.42

g/l

11.06

2146

4546

Benign neoplasm: Colon

2403

10631

2.27

278.27

1.7

1.6

1.58

g/l

0.02

2082

8996

Diarrhoea and gastroenteritis of presumed infectious origin

2681

11570

2.16

277.91

2.0

1.7

1.54

1.50

g/l

1.65

2316

9834

Autoimmune diseases related-to ILD

3138

13578

2.04

277.68

1.9

1.7

1.57

1.51

g/l

3.03

2700

11588

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

907

2581

3.94

277.34

1.9

1.7

1.12

1.58

g/l

40.21

765

2217

Non-invasive ventilation

836

1929

4.06

276.40

1.9

1.7

1.59

1.43

g/l

3.97

736

1652

Hypertensive Renal Disease

362

468

9.79

273.94

2.2

1.6

1.62

1.49

g/l

1.34

343

385

Hyperkalaemia

490

872

6.81

273.72

2.2

1.7

1.55

1.49

g/l

0.61

432

739

Conduction disorders

1299

3598

3.10

273.54

1.6

1.53

1.60

g/l

1.38

1092

3055

Opioids

3303

8522

2.06

272.52

1.8

1.55

1.43

g/l

8.73

2836

7258

Codeine

3147

8418

2.09

269.39

1.8

1.56

1.43

g/l

9.94

2700

7170

Type 1 diabetes, wide definition, subgroup 1

911

2621

3.70

267.55

2.0

1.7

1.54

1.40

g/l

3.44

816

2220

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2458

11536

2.19

265.97

2.0

1.6

1.58

1.53

g/l

1.65

2106

9824

Endocrine, nutritional and metabolic diseases

2485

5603

2.30

265.86

1.9

1.7

1.50

1.40

g/l

5.36

2152

4716

Osteopathies and chondropathies

2248

9588

2.28

265.05

1.9

1.7

1.59

1.54

g/l

1.34

1950

8124

Coronary atherosclerosis

2494

7280

2.26

264.96

1.7

1.62

1.59

g/l

0.45

2142

6187

Hypo-osmolality and hyponatraemia

946

2824

3.64

263.30

1.7

1.6

1.58

1.56

g/l

0.26

826

2378

Pain in limb

3031

10140

2.06

263.25

1.9

1.7

1.55

1.50

g/l

1.63

2613

8617

Syncope and collapse

1752

6227

2.51

253.92

1.7

1.6

1.55

1.51

g/l

0.91

1471

5256

Disorders of lens

2534

7457

2.20

253.82

1.8

1.7

1.56

1.58

g/l

0.33

2205

6353

Parasetamol

2438

5599

2.26

250.57

1.8

1.53

1.38

g/l

9.21

2102

4776

Other bacterial intestinal infections

967

3037

3.46

250.33

2.1

1.6

1.62

1.55

g/l

1.31

847

2571

Persons encountering health services in other circumstances, wide

4138

11819

1.85

247.18

1.8

1.7

1.51

1.53

g/l

0.43

3602

9991

Intestinal infectious diseases

4076

12973

1.84

246.51

1.9

1.7

1.54

1.51

g/l

0.77

3505

11041

Asthma, unspecified (mode)

1810

5784

2.43

241.46

1.7

1.61

1.44

g/l

10.38

1545

4910

Other bacterial intestinal infections

1104

3815

3.10

241.16

2.1

1.6

1.60

1.55

g/l

0.86

963

3239

Type 1 diabetes, wide definition

930

2902

3.39

239.91

2.0

1.7

1.53

1.41

g/l

3.29

834

2449

Hypothyroidism (congenital or acquired)

610

656

5.40

239.88

2.1

1.8

1.37

1.09

g/l

8.09

520

569

Symptoms and signs involving the urinary system

2927

11560

1.99

237.08

1.8

1.7

1.58

1.54

g/l

1.22

2480

9861

AV-block

900

2394

3.55

236.95

1.6

1.5

1.53

1.60

g/l

1.30

760

2012

Other soft tissue disorders, not elsewhere classified

3328

10341

1.94

236.65

1.8

1.7

1.53

1.49

g/l

1.43

2863

8794

Bacterial intestinal infections, IBD co-morbidities

982

3229

3.30

235.66

2.1

1.6

1.62

1.55

g/l

1.25

860

2736

Chronic gastritis

1301

4967

2.79

235.34

1.7

1.6

1.48

1.59

g/l

3.90

1118

4183

Explicit bacterial Sepsis

612

1474

4.61

234.93

2.3

1.6

1.64

1.49

g/l

2.48

521

1240

Major coronary heart disease event excluding revascularizations

2360

7505

2.18

233.71

1.7

1.65

1.59

g/l

2.04

2045

6375

Streptococcal septicaemia

542

1201

5.10

232.42

2.3

1.6

1.66

1.44

g/l

4.71

466

1012

Bacterial pneumoniae

1674

6295

2.45

230.90

1.8

1.6

1.68

1.48

g/l

12.89

1460

5309

Abnormal findings on examination of blood, without diagnosis

2066

8889

2.24

230.90

1.8

1.7

1.64

1.53

g/l

4.35

1782

7557

Implicit fungal Sepsis

454

878

5.99

229.58

1.9

1.6

1.58

1.49

g/l

1.01

392

747

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

414

746

6.85

229.45

2.0

1.6

1.43

1.51

g/l

0.75

348

637

Hypothyroidism, levothyroxine purchases

594

653

5.29

228.85

2.1

1.8

1.36

1.09

g/l

7.61

506

566

Hypothyroidism and >3 levothyroxin purchases

594

653

5.29

228.85

2.1

1.8

1.36

1.09

g/l

7.61

506

566

Haemorrhage from respiratory passages

1515

5623

2.55

227.71

1.8

1.6

1.46

1.57

g/l

4.36

1291

4770

Acute myeloid leukaemia and myelodysplastic syndromes

254

271

13.39

227.27

2.0

1.6

1.27

1.52

g/l

2.80

219

231

Failure and rejection of transplanted organs and tissues

188

125

23.58

226.84

3.0

1.7

1.37

1.49

g/l

0.63

175

112

Nausea and vomiting

1216

4454

2.83

226.78

2.1

1.6

1.55

1.54

g/l

0.16

1053

3759

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3845

11717

1.83

225.02

1.9

1.7

1.52

1.53

g/l

0.21

3340

9919

Paroxysmal tachycardia

697

1512

4.03

224.67

2.1

1.6

1.46

1.44

g/l

0.23

591

1261

Finngen Rheumatological endpoints

3166

9551

1.93

222.52

1.8

1.57

1.46

g/l

7.12

2705

8147

Endocarditis

313

434

8.94

222.47

2.2

1.5

1.43

1.52

g/l

0.69

254

371

Ischaemic heart disease, wide definition

2770

8785

2.02

222.27

1.7

1.61

1.57

g/l

1.44

2392

7447

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2586

11894

2.02

222.15

1.8

1.6

1.62

1.55

g/l

2.79

2172

10129

Enterocolitis due to Clostridium difficile

685

1882

4.09

220.70

2.2

1.7

1.65

1.53

g/l

2.07

604

1593

Cardiomyopathy

791

2363

3.60

220.62

1.8

1.6

1.54

1.58

g/l

0.57

683

2003

Bacterial pneumonia, not elsewhere classified

1597

6023

2.44

218.38

1.8

1.6

1.67

1.48

g/l

11.94

1399

5073

Pain in throat and chest

2750

8445

2.00

217.75

1.7

1.52

1.51

g/l

0.29

2336

7226

Gastroduodenal ulcer

1269

4959

2.72

217.63

1.8

1.6

1.54

1.57

g/l

0.48

1094

4159

Diaphragmatic hernia

1583

6862

2.44

217.55

1.6

1.62

1.59

g/l

0.59

1361

5837

Myocardial infarction

1963

6341

2.28

217.24

1.7

1.69

1.60

g/l

3.24

1715

5388

Codeine or tramadol medication

3906

12192

1.79

216.21

1.7

1.8

1.58

1.49

g/l

7.50

3361

10392

Adjustment and management of implanted device

988

3429

3.13

215.91

1.8

1.5

1.43

1.53

g/l

2.69

863

2890

Type 2 diabetes, definitions combined

3121

9855

1.91

212.33

1.8

1.7

1.66

1.47

g/l

19.40

2681

8323

Gastrointestinal diseases

1694

3511

2.47

211.64

1.9

1.7

1.47

1.48

g/l

0.08

1469

2971

Care involving use of rehabilitation procedures

2129

9542

2.11

211.42

1.7

1.6

1.57

1.51

g/l

2.21

1859

8015

Reimbursement for rheumatic diseases

2101

10223

2.12

211.40

1.7

1.58

1.53

g/l

1.58

1788

8716

Systemic connective tissue disorders

1485

6342

2.47

210.70

2.2

1.6

1.69

1.55

g/l

5.76

1288

5390

Infections of the skin and subcutaneous tissue

2115

10264

2.11

210.56

1.9

1.7

1.58

1.49

g/l

3.94

1841

8777

Type 2 diabetes, strict (exclude DM1)

3136

9948

1.90

210.43

1.8

1.7

1.66

1.47

g/l

19.37

2695

8406

Fall on same level

3807

11861

1.79

210.02

1.7

1.8

1.52

1.50

g/l

0.56

3282

10135

Asthma, excluding more controls

2128

5151

2.21

208.38

1.7

1.57

1.42

g/l

9.70

1841

4400

Gastric ulcer

930

3183

3.16

207.80

1.8

1.6

1.55

1.56

g/l

0.21

796

2673

Disorders of choroid and retina

3032

11790

1.89

205.53

1.8

1.7

1.54

1.56

g/l

0.40

2603

9995

Other pulmonary diagnosis

2501

6209

2.07

205.45

1.8

1.7

1.56

1.42

g/l

8.05

2161

5276

Amputation

657

1872

3.96

201.07

2.1

1.7

1.80

1.52

g/l

9.29

577

1573

Excluding asthma or asthma-COPD overlap

2486

6209

2.05

200.95

1.8

1.7

1.55

1.42

g/l

7.45

2150

5276

Nephrotic syndrome

283

395

9.08

200.93

2.4

1.9

1.53

1.49

g/l

0.22

258

350

Multiple myeloma, including Hilmo

371

685

6.62

200.08

2.4

1.6

1.36

1.51

g/l

1.98

334

584

Genitourinary diseases

1835

4065

2.32

199.61

2.0

1.6

1.49

1.47

g/l

0.47

1601

3370

Depression medications

621

687

4.65

198.89

1.9

1.8

1.44

1.09

g/l

12.60

543

597

Fibrosis and cirrhosis of liver

505

1206

4.82

198.61

2.0

1.8

1.08

1.57

g/l

23.70

431

1053

Cytomegalovirus infection, IBD co-morbidity

226

244

12.33

198.40

3.0

2.0

1.45

1.53

g/l

0.41

205

212

COPD differential diagnosis

2470

6211

2.04

196.05

1.8

1.7

1.55

1.43

g/l

6.74

2137

5289

ILD differential diagnosis

2469

6211

2.04

195.73

1.8

1.7

1.55

1.43

g/l

6.76

2136

5289

Other disorders involving the immune mechanism, not elsewhere classified

277

393

8.87

193.62

2.7

2.1

1.41

1.44

g/l

0.17

248

343

Cystic kidney disease

282

410

8.64

192.83

1.9

2.0

1.49

1.48

g/l

0.06

264

360

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2184

11185

2.02

192.50

2.0

1.6

1.57

1.53

g/l

0.85

1859

9515

Other/unspecified cytomegaloviral diseases

208

211

13.59

191.86

3.1

2.0

1.45

1.54

g/l

0.41

188

183

Other gastritis (incl. Duodenitis)

1022

3829

2.84

191.81

1.8

1.6

1.48

1.57

g/l

1.99

886

3240

Other and unspecified acquired haemolytic anaemias

165

122

25.07

191.35

6.7

1.8

0.72

1.54

g/l

11.75

107

106

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

264

362

9.25

190.38

2.7

2.1

1.40

1.43

g/l

0.17

236

315

Polycystic kidney disease

252

329

9.92

190.11

1.8

2.1

1.50

1.48

g/l

0.13

238

288

Vascular disorders of the intestines

471

1104

4.90

189.43

2.1

1.6

1.52

1.54

g/l

0.13

407

939

Other arrhythmias

1867

6718

2.15

188.12

1.8

1.6

1.48

1.54

g/l

1.77

1590

5732

Type 2 diabetes, definitions combined, including avohilmo

3051

9854

1.85

188.04

1.8

1.7

1.65

1.47

g/l

19.01

2606

8326

Senile cataract

2255

6975

2.05

188.01

1.8

1.6

1.57

1.59

g/l

0.36

1947

5925

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

484

737

4.99

187.66

2.1

1.6

1.62

1.50

g/l

1.31

412

619

Other retinal disorders

2515

10478

1.94

187.34

1.8

1.7

1.55

1.57

g/l

0.41

2169

8876

Fungal Sepsis

314

527

7.18

186.00

2.0

1.7

1.65

1.46

g/l

1.82

269

450

Other (not insulin) diabetes medications

3190

10698

1.81

185.70

1.7

1.69

1.48

g/l

26.22

2745

9038

Cytomegaloviral disease

226

266

11.11

185.49

3.0

2.0

1.45

1.55

g/l

0.63

205

231

Asthma (only as main-diagnosis), excluding more controls

1909

5151

2.17

184.16

1.6

1.7

1.58

1.42

g/l

9.71

1635

4400

Diabetic maculopathy, excluding more controls

567

1540

4.03

183.99

2.0

1.7

1.61

1.46

g/l

2.88

509

1307

Cystic kidney disease

289

459

7.77

181.58

1.9

1.48

1.46

g/l

0.16

270

402

Cirrhosis of liver, NAS

403

873

5.52

180.85

2.1

1.8

1.00

1.56

g/l

23.58

341

759

Other special examinations and investigations of persons without complaint or reported diagnosis

2117

5245

2.09

180.48

1.9

1.6

1.50

1.52

g/l

0.54

1809

4417

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

997

1691

3.03

180.45

1.9

1.7

1.51

1.38

g/l

3.29

879

1427

Rheumatoid arthritis

1253

4717

2.49

179.87

1.5

1.7

1.64

1.53

g/l

3.13

1068

3988

Symptoms and signs involving the circulatory and respiratory systems

3109

8700

1.83

179.84

1.9

1.7

1.49

g/l

0.03

2672

7455

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

518

1361

4.33

178.88

1.7

2.01

1.53

g/l

15.09

435

1165

Chronic nephritic syndrome

306

525

7.05

177.51

2.3

1.9

1.55

1.52

g/l

0.19

276

457

Peripheral artery operations in Hilmo

737

2436

3.32

176.19

2.0

1.6

1.79

1.54

g/l

8.94

657

2048

Diabetic retinopathy, excluding more controls

1184

2609

2.72

175.55

1.9

1.7

1.64

1.62

g/l

0.24

1056

2199

Diseases of the skin and subcutaneous tissue

3281

9423

1.78

175.15

1.9

1.7

1.52

1.49

g/l

0.64

2799

8007

Hyperlipidaemia, other/unspecified

1528

6531

2.25

174.36

1.7

1.6

1.59

1.56

g/l

0.85

1304

5506

Enlarged lymph nodes

649

1983

3.48

173.94

2.0

1.6

1.63

1.50

g/l

2.12

550

1701

Diarrhoea and gastroenteritis of presumed infectious origin

3346

12966

1.74

173.74

1.9

1.7

1.52

1.51

g/l

0.36

2877

11040

Myocardial infarction, without ST-elevation

1831

8331

2.10

173.57

1.6

1.68

1.55

g/l

7.00

1584

7014

Congenital malformations of the urinary system

359

722

5.69

173.29

1.9

1.50

1.48

g/l

0.18

325

634

Sub-endpoint used in defining T1D endpoints

1193

4944

2.48

173.25

2.0

1.7

1.56

1.49

g/l

1.45

1076

4158

Viral pneumonia

616

1835

3.63

173.23

2.2

1.6

1.60

1.46

g/l

2.89

540

1550

Unspecified haematuria

1780

7242

2.13

172.70

1.8

1.6

1.56

1.55

g/l

0.17

1522

6179

Pre-eclampsia

650

1992

3.43

172.51

3.2

1.7

1.13

1.53

g/l

20.88

589

1707

Cardiomyopathies, Primary/intrinsic

569

1615

3.81

172.38

1.8

1.6

1.53

1.58

g/l

0.59

492

1370

Disorders of gallbladder, biliary tract and pancreas

3363

12497

1.74

171.95

1.8

1.7

1.52

1.54

g/l

0.62

2901

10630

L01XX Other antineoplastic agents

429

1018

4.99

171.88

2.2

1.8

1.07

1.55

g/l

21.43

376

875

Other cataract

1673

6030

2.18

171.57

1.8

1.6

1.51

1.58

g/l

2.01

1468

5100

Peripheral arterial reconstruction

951

3682

2.81

169.88

1.7

1.6

1.74

1.54

g/l

8.66

828

3113

Bacterial pneumonia (organism specified)

1819

8251

2.08

169.76

1.9

1.6

1.67

1.52

g/l

8.66

1587

6975

IgA nephropathy (IgA glomerulonephritis)

226

297

9.84

169.55

2.9

2.2

1.38

1.48

g/l

0.73

205

254

Congenital malformations of the urinary system

371

783

5.38

169.12

1.9

1.50

1.49

g/l

0.07

335

686

Gastro-oesophageal reflux disease

2233

10281

1.93

169.11

1.7

1.58

1.55

g/l

0.93

1899

8730

Cardiomyopathy (excluding other)

576

1671

3.72

168.68

1.8

1.6

1.53

1.58

g/l

0.58

499

1418

Pacemaker

1564

7172

2.21

168.57

1.8

1.6

1.47

1.58

g/l

4.62

1310

6077

COPD (mode)

1199

3943

2.50

168.46

1.6

1.72

1.50

g/l

11.40

1039

3302

Implicit fungal Sepsis

285

481

7.13

167.87

2.0

1.7

1.63

1.47

g/l

1.38

245

412

Malignant neoplasm

2656

8663

1.86

167.65

1.8

1.7

1.58

1.51

g/l

3.00

2283

7397

Myocardial infarction, strict

1752

6079

2.14

167.25

1.6

1.7

1.69

1.60

g/l

2.91

1534

5166

Myelodysplastic syndrome

165

151

17.75

166.52

2.2

1.7

1.05

1.58

g/l

7.30

141

133

Pregnancy hypertension

1133

4198

2.50

166.35

2.7

1.7

1.20

1.51

g/l

23.77

1013

3608

Other arthritis (FG)

1125

4718

2.49

165.20

1.7

1.67

1.49

g/l

6.09

951

4036

Pre-eclampsia or eclampsia

686

2231

3.23

164.94

3.1

1.6

1.15

1.53

g/l

20.24

621

1913

Non-Hodgkin lymphoma, all, including Hilmo

668

2167

3.36

164.51

2.0

1.5

1.60

1.55

g/l

0.58

550

1839

Disorders of mineral metabolism

439

1079

4.50

164.10

2.0

1.8

1.59

1.51

g/l

0.84

379

934

All influenza

974

3843

2.66

163.39

2.0

1.6

1.54

1.46

g/l

1.68

834

3245

Malignant neoplasm, wide definition for exclusion

2693

8825

1.83

162.24

1.8

1.7

1.58

1.50

g/l

2.95

2309

7535

Asthma

2243

6149

1.95

160.72

1.7

1.57

1.43

g/l

9.72

1934

5231

Volume depletion

529

1519

3.83

158.60

1.9

1.7

1.62

1.50

g/l

1.93

453

1288

Multiple myeloma and malignant plasma cell neoplasms

374

854

5.27

158.01

2.3

1.7

1.39

1.55

g/l

2.44

335

735

Amputation of toe

483

1335

4.15

155.93

2.0

1.7

1.77

1.51

g/l

6.42

427

1141

Cerebrovascular diseases

2690

10844

1.80

155.90

1.8

1.6

1.60

1.56

g/l

1.32

2291

9229

Neoplasms

2126

5856

1.96

155.16

1.9

1.8

1.45

1.43

g/l

0.26

1842

5030

Ascites

437

1126

4.35

154.15

2.0

1.7

1.22

1.52

g/l

7.19

361

971

Exposure to unspecified factor

3253

14189

1.68

153.39

1.8

1.7

1.51

g/l

0.01

2791

12110

Other and unspecified aplastic anaemias

141

112

18.36

153.13

2.6

1.6

1.22

1.43

g/l

1.17

117

Symptoms and signs involving cognition, perception, emotional state and behaviour

3163

12968

1.70

152.18

1.7

1.51

1.53

g/l

0.49

2699

11080

Abnormal findings on diagnostic imaging of lung

1917

9773

1.95

151.35

1.8

1.6

1.66

1.56

g/l

3.57

1620

8323

Hypothyroidism, drug reimbursement

309

369

6.10

151.31

2.1

1.6

1.44

1.13

g/l

5.04

265

319

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

672

2201

3.15

151.31

2.0

1.8

1.40

1.49

g/l

1.61

565

1906

Factors influencing health status and contact with health services

914

1643

2.87

150.63

1.9

1.5

1.53

1.56

g/l

0.34

795

1390

Other diseases of pleura

1893

8768

1.97

150.62

1.8

1.6

1.67

1.55

g/l

5.32

1603

7424

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

704

2378

3.05

150.42

2.0

1.7

1.40

1.50

g/l

1.97

586

2056

Symptoms and signs involving the digestive system and abdomen

3259

9746

1.71

150.36

1.8

1.7

1.50

1.53

g/l

0.88

2784

8293

Any event in cancer register

2799

9536

1.77

150.09

1.8

1.7

1.56

1.50

g/l

2.47

2410

8147

Asthma (mode)

2183

6211

1.92

150.08

1.7

1.56

1.43

g/l

8.23

1869

5289

Persons encountering health services for examination and investigation

2029

5245

1.98

149.73

1.8

1.6

1.50

1.52

g/l

0.39

1751

4417

Other specified/unspecified arthritis

996

4139

2.51

149.46

1.7

1.67

1.50

g/l

4.96

844

3532

Hypokalaemia

554

1701

3.52

148.62

1.7

1.6

1.72

1.52

g/l

4.27

476

1446

Certain disorders involving the immune mechanism

785

2930

2.85

148.46

2.2

1.7

1.46

1.54

g/l

1.59

674

2521

Alcohol use disorder, Swedish definition

1955

9619

1.92

147.78

1.6

1.7

1.52

1.53

g/l

0.21

1666

8210

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1212

4716

2.30

147.77

2.6

1.7

1.21

1.52

g/l

25.10

1083

4047

Other disorders of urethra and urinary system

2350

9507

1.83

147.19

1.7

1.57

1.50

g/l

3.00

2005

8093

Myeloproliferative diseases

484

1385

3.92

147.17

1.8

1.7

1.11

1.54

g/l

20.85

415

1190

Use of hypnotics and sedatives

3438

12128

1.66

146.89

1.7

1.57

1.52

g/l

2.46

2953

10341

Biguanides

3074

11242

1.70

145.91

1.7

1.69

1.48

g/l

25.71

2636

9538

Other nutritional deficiencies

2065

10660

1.87

145.71

1.8

1.63

1.48

g/l

10.19

1767

9196

Pre-eclampsia or poor fetal growth

822

3134

2.71

145.46

3.0

1.7

1.16

1.45

g/l

16.00

739

2695

Other necrotizing vasculopathies

435

1174

4.19

144.51

3.1

1.7

1.84

1.52

g/l

6.44

376

1005

Other diseases of urinary system

3271

11189

1.68

144.40

1.7

1.55

1.50

g/l

2.46

2811

9550

Hernia

3009

12137

1.70

143.97

1.7

1.54

1.55

g/l

0.15

2576

10341

Agranulocytosis

535

1646

3.54

143.75

1.8

1.7

1.51

1.57

g/l

0.57

461

1411

Asthma (only as main-diagnosis)

2012

6149

1.93

143.74

1.6

1.7

1.58

1.43

g/l

9.94

1719

5231

3691

11922

1.63

143.51

1.8

1.7

1.53

1.51

g/l

0.62

3157

10171

Benign neoplasms

3105

10277

1.70

143.27

1.8

1.7

1.51

1.49

g/l

0.45

2655

8790

Constipation

2969

12372

1.70

143.10

1.7

1.53

1.55

g/l

0.53

2483

10588

Substance abuse, excluding more controls

1906

8707

1.92

142.46

1.6

1.7

1.58

1.50

g/l

3.06

1639

7458

Disorders of other endocrine glands

1517

7481

2.06

142.02

2.0

1.7

1.55

1.52

g/l

0.70

1318

6383

Headache

1790

7462

1.96

141.94

1.8

1.7

1.49

1.46

g/l

0.73

1540

6354

Sulfasalazine

984

4167

2.46

141.25

1.5

1.6

1.56

1.50

g/l

1.12

843

3542

Polyneuropathies and other disorders of the peripheral nervous system

985

4232

2.48

139.33

2.1

1.6

1.58

1.56

g/l

0.22

853

3598

Cellulitis

870

3519

2.60

139.20

1.9

1.7

1.59

1.51

g/l

1.46

760

3000

Statin medication

1877

5508

1.96

137.79

1.9

1.8

1.54

1.43

g/l

4.86

1629

4629

Disorders of calcium metabolism

346

813

4.75

137.69

2.1

1.8

1.70

1.51

g/l

2.60

301

698

Insulin, fast-acting (human)

570

1862

3.24

136.91

2.0

1.7

1.45

1.46

g/l

0.11

518

1584

2085

10269

1.84

136.83

1.6

1.7

1.53

1.52

g/l

0.06

1773

8784

2015

10098

1.86

136.68

1.6

1.7

1.53

g/l

0.01

1716

8624

Angina pectoris

1921

6881

1.92

136.20

1.6

1.7

1.57

1.60

g/l

0.56

1634

5841

SLE (Finngen)

207

309

7.69

135.71

2.4

1.5

1.55

1.50

g/l

0.21

186

268

Alcoholic liver disease

525

1659

3.48

135.71

1.7

1.16

1.58

g/l

21.08

426

1430

Osteoporosis

1084

4554

2.35

135.41

2.1

1.6

1.56

1.60

g/l

0.60

921

3848

Other and unspecified polyneuropathies, also in other diseases

887

3688

2.57

135.33

2.1

1.7

1.58

1.56

g/l

0.24

766

3144

Other diseases of pericardium

267

514

5.92

135.32

1.9

1.6

1.64

1.55

g/l

0.67

217

441

Bronchitis

3448

13691

1.62

135.23

1.9

1.7

1.51

g/l

0.00

2963

11677

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

226

379

7.42

135.13

2.5

1.6

1.44

1.57

g/l

0.94

208

326

Multiple myeloma

226

379

7.42

135.13

2.5

1.6

1.44

1.57

g/l

0.94

208

326

Other necrotizing vasculopathies (FG)

350

848

4.65

134.35

2.2

1.7

1.91

1.47

g/l

8.92

308

719

Asthma-related pneumonia or sepsis

1440

7252

2.06

133.60

1.8

1.7

1.67

1.53

g/l

6.75

1228

6124

Asthma, hospital admissions 3, pneumonia

1440

7252

2.06

133.60

1.8

1.7

1.67

1.53

g/l

6.75

1228

6124

Seropositive rheumatoid arthritis

926

3908

2.47

133.30

1.5

1.6

1.61

1.54

g/l

1.41

798

3314

Asthma-related pneumonia

1437

7239

2.06

133.24

1.8

1.7

1.67

1.53

g/l

6.62

1225

6113

Myeloid leukaemia

229

396

7.19

132.82

1.8

2.0

1.42

1.57

g/l

1.09

202

350

Pain, not elsewhere classified

876

3616

2.51

132.66

1.7

1.6

1.58

1.48

g/l

2.13

757

3088

Disorders of parathyroid gland

899

3735

2.52

132.63

2.2

1.6

1.58

1.59

g/l

0.08

787

3153

Other systemic involvement of connective tissue (FG)

936

3937

2.45

132.58

2.0

1.7

1.68

1.52

g/l

4.46

806

3334

Cardiomyopathy, other and unspecified

373

956

4.27

131.44

1.9

1.6

1.62

1.60

g/l

0.15

328

822

Symptoms and signs concerning food and fluid intake

458

1344

3.65

131.23

1.5

1.6

1.48

1.51

g/l

0.33

399

1149

Other diseases of intestine

619

2184

3.03

130.52

1.7

1.6

1.63

1.56

g/l

0.89

538

1853

Convulsions, not elsewhere classified

770

2979

2.65

129.97

1.9

1.7

1.47

1.45

g/l

0.20

656

2541

Noninfective enteritis and colitis

1560

8151

1.97

129.24

1.8

1.7

1.53

1.51

g/l

0.38

1359

6962

Acute peritonitis

380

1015

4.21

127.89

2.2

1.8

1.56

1.51

g/l

0.37

356

878

Oesophageal varices

283

610

5.43

127.20

2.0

1.7

0.99

1.61

g/l

21.76

241

522

508

1625

3.31

126.34

2.4

1.7

1.49

1.50

g/l

0.07

444

1372

Falls/tendency to fall

3267

10247

1.62

124.88

1.7

1.8

1.50

g/l

0.16

2803

8782

Other diseases of liver

696

2680

2.75

123.58

1.9

1.7

1.32

1.57

g/l

9.22

593

2313

Other diseases of anus and rectum

1102

5172

2.21

123.33

1.7

1.6

1.53

1.56

g/l

0.37

938

4370

Osteomyelitis

375

1020

4.12

122.90

2.1

1.8

1.80

1.52

g/l

5.55

340

885

Other functional intestinal disorders

1490

7220

1.97

122.40

1.7

1.6

1.53

1.52

g/l

0.11

1275

6087

Cutaneous abscess, furuncle and carbuncle

911

3984

2.38

121.91

2.0

1.7

1.61

1.49

g/l

2.94

787

3397

Acute posthaemorrhagic anaemia

218

385

6.51

121.42

1.9

1.42

1.51

g/l

0.64

179

329

Hepatic failure, not elsewhere classified

259

540

5.63

121.11

1.9

1.11

1.57

g/l

9.57

197

470

Disorders of thyroid, IBD co-morbidities

515

1122

3.33

120.94

1.8

1.7

1.50

1.37

g/l

2.00

436

953

Charcot foot

151

184

10.28

119.84

2.2

2.1

1.64

1.42

g/l

1.58

138

157

Myeloproliferative diseases (CML excluded)

423

1271

3.71

119.33

1.8

1.08

1.53

g/l

19.50

361

1090

General examination and investigation of persons without complaint and reported diagnosis

1849

5227

1.88

119.26

1.8

1.6

1.51

1.52

g/l

0.12

1571

4404

Obesity due to excess calories

1448

7607

1.96

118.39

1.8

1.67

1.47

g/l

12.29

1247

6575

Retention of urine

1411

5992

2.01

118.15

1.6

1.63

1.54

g/l

2.76

1191

5100

Venous thromboembolism

1958

10906

1.79

118.13

2.0

1.6

1.66

1.55

g/l

5.38

1705

9205

Chronic tubulo-interstitial nephritis

214

384

6.30

116.69

2.1

1.6

1.46

1.48

g/l

0.10

195

328

Rheumatoid arthritis, including avohilmo

1344

6939

2.01

116.63

1.5

1.7

1.63

1.56

g/l

1.62

1152

5914

Mental and behavioural disorders due to psychoactive substance use

1961

10506

1.77

115.69

1.6

1.8

1.58

1.51

g/l

2.45

1684

8978

Asthma, hospital admission 2, infections

1947

11034

1.77

115.42

1.7

1.64

1.50

g/l

8.36

1668

9381

Asthma-related infections

1947

11034

1.77

115.42

1.7

1.64

1.50

g/l

8.36

1668

9381

Pulmonary heart disease, diseases of pulmonary circulation

1268

6456

2.05

115.19

2.1

1.6

1.66

1.56

g/l

2.97

1095

5464

Other disorders of white blood cells

317

802

4.46

115.13

2.2

1.8

1.36

1.53

g/l

2.57

268

691

Substance abuse

1906

10312

1.78

114.42

1.6

1.7

1.58

1.51

g/l

2.09

1639

8806

Obesity

1871

10344

1.79

114.35

1.8

1.67

1.47

g/l

15.57

1604

8921

Injuries to the head

3430

13799

1.55

113.78

1.7

1.8

1.50

1.52

g/l

0.39

2929

11787

Abdominal and pelvic pain

3072

9746

1.61

113.72

1.8

1.7

1.51

1.53

g/l

0.42

2621

8293

Presence of other functional implants

1949

7734

1.80

113.62

1.8

1.6

1.55

1.60

g/l

1.45

1644

6551

Obesity and other hyperalimentation

1877

10392

1.78

113.54

1.8

1.67

1.47

g/l

15.57

1608

8966

Persons encountering health services for specific procedures, not carried out

351

957

3.94

112.68

1.8

1.7

1.61

1.44

g/l

2.40

309

833

Other and unspecified disorders of white blood cells

255

565

5.20

110.43

2.4

1.8

1.29

1.53

g/l

3.55

217

487

Follow-up examination after treatment for conditions other than malignant neoplasms

1288

4289

2.03

109.54

1.7

1.6

1.52

g/l

0.03

1138

3624

Coronary artery bypass grafting

1092

3925

2.17

109.24

1.7

1.6

1.61

1.59

g/l

0.29

921

3309

Pain in joint

1781

6355

1.83

109.07

1.7

1.56

1.52

g/l

1.05

1546

5401

Hyperparathyroidism

778

3321

2.45

108.31

2.1

1.6

1.60

1.59

g/l

0.13

683

2798

Persons encountering health services in other circumstances

1256

6448

1.99

108.17

1.9

1.7

1.54

1.50

g/l

0.71

1098

5478

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

183

303

6.71

107.88

2.0

1.7

1.44

1.55

g/l

0.67

170

257

Gestational [pregnancy-induced] hypertension

633

2470

2.64

107.24

2.6

1.7

1.21

1.47

g/l

10.90

570

2111

Paralytic ileus and intestinal obstruction

954

4484

2.21

107.09

1.8

1.6

1.66

1.56

g/l

2.36

829

3772

SLE, strict definition

205

386

6.10

106.79

2.4

1.9

1.55

g/l

0.00

184

334

SLE, ICD10

205

386

6.10

106.79

2.4

1.9

1.55

g/l

0.00

184

334

Left ventricular outflow tract obstruction (LVOTO), broad definition

422

1346

3.37

106.49

2.1

1.8

1.30

1.51

g/l

3.40

290

1175

Dizziness and giddiness

2401

11797

1.65

105.91

1.7

1.51

1.54

g/l

0.87

2057

10069

Other disorders of skin and subcutaneous tissue, not elsewhere classified

604

2351

2.73

105.48

1.9

1.6

1.70

1.55

g/l

2.95

528

2002

Vocal cord dysfunction

352

876

3.73

105.31

1.8

1.6

1.67

1.41

g/l

3.89

300

733

Later onset COPD, excluding more controls

869

3010

2.35

105.20

1.5

1.73

1.50

g/l

9.58

752

2520

Other diseases of blood and blood-forming organs

352

1017

3.82

105.02

2.4

1.8

1.20

1.54

g/l

8.24

301

875

Systemic lupus erythematosus

207

399

5.92

104.93

2.4

1.8

1.55

1.52

g/l

0.13

186

344

Other antidepressants

3266

10946

1.55

104.52

1.6

1.8

1.55

1.50

g/l

1.85

2794

9367

Other noninfective gastroenteritis and colitis

875

4021

2.26

103.88

1.9

1.7

1.55

1.52

g/l

0.32

771

3420

Idiopathic thrombocytopenic purpura

202

388

6.09

103.52

2.6

1.9

1.14

1.52

g/l

6.59

171

345

Chronic periodontitis, including avohilmo

2982

13011

1.57

103.41

1.9

1.7

1.56

1.54

g/l

0.66

2570

11093

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3003

12517

1.56

103.25

1.8

1.7

1.51

1.55

g/l

1.81

2574

10655

Periodontitis

2988

13019

1.56

103.21

1.9

1.7

1.57

1.54

g/l

0.90

2575

11101

Viral infections characterized by skin and mucous membrane lesions

1365

7368

1.91

102.74

1.9

1.7

1.52

g/l

0.07

1203

6291

Abnormalities of heart beat

1138

5669

2.03

102.37

1.8

1.7

1.53

g/l

0.02

965

4807

Injuries to the abdomen, lower back, lumbar spine and pelvis

1400

7562

1.89

101.96

1.9

1.7

1.51

1.53

g/l

0.46

1167

6440

Chronic myeloproliferative disease

149

224

9.21

100.99

2.4

1.9

0.85

1.48

g/l

13.47

131

201

Other and unspecified diseases of blood and blood-forming organs

188

348

6.44

100.76

2.8

1.8

1.25

1.53

g/l

3.04

166

302

Neurological diseases, wide definition

733

1455

2.58

100.63

1.9

1.8

1.46

1.31

g/l

3.39

640

1238

Viral hepatitis, IBD co-morbidity

182

318

6.06

100.31

1.7

1.8

1.44

1.32

g/l

0.69

146

261

Idiopathic gout

480

1720

3.05

100.01

1.7

1.72

1.55

g/l

3.39

430

1467

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

104

102

15.76

99.76

2.5

1.6

1.41

1.54

g/l

0.57

Other external causes of accidental injury

2437

7528

1.65

99.30

1.7

1.50

g/l

0.02

2075

6462

Benzodiazepine use

3090

14097

1.53

98.99

1.6

1.8

1.60

1.50

g/l

6.04

2576

12099

Diabetic retinopathy

1471

5033

1.91

98.91

1.9

1.7

1.64

g/l

0.02

1302

4314

Benign neoplasm: Colon, unspecified

1014

5056

2.10

98.44

1.9

1.6

1.55

1.58

g/l

0.52

847

4287

Diseases of peritoneum

461

1626

3.05

97.95

2.1

1.7

1.53

1.54

g/l

0.11

428

1388

Aortic valve malfunction, age under 60 years

393

1264

3.35

97.94

2.1

1.8

1.30

1.53

g/l

3.49

268

1099

Stroke, including SAH

2204

9879

1.66

97.83

1.7

1.59

1.57

g/l

0.35

1879

8394

Spondylopathies

2508

9459

1.62

97.27

1.6

1.7

1.58

1.54

g/l

1.00

2149

8052

Diseases of the respiratory system

1867

5400

1.76

97.08

1.8

1.7

1.55

1.43

g/l

4.75

1614

4599

Other CVD

882

4207

2.21

96.83

1.7

1.6

1.54

1.56

g/l

0.27

745

3548

Pain (limb, back, neck, head abdominally)

2230

6779

1.68

96.81

1.8

1.7

1.50

1.52

g/l

0.25

1919

5728

Dermatitis

1930

11659

1.69

96.58

1.7

1.57

1.52

g/l

1.36

1658

9968

Stroke, excluding SAH

2134

9590

1.67

96.40

1.7

1.60

1.58

g/l

0.45

1817

8144

DVT of lower extremities and pulmonary embolism

1523

8672

1.81

95.54

2.0

1.6

1.68

1.55

g/l

5.15

1320

7354

Accidents

2415

7528

1.63

94.93

1.7

1.50

g/l

0.04

2051

6462

Other acute lower respiratory infections

1747

9866

1.73

94.81

1.9

1.7

1.55

1.51

g/l

0.69

1523

8365

Gout due to impairment of renal function

126

169

10.67

94.75

2.1

1.9

1.67

1.50

g/l

1.00

117

148

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1466

8261

1.82

94.54

1.6

1.7

1.56

1.53

g/l

0.62

1267

7055

ILD, hospital admission 2, with pulmonary infections

443

1559

3.06

94.46

2.0

1.6

1.65

1.48

g/l

2.96

372

1316

Disorder of lipoprotein metabolism, unspecified

553

2178

2.70

94.36

1.7

1.61

1.54

g/l

0.96

481

1848

Essential (haemorrhagic) thrombocythaemia

217

481

5.14

93.66

1.8

1.7

1.09

1.49

g/l

7.35

183

416

Other specific joint derangements/joint disorders

2035

7979

1.68

93.58

1.7

1.8

1.54

1.45

g/l

3.94

1762

6830

Mycoses

938

4628

2.11

92.94

1.9

1.7

1.56

1.54

g/l

0.34

801

3958

Sequelae of external causes of morbidity and mortality

941

4653

2.11

92.90

1.9

1.7

1.62

1.55

g/l

1.43

811

3981

Vitamin B12 deficiency anaemia

455

1640

2.96

92.51

1.9

1.7

1.47

1.54

g/l

0.91

381

1389

Hydronephrosis

432

1510

3.03

92.50

1.7

1.6

1.86

1.50

g/l

9.16

380

1256

Chronic ulcer of skin, not elsewhere classified

356

1128

3.47

91.87

1.9

1.8

1.79

1.50

g/l

5.78

313

959

Soft tissue disorders

3061

10455

1.53

91.85

1.8

1.7

1.49

g/l

0.01

2618

8881

Decubitus ulcer and pressure area

343

1066

3.57

91.72

2.0

1.7

1.80

1.53

g/l

4.72

305

901

Other diseases of arteries and capillaries

401

1360

3.18

91.40

2.0

1.7

1.54

1.50

g/l

0.31

357

1153

Mental and behavioural disorders due to alcohol

1639

9279

1.74

91.18

1.6

1.7

1.56

1.52

g/l

0.87

1414

7932

Pulmonary embolism

1110

5858

1.97

90.76

2.0

1.6

1.71

1.56

g/l

4.91

955

4957

Diabetic retinopathy, strict definition

795

3290

2.28

90.32

2.1

1.8

1.57

1.61

g/l

0.63

710

2833

Other systemic involvement of connective tissue

959

4822

2.07

90.12

1.9

1.6

1.67

1.55

g/l

3.24

827

4107

Cardiac arrest

244

495

4.48

90.00

1.9

1.5

1.60

1.51

g/l

0.66

211

399

Rare circulating lymphoid malignancy, including Hilmo

186

378

5.68

89.24

2.1

1.7

1.44

1.48

g/l

0.22

152

334

Pulmonary heart disease

1110

5893

1.96

89.15

2.0

1.6

1.71

1.56

g/l

5.08

955

4994

Intracranial trauma

1622

6633

1.75

88.70

1.7

1.8

1.52

1.48

g/l

1.05

1365

5702

Diseases of the eye and adnexa

2150

6620

1.65

88.54

1.9

1.7

1.44

1.49

g/l

1.15

1854

5665

Malignant immunoproliferative diseases

120

165

10.49

88.53

2.8

2.2

1.49

1.53

g/l

0.15

106

145

Other and unspecified dermatitis

1616

9579

1.73

88.38

1.7

1.58

1.52

g/l

1.26

1390

8191

Systemic lupus erythematosus, unspecified

173

332

5.97

88.29

2.5

2.0

1.51

1.54

g/l

0.09

154

292

Cystitis

2576

9944

1.57

88.27

1.7

1.55

1.49

g/l

2.54

2227

8476

Pleural effusion

699

3162

2.35

88.01

1.7

1.6

1.67

1.55

g/l

2.23

583

2682

Low back pain

2269

10367

1.60

87.97

1.7

1.56

1.50

g/l

2.18

1913

8878

Solid cancers, helper endpoint

2297

8577

1.61

87.88

1.7

1.63

1.51

g/l

5.46

1955

7323

Fracture of lumbar spine and pelvis

879

4328

2.12

87.75

2.0

1.6

1.51

1.57

g/l

1.26

740

3663

Ischaemic Stroke, excluding all haemorrhages

2012

9321

1.65

87.36

1.7

1.6

1.61

1.58

g/l

0.77

1711

7900

Intestinal stricture

1142

6162

1.92

87.21

1.7

1.6

1.65

1.55

g/l

2.65

993

5217

Need for immunization against other single viral diseases

141

230

7.37

86.09

3.0

1.9

1.41

1.51

g/l

0.57

133

202

Non-Hodgkin lymphoma, all

253

673

4.24

85.94

1.9

1.6

1.63

1.50

g/l

1.10

201

570

Secondary and unspecified malignant neoplasm of lymph nodes

367

1230

3.22

85.54

1.7

1.6

1.68

1.52

g/l

1.91

301

1055

Haemorrhage, not elsewhere classified

221

533

4.66

85.50

2.1

1.5

1.31

1.50

g/l

2.03

183

453

Alcohol use disorder, ICD-based

1339

7609

1.81

85.47

1.6

1.7

1.55

1.52

g/l

0.54

1153

6512

Non-follicular lymphoma

459

1751

2.84

84.64

2.1

1.7

1.57

1.54

g/l

0.24

385

1505

Chronic periodontitis, complicated

1728

10453

1.68

84.62

1.8

1.6

1.62

1.56

g/l

2.15

1491

8935

Chronic pancreatitis

512

2052

2.66

84.48

1.8

1.7

1.52

1.55

g/l

0.22

455

1756

Zoster [herpes zoster]

720

3344

2.26

84.30

2.0

1.7

1.49

1.55

g/l

0.97

630

2840

Arthropathies in other diseases classified elsewhere

201

455

4.97

84.26

2.1

1.9

1.67

1.51

g/l

1.33

184

389

Pneumocystosis

151

273

6.88

83.90

2.5

2.1

1.53

1.49

g/l

0.16

126

239

Unstable angina pectoris

1291

5699

1.85

83.86

1.5

1.6

1.56

1.59

g/l

0.53

1081

4825

Coxarthrosis [arthrosis of hip](FG)

1685

7095

1.71

83.77

1.5

1.6

1.62

1.54

g/l

2.95

1429

6001

Hypotension

771

3699

2.21

83.64

1.8

1.6

1.55

1.56

g/l

0.15

656

3119

Other (seronegative) rheumatoid arthritis, wide

698

3219

2.27

82.98

1.6

1.7

1.66

1.57

g/l

1.48

592

2740

Cholelithiasis, broad definition with cholecystitis

2637

11812

1.53

82.73

1.8

1.7

1.52

1.55

g/l

0.81

2255

10035

Chronic apical periodontitis

3338

13172

1.46

82.66

1.8

1.7

1.55

1.51

g/l

1.80

2847

11263

Cough

1190

6221

1.85

82.26

1.8

1.7

1.54

1.53

g/l

0.15

1008

5287

Seropositive rheumatoid arthritis, wide

925

4746

2.02

82.20

1.5

1.7

1.61

1.57

g/l

0.67

798

4039

Unspecified fall

1632

9742

1.69

82.10

1.7

1.56

1.53

g/l

0.58

1376

8306

Vitreous haemorrhage

446

1698

2.82

82.05

2.2

1.7

1.51

1.56

g/l

0.50

397

1462

Candidiasis

917

4690

2.02

81.82

1.8

1.7

1.50

1.52

g/l

0.17

785

4016

Isolated proteinuria

179

381

5.43

81.52

2.2

2.0

1.47

1.49

g/l

0.12

163

324

Seronegative rheumatoid arthritis

425

1577

2.84

81.33

1.6

1.7

1.66

1.51

g/l

1.96

359

1339

Osteonecrosis

291

877

3.64

81.32

1.8

1.73

1.54

g/l

2.15

261

767

Pericarditis

180

383

5.21

80.99

1.8

1.7

1.76

1.50

g/l

2.24

159

335

Acute bronchitis

1361

7730

1.77

80.92

1.8

1.7

1.54

1.53

g/l

0.27

1186

6519

Viral infections characterized by skin and mucous membrane lesions

2525

14424

1.52

80.69

1.9

1.7

1.51

g/l

0.09

2193

12306

Nonischemic cardiomyopathy

407

1495

2.90

79.81

1.8

1.7

1.56

1.54

g/l

0.13

335

1278

Any mental disorder

3253

11255

1.47

79.48

1.7

1.8

1.55

1.51

g/l

1.61

2778

9623

External causes of morbidity and mortality

1848

5636

1.67

79.29

1.7

1.51

1.48

g/l

0.59

1576

4818

Dorsalgia

2916

10612

1.49

78.79

1.7

1.8

1.54

1.49

g/l

1.92

2479

9080

Arthropathies

2513

8359

1.54

78.78

1.8

1.53

1.45

g/l

3.67

2162

7130

Other viral diseases

820

4065

2.07

78.73

2.4

1.8

1.44

1.46

g/l

0.22

725

3489

Benign neoplasm of other and ill-defined parts of digestive system

678

3161

2.25

78.71

1.8

1.7

1.55

1.58

g/l

0.27

576

2718

Budesonide

453

1760

2.69

78.70

1.9

1.6

1.42

1.47

g/l

0.57

408

1497

Other or unspecified ileus, impaction or obstruction

674

3127

2.25

78.58

1.7

1.6

1.70

1.54

g/l

3.76

589

2628

Malignant neoplasm of skin

1562

6384

1.72

78.57

1.7

1.6

1.49

1.57

g/l

2.46

1348

5419

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

891

4586

2.02

78.48

1.5

1.7

1.61

1.57

g/l

0.52

768

3902

Other reaction to severe stress, and adjustment disorders

944

4946

1.95

77.65

2.2

1.8

1.42

1.43

g/l

0.11

818

4268

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1535

6206

1.72

77.29

1.7

1.6

1.50

1.57

g/l

2.14

1318

5262

Other/unspecified seropositive rheumatoid arthritis

902

4693

1.99

76.96

1.5

1.7

1.61

1.57

g/l

0.61

777

3994

Benign neoplasm: Sigmoid colon

739

3605

2.15

76.39

1.7

1.62

1.57

g/l

0.71

647

3073

Myocarditis

153

294

5.52

76.25

1.8

1.6

1.50

1.45

g/l

0.23

132

243

Colectomy operation

675

3186

2.23

76.16

1.5

1.7

1.72

1.55

g/l

4.99

589

2724

Mood disorders, excluding more controls

2685

10837

1.50

76.05

1.7

1.8

1.52

1.50

g/l

0.30

2318

9284

Methotrexate

477

1934

2.58

75.96

1.5

1.6

1.51

1.52

g/l

0.06

417

1651

Diseases of the musculoskeletal system and connective tissue

1457

4214

1.76

75.95

1.9

1.7

1.47

1.42

g/l

1.29

1265

3574

Symptoms and signs involving the skin and subcutaneous tissue

2090

13387

1.56

75.38

1.8

1.7

1.47

1.53

g/l

2.31

1786

11435

Candidiasis

494

2053

2.53

74.97

1.9

1.8

1.56

1.51

g/l

0.43

420

1762

Status post-ami

981

3977

1.95

74.84

1.6

1.65

1.59

g/l

1.02

830

3361

ILD, hospital admissions 3, with pneumonia sepsis

389

1452

2.88

74.60

2.0

1.6

1.69

1.49

g/l

3.42

330

1222

Noninfectious colitis NAS

493

2051

2.52

74.52

1.8

1.7

1.58

1.52

g/l

0.54

439

1771

Open wound of head

1734

10519

1.62

74.43

1.7

1.53

1.55

g/l

0.29

1476

8946

Coxarthrosis

1551

6171

1.70

74.29

1.5

1.7

1.63

1.55

g/l

2.17

1314

5219

Folate deficiency anaemia

123

10.42

74.10

1.9

2.1

1.52

1.54

g/l

0.05

109

Missing teeth due to accident, extraction or parodontitis

1883

11397

1.59

74.04

1.7

1.54

1.57

g/l

0.70

1591

9735

Diseases of oral cavity, salivary glands and jaws

1971

6404

1.61

73.94

1.7

1.6

1.54

1.57

g/l

0.66

1676

5431

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

707

3396

2.12

73.49

1.8

1.54

1.39

g/l

3.34

599

2933

Spinal stenosis

1706

8088

1.64

73.26

1.6

1.63

1.58

g/l

1.41

1469

6857

Cardiodefibrillation

1335

7944

1.74

72.66

1.7

1.6

1.43

1.58

g/l

7.97

1116

6774

Hepatomegaly and splenomegaly, not elsewhere classified

100

11.06

72.48

2.2

2.5

1.24

1.42

g/l

0.71

Osteoporosis with pathological fracture (FG)

310

1040

3.22

72.27

1.9

1.6

1.62

1.55

g/l

0.57

272

880

Protozoal diseases

180

427

4.85

71.82

2.5

2.1

1.49

1.50

g/l

0.03

153

375

Cholelithiasis

2495

11665

1.50

71.79

1.8

1.7

1.51

1.54

g/l

1.20

2123

9911

Injuries to the hip and thigh

1620

9156

1.64

71.76

1.7

1.54

1.55

g/l

0.17

1360

7797

Mycoses

2453

14525

1.49

71.70

1.7

1.8

1.52

1.51

g/l

0.04

2083

12450

Viral pneumonia (unknown virus, not influenza)

294

962

3.29

71.35

2.5

1.8

1.59

1.51

g/l

0.70

261

838

Sequelae with surgical and medical care as external cause

736

3672

2.09

71.23

2.0

1.7

1.63

1.55

g/l

1.35

633

3134

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1444

5948

1.71

70.85

1.7

1.6

1.50

1.57

g/l

2.42

1233

5036

Pneumonia due to other infectious organisms, not elsewhere classified

178

420

4.74

70.84

2.5

1.8

1.55

1.49

g/l

0.28

149

361

Asthma (diagnoses ohter than nonallergic)

2544

14494

1.48

70.59

1.7

1.8

1.60

1.50

g/l

6.46

2183

12358

Acute pancreatitis

695

3405

2.13

70.48

1.8

1.7

1.63

1.55

g/l

1.31

605

2880

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

617

1751

2.28

70.20

2.6

2.0

1.10

1.27

g/l

5.29

548

1520

Other neurological diseases

2284

12082

1.51

70.10

1.6

1.7

1.54

1.56

g/l

0.36

1948

10249

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

408

1609

2.71

69.86

2.0

1.8

1.62

1.52

g/l

1.11

361

1389

Acute upper respiratory infections of multiple and unspecified sites

2137

10485

1.53

69.84

2.0

1.7

1.49

1.50

g/l

0.07

1833

8972

Dermatitis and eczema

3210

14166

1.42

69.68

1.8

1.7

1.55

1.51

g/l

1.34

2731

12112

Other respiratory diseases principally affecting the interstitium

738

3727

2.08

69.52

2.0

1.6

1.63

1.56

g/l

1.06

624

3157

Other disorders of glucose regulation and pancreatic internal secretion

347

1264

2.93

69.30

2.0

1.8

1.43

1.49

g/l

0.51

306

1088

Amputation of foot

177

430

4.84

69.05

2.0

1.82

1.48

g/l

3.65

159

368

COPD

1591

8143

1.64

68.86

1.6

1.71

1.55

g/l

8.91

1371

6915

Hypocalcemia

142

288

5.74

68.59

2.1

2.0

1.67

1.54

g/l

0.67

125

254

Malignant neoplasm of digestive organs

1235

5708

1.76

68.56

1.5

1.6

1.68

1.56

g/l

3.96

1063

4835

Secondary thrombocytopenia

139

8.73

68.50

1.9

1.6

1.59

1.56

g/l

0.08

122

Amiodarone users

457

1927

2.55

68.37

1.8

1.7

1.43

1.55

g/l

2.13

389

1644

Hypothyroidism, strict autoimmune

1961

8387

1.56

68.03

1.8

1.6

1.51

g/l

0.06

1661

7134

Inflammatory bowel disease

923

5024

1.89

67.97

1.7

1.8

1.51

1.50

g/l

0.10

800

4303

Pyogenic arthritis

288

958

3.22

67.91

2.0

1.8

1.74

1.49

g/l

3.06

241

820

Lower back pain or/and sciatica

3055

14183

1.43

67.58

1.7

1.8

1.55

1.51

g/l

1.68

2601

12127

Other obstetric conditions, not elsewhere classified

618

1790

2.24

67.30

2.6

2.0

1.09

1.27

g/l

5.74

549

1554

Renal tubulo-interstitial disorders in diseases classified elsewhere

10.90

66.95

2.9

1.7

1.61

1.41

g/l

0.97

Dilated cardiomyopathy

504

2234

2.40

66.89

1.8

1.7

1.55

1.54

g/l

0.04

436

1918

Gonarthrosis [arthrosis of knee](FG)

2075

7937

1.54

66.77

1.5

1.7

1.59

1.52

g/l

2.64

1749

6728

1269

7537

1.71

66.70

1.8

1.7

1.61

1.48

g/l

4.82

1093

6427

Congenital malformations, deformations and chromosomal abnormalities

1522

9061

1.63

66.64

1.9

1.8

1.42

1.48

g/l

1.44

1286

7805

Acute myeloid leukaemia, including Hilmo

125

9.24

65.72

1.6

1.65

1.55

g/l

0.34

108

Acute myeloid leukaemia, helper endpoint

125

9.24

65.72

1.6

1.65

1.55

g/l

0.34

108

Acute myeloid leukaemia

125

9.24

65.72

1.6

1.65

1.55

g/l

0.34

108

Gingivitis and periodontal diseases

3029

11061

1.43

65.69

1.8

1.7

1.50

1.54

g/l

1.39

2581

9444

Abnormal findings on examination of urine, without diagnosis

224

657

3.77

65.64

2.2

1.9

1.49

1.51

g/l

0.09

199

571

Sequelae of cerebrovascular disease

1310

6841

1.70

65.57

1.8

1.6

1.60

1.56

g/l

0.86

1103

5786

Crohn disease

420

1720

2.55

65.54

1.7

1.8

1.55

1.50

g/l

0.44

367

1498

Immunodeficiency with predominantly antibody defects

135

271

5.60

65.33

2.7

2.0

1.42

1.50

g/l

0.40

115

240

Other dorsopathies, not elsewhere classified

2888

10635

1.44

64.73

1.7

1.8

1.52

1.49

g/l

0.73

2450

9099

Misadventures to patients during surgical and medical care

502

2244

2.34

64.50

1.9

1.7

1.47

1.54

g/l

0.86

431

1925

Congenital malformations, deformations and chromosomal abnormalities

1672

9912

1.58

64.42

1.9

1.8

1.43

1.48

g/l

1.81

1401

8572

Psychiatric diseases

2880

10146

1.44

64.10

1.7

1.8

1.55

1.51

g/l

1.40

2469

8682

Secondary uncertain malignant neoplasm

486

2152

2.37

64.04

1.7

1.6

1.74

1.52

g/l

3.60

399

1829

Obesity, other/unspecified

905

4984

1.86

64.00

1.8

1.7

1.69

1.46

g/l

10.43

780

4300

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

332

1234

2.85

63.62

1.9

1.7

1.66

1.52

g/l

1.52

289

1080

Chronic lower respiratory diseases

3415

13238

1.39

63.11

1.7

1.8

1.58

1.49

g/l

6.55

2934

11302

Benign neoplasm: Ascending colon

551

2591

2.25

63.11

1.7

1.61

1.57

g/l

0.50

489

2206

Elevated blood glucose level

329

1228

2.85

62.78

2.1

1.7

1.58

1.49

g/l

0.81

288

1065

Dental caries, including avohilmo

2360

8225

1.49

62.70

1.7

1.53

1.55

g/l

0.33

2011

6955

Unspecified privation

404

1669

2.55

62.39

2.2

1.7

1.61

1.53

g/l

0.85

350

1443

Other symptoms and signs involving cognitive functions and awareness

1509

8723

1.61

62.34

1.6

1.7

1.54

1.57

g/l

0.71

1255

7412

Other viral diseases

949

5298

1.82

62.27

2.4

1.8

1.44

1.45

g/l

0.12

828

4560

Need for other prophylactic measures

249

804

3.35

62.05

1.9

1.65

1.52

g/l

1.40

219

709

Acute pancreatitis (for exclusion)

695

3566

2.03

62.03

1.8

1.7

1.63

1.55

g/l

1.31

605

3036

Other chronic obstructive pulmonary disease

1516

7932

1.62

62.03

1.6

1.72

1.55

g/l

9.47

1305

6730

Injuries to the thorax

1456

9209

1.62

61.79

1.8

1.7

1.52

1.54

g/l

0.40

1259

7836

Other hereditary haemolytic anaemias

14.29

61.51

3.9

1.5

0.74

1.47

g/l

4.76

Substance use, excluding alcohol

551

2597

2.19

61.39

1.6

1.8

1.66

1.48

g/l

4.16

465

2239

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

17.45

61.33

2.1

1.7

1.46

1.48

g/l

0.05

Acquired pure red cell aplasia [erythroblastopenia]

19.49

61.17

2.7

2.1

1.28

1.52

g/l

0.79

Concussion

1313

6559

1.66

61.11

1.6

1.8

1.51

1.48

g/l

0.61

1097

5640

Poisoning by drugs, medicaments and biological substances

631

3133

2.07

61.03

1.6

1.8

1.60

1.44

g/l

3.66

533

2704

Early onset COPD, excluding more controls

586

2837

2.13

60.79

1.6

1.5

1.71

1.48

g/l

7.19

504

2388

Other pleural conditions

456

2024

2.40

60.42

2.0

1.7

1.64

1.54

g/l

1.18

395

1711

All influenza (not pneumonia)

450

1969

2.37

60.33

2.1

1.6

1.52

1.45

g/l

0.83

389

1671

Diabetic maculopathy

558

2528

2.22

60.28

2.0

1.8

1.60

1.62

g/l

0.19

500

2170

Diseases of the myoneural junction and muscle

469

2105

2.35

60.08

1.7

1.66

1.54

g/l

1.64

389

1798

Diseases of pulp and periapical tissues and dental caries

2144

7409

1.51

59.91

1.7

1.6

1.54

g/l

0.05

1827

6251

Acidosis

129

271

5.50

59.80

2.0

2.1

1.64

1.55

g/l

0.46

121

236

Episodal and paroxysmal disorders

3112

11452

1.40

59.34

1.8

1.52

1.50

g/l

0.47

2634

9801

Caries of dentine, including avohilmo

2468

8766

1.46

59.08

1.7

1.53

1.54

g/l

0.18

2111

7434

Personality disorders, excluding more controls

602

2970

2.07

58.95

1.7

1.9

1.56

1.40

g/l

3.57

520

2568

Basal cell carcinoma

1355

5825

1.65

58.55

1.7

1.6

1.48

1.58

g/l

3.49

1152

4931

Basal cell carcinoma, including avohilmo

1388

5975

1.64

58.48

1.7

1.6

1.48

1.57

g/l

3.44

1185

5060

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

517

2442

2.21

58.01

1.7

1.6

1.73

1.54

g/l

3.39

430

2080

Immunodeficiencies

203

604

3.65

57.81

2.3

1.8

1.43

1.52

g/l

0.64

170

527

Zoster [herpes zoster]

1530

9782

1.57

57.78

1.9

1.6

1.52

1.56

g/l

0.95

1312

8297

Sulfonylureas

1265

6228

1.66

57.54

1.6

1.76

1.51

g/l

16.34

1109

5229

Benign neoplasm: Stomach

387

1636

2.52

57.24

1.8

1.7

1.55

1.56

g/l

0.01

325

1403

Anxiety disorders, excluding more controls

2151

9614

1.47

57.24

1.8

1.49

1.50

g/l

0.05

1853

8265

Diseases of spleen

120

247

5.70

57.22

2.5

1.8

1.27

1.55

g/l

1.84

219

Dental operations

2000

6901

1.51

57.15

1.7

1.6

1.53

1.57

g/l

1.08

1696

5841

Dysphagia

805

4445

1.87

57.04

1.7

1.6

1.51

1.56

g/l

0.88

684

3778

Unspecified nephritic syndrome

129

282

5.22

56.86

2.3

2.0

1.60

1.57

g/l

0.13

114

247

Other and unspecified coagulation defects

193

562

3.69

56.56

2.9

1.8

1.35

1.53

g/l

1.82

171

499

Viral pneumonia (known virus, not influenza)

152

380

4.54

56.53

2.4

1.9

1.52

1.50

g/l

0.09

137

335

Malignant neoplasm of colon, including Hilmo

653

3389

2.00

56.32

1.5

1.76

1.55

g/l

6.91

559

2876

Complications of cardiac and vascular prosthetic devices, implants and grafts

136

315

5.01

56.20

2.8

1.9

1.57

1.50

g/l

0.28

115

276

Complications of internal orthopaedic prosthetic devices, implants and grafts

771

4231

1.89

56.09

1.6

1.67

1.56

g/l

2.47

629

3581

Weight loss

390

1669

2.48

56.00

1.6

1.8

1.45

1.53

g/l

0.92

339

1438

Other diseases of stomach and duodenum

261

917

3.05

55.97

1.8

1.7

1.54

1.57

g/l

0.14

232

782

Neurological diseases

2328

8114

1.46

55.84

1.8

1.47

1.49

g/l

0.24

2000

6958

COPD related to multimorbidity

1416

7672

1.60

55.84

1.6

1.72

1.54

g/l

10.12

1218

6473

Arthrosis

1934

7138

1.51

55.47

1.6

1.7

1.58

1.52

g/l

1.55

1635

6044

Acute sinusitis

1330

7787

1.61

55.40

1.9

1.8

1.51

1.48

g/l

0.65

1125

6696

Other coagulation defects

271

975

2.95

55.37

2.5

1.8

1.39

1.52

g/l

1.45

238

851

Polycythaemia vera

174

486

3.98

55.07

1.8

1.5

0.98

1.54

g/l

14.71

153

422

Mood [affective] disorders

2803

13177

1.40

55.05

1.8

1.7

1.51

1.52

g/l

0.06

2419

11262

Viral and other specified intestinal infections

683

3476

1.94

54.84

2.1

1.8

1.46

1.39

g/l

1.12

595

2993

Depression

2551

12367

1.41

54.80

1.8

1.50

1.51

g/l

0.27

2200

10588

Mood disorders

2809

13198

1.39

54.79

1.8

1.7

1.51

1.52

g/l

0.06

2424

11281

Other nutritional anaemias

119

8.35

54.76

2.9

2.1

1.37

1.53

g/l

0.69

105

Open wound of lower leg

508

2438

2.17

54.56

1.8

1.7

1.58

1.51

g/l

0.99

437

2094

Unspecified jaundice

232

777

3.23

54.45

2.0

1.8

1.17

1.48

g/l

5.26

200

661

Invasive ventilation

298

1145

2.78

54.01

1.9

1.8

1.67

1.49

g/l

2.26

259

979

Poisoning by medicine

559

2781

2.06

53.86

1.6

1.8

1.59

1.45

g/l

2.66

472

2412

Benign neoplasm: Rectum

651

3437

1.98

53.82

1.6

1.7

1.57

g/l

0.01

569

2932

Hypoglycaemia, other or unspecified

268

975

2.93

53.77

2.1

1.8

1.40

1.52

g/l

1.14

233

844

Visual disturbances and blindness

1528

10078

1.55

53.70

1.7

1.53

1.54

g/l

0.17

1304

8599

Polyarthrosis

619

2962

2.00

53.60

1.6

1.7

1.57

1.59

g/l

0.22

535

2487

Other chronic obstructive pulmonary disease, including avohilmo

1760

9849

1.51

53.39

1.6

1.7

1.71

1.55

g/l

10.26

1503

8374

Exposure to other specified factors

2032

12987

1.46

53.39

1.8

1.7

1.57

1.50

g/l

2.87

1752

11130

Benign neoplasm: Rectum, anus and anal canal

715

3898

1.91

53.37

1.6

1.7

1.57

g/l

0.05

619

3318

Other nonautoimmune haemolytic anaemias

38.20

53.27

7.1

1.6

0.73

1.79

g/l

4.85

Abnormal weight loss

362

1534

2.51

53.25

1.6

1.8

1.46

1.53

g/l

0.78

314

1319

Aortic aneurysm

839

4703

1.81

53.21

1.8

1.6

1.51

g/l

0.03

675

3961

Thoracic aortic aneurysm

521

2560

2.14

53.04

1.7

1.46

1.52

g/l

0.66

401

2183

Injury, poisoning and certain other consequences of external causes

1453

4621

1.60

53.03

1.8

1.7

1.50

1.47

g/l

0.62

1270

3923

Thrombotic microangiopathy

12.12

52.97

9.2

1.9

1.34

1.42

g/l

0.20

Drug-induced cataract

125

282

5.01

52.91

2.1

2.0

1.46

1.53

g/l

0.32

111

247

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

176

500

3.66

52.79

2.8

1.7

1.23

1.45

g/l

2.55

153

424

Nerve, nerve root and plexus disorders

3024

13675

1.37

52.79

1.7

1.56

1.52

g/l

1.06

2623

11619

Fracture of rib(s), sternum and thoracic spine

990

5932

1.72

52.75

1.8

1.7

1.54

1.55

g/l

0.10

852

5044

Other infectious diseases

359

1521

2.50

52.72

2.0

1.7

1.77

1.49

g/l

4.73

315

1294

Amputation of ankle bones

139

344

4.65

52.66

2.5

2.0

1.86

1.50

g/l

2.98

123

300

Other/unspecified dorsalgia

1082

6562

1.67

52.55

1.9

1.7

1.56

1.52

g/l

0.85

926

5593

Other infectious diseases

319

1284

2.65

52.51

1.9

1.7

1.78

1.50

g/l

4.14

281

1098

Other joint disorders

2262

8346

1.45

52.41

1.8

1.49

1.45

g/l

1.08

1919

7121

Depression or dysthymia

1951

7345

1.49

52.38

1.7

1.8

1.51

1.52

g/l

0.08

1671

6290

Benign neoplasm: Transverse colon

426

1955

2.31

52.10

1.8

1.7

1.58

1.57

g/l

0.08

382

1678

COPD, hospital admission 2, with asthma infections

1155

6172

1.65

51.65

1.5

1.6

1.75

1.54

g/l

11.02

994

5207

Other diseases of hard tissues of teeth

1811

6299

1.51

51.65

1.7

1.6

1.50

1.57

g/l

2.48

1531

5350

Other complications of surgical and medical care, not elsewhere classified

325

1324

2.57

51.60

1.9

1.7

1.59

1.53

g/l

0.42

271

1148

Other arthrosis

1436

6451

1.57

51.33

1.6

1.7

1.56

1.54

g/l

0.26

1231

5485

Isolated proteinuria with specified morphological lesion

145

7.22

51.12

2.4

2.2

1.64

1.58

g/l

0.17

129

Diabetic neuropathy

522

2611

2.13

50.81

1.9

1.7

1.62

1.64

g/l

0.21

467

2237

Diffuse large B-cell lymphoma

206

674

3.34

50.59

1.6

1.78

1.53

g/l

2.24

167

582

Diffuse large B-cell lymphoma, helper endpoint

206

674

3.34

50.59

1.6

1.78

1.53

g/l

2.24

167

582

Diffuse large B-cell lymphoma, including Hilmo

206

674

3.34

50.59

1.6

1.78

1.53

g/l

2.24

167

582

Obesity related asthma

970

5837

1.70

50.52

1.8

1.7

1.69

1.52

g/l

6.33

833

4994

Injuries to the knee and lower leg

3321

13854

1.34

50.51

1.7

1.8

1.56

1.50

g/l

2.47

2864

11813

Other inflammatory liver diseases

248

896

2.95

50.46

1.8

1.40

1.57

g/l

1.79

215

785

Spondyloarthritis

539

2721

2.04

50.11

1.7

1.58

1.52

g/l

0.77

459

2328

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

707

3897

1.85

49.92

1.8

1.9

1.54

1.41

g/l

2.61

599

3382

Diseases of pulp and periapical tissues, including avohilmo

3038

11675

1.36

49.76

1.7

1.8

1.53

1.50

g/l

0.85

2600

9959

Other and unspecified drugs and medicaments

308

1248

2.61

49.76

1.9

1.8

1.61

1.53

g/l

0.75

269

1083

Explicit fungal Sepsis

10.00

49.72

2.0

1.9

1.69

1.41

g/l

1.02

Other and unspecified myopathies

352

1522

2.45

49.56

1.6

1.7

1.64

1.53

g/l

1.29

288

1289

Wegener granulomatosis

184

6.07

49.46

3.0

2.1

1.66

1.45

g/l

0.95

165

ILD, hospital admissions

582

3053

2.00

49.31

2.0

1.7

1.60

1.57

g/l

0.34

487

2610

Biological medication for rheuma

448

2124

2.17

49.30

1.6

1.8

1.61

1.47

g/l

1.85

377

1838

5-aminosalicylic acid

539

2733

2.02

49.22

1.8

1.6

1.42

1.46

g/l

0.51

465

2334

Other/unspecified rheumatoid arthritis

447

2136

2.19

48.96

1.5

1.7

1.66

1.55

g/l

1.43

375

1816

Vascular diseases of the intestine

196

636

3.38

48.92

2.2

1.8

1.59

1.47

g/l

0.85

167

541

Gonarthrosis

1749

6763

1.49

48.49

1.5

1.7

1.59

1.54

g/l

1.29

1463

5728

Collagenous colitis

320

1336

2.52

48.44

1.8

1.60

1.54

g/l

0.45

282

1163

COPD, hospital admissions 3, with asthma pneumonia sepsis

1013

5314

1.68

48.29

1.5

1.7

1.76

1.54

g/l

11.67

866

4470

Other and unspecified local infections of skin and subcutaneous tissue

335

1430

2.46

48.16

1.8

1.7

1.71

1.51

g/l

2.93

296

1227

Intestinal adhesions without obstruction

301

1225

2.59

48.11

1.7

1.63

1.55

g/l

0.70

254

1044

Disorders of eyelid, lacrimal system and orbit

2423

13394

1.39

48.09

1.7

1.50

1.54

g/l

1.49

2078

11417

COPD, early/later onset

1533

8705

1.52

48.04

1.5

1.6

1.72

1.55

g/l

9.85

1319

7376

Acute upper respiratory infections

2944

13532

1.36

48.03

1.8

1.7

1.52

g/l

0.11

2516

11546

Other interstitial pulmonary diseases

588

3122

1.97

48.02

2.0

1.6

1.61

1.56

g/l

0.48

493

2661

Hypercalcemia

204

686

3.26

47.98

2.0

1.8

1.73

1.57

g/l

1.38

178

590

Suppurative and necrotic conditions of lower respiratory tract

246

915

2.90

47.82

1.6

1.8

1.82

1.52

g/l

3.57

207

786

Anxiety (asthma-related co-morbidities)

1377

6975

1.55

47.73

1.8

1.47

1.45

g/l

0.34

1208

5977

Problems related to lifestyle

307

1262

2.53

47.56

1.7

1.8

1.60

1.48

g/l

1.30

260

1086

Delirium, not induced by alcohol and other psychoactive substances

495

2483

2.09

47.55

1.6

1.7

1.60

1.53

g/l

0.84

406

2131

Interstitial lung disease endpoints

588

3134

1.96

47.47

2.0

1.6

1.61

1.57

g/l

0.44

493

2673

Interstitial lung disease

588

3134

1.96

47.47

2.0

1.6

1.61

1.57

g/l

0.44

493

2673

Fracture of femur

976

5419

1.68

47.33

1.6

1.56

1.58

g/l

0.29

812

4591

COPD, hospital admissions

1517

8652

1.52

47.27

1.5

1.6

1.72

1.55

g/l

9.86

1302

7332

Alcohol dependence

804

4695

1.76

47.03

1.5

1.7

1.61

1.53

g/l

1.47

682

4029

Malignant neoplasm of colon

511

2600

2.05

46.98

1.4

1.5

1.76

1.55

g/l

5.43

444

2220

Transient ischemic attack

1668

9273

1.49

46.96

1.6

1.56

1.58

g/l

0.39

1410

7851

Other local infections of skin and subcutaneous tissue

348

1527

2.39

46.93

1.8

1.7

1.71

1.51

g/l

2.85

306

1308

Duodenal ulcer

413

1947

2.22

46.84

1.7

1.6

1.52

1.57

g/l

0.56

363

1643

Crohn's disease NAS

223

791

2.98

46.78

1.7

1.9

1.50

1.49

g/l

0.06

192

702

In situ neoplasms

1179

7593

1.59

46.67

1.8

1.6

1.51

1.56

g/l

1.25

1016

6445

Secondary right heart disease

206

709

3.18

46.56

2.1

1.8

1.31

1.55

g/l

2.99

179

603

Drug-induced osteoporosis with pathological fracture

106

235

5.30

46.46

1.9

2.0

1.69

1.60

g/l

0.32

204

Colorectal cancer

743

4175

1.79

46.10

1.5

1.76

1.55

g/l

7.20

643

3550

Cholangitis (primary sclerosing, PSC)

252

966

2.78

45.91

1.8

1.43

1.49

g/l

0.40

211

826

Nonhereditary hypogammaglobulinemia

107

7.74

45.40

2.4

2.3

1.41

1.48

g/l

0.19

Other specified/unspecified systemic involvement of connective tissue

206

716

3.06

45.02

2.3

1.8

1.42

1.52

g/l

0.77

187

621

Fracture of shoulder and upper arm

1060

6707

1.61

44.91

1.8

1.7

1.52

1.55

g/l

0.62

895

5723

Cholangitis (primary sclerosing, PSC), with reimbursement 202

192

5.50

44.72

2.1

2.2

1.28

1.47

g/l

1.06

171

Ulcerative colitis

671

3773

1.82

44.66

1.8

1.7

1.51

1.50

g/l

0.16

579

3237

Disorders of oesophagus in diseases classified elsewhere

121

305

4.51

44.63

2.0

1.72

1.65

g/l

0.24

106

264

Undetermined asthma, excluding more controls

321

1383

2.39

44.51

1.7

1.6

1.66

1.47

g/l

2.60

272

1173

Functional dyspepsia

692

3930

1.80

44.45

1.8

1.7

1.53

1.55

g/l

0.15

597

3336

Other anxiety disorders

1056

5762

1.61

44.43

1.9

1.8

1.45

1.42

g/l

0.38

930

4951

Superficial injury of head

725

4180

1.78

44.38

1.6

1.7

1.46

1.53

g/l

1.20

617

3562

Degeneration of macula and posterior pole

1576

8622

1.49

44.24

1.6

1.53

1.59

g/l

1.49

1324

7272

Viral and other specified intestinal infections

515

2607

1.97

43.83

2.2

1.9

1.44

1.37

g/l

0.79

440

2251

Sleep disorders (combined)

3159

12617

1.33

43.72

1.7

1.8

1.53

1.51

g/l

0.70

2701

10779

Other Crohn's disease

218

792

2.89

43.63

1.6

2.0

1.55

1.46

g/l

0.67

191

697

ILD, hospital admissions 1, main diag only

515

2704

2.00

43.62

2.1

1.7

1.61

1.57

g/l

0.37

434

2308

Artificial opening status

217

793

2.93

43.49

1.7

1.83

1.55

g/l

2.99

192

682

Intestinal malabsorption

176

574

3.28

43.13

1.7

2.0

1.41

1.52

g/l

0.84

155

501

Dorsopathies

2800

10663

1.35

42.82

1.8

1.51

1.49

g/l

0.52

2388

9122

Failed induction of labour

149

437

3.55

42.74

2.4

2.2

1.01

1.23

g/l

2.94

136

381

Other metabolic disorders

339

1525

2.29

42.65

2.0

1.7

1.47

1.49

g/l

0.16

299

1300

Mixed connective tissue disease

221

822

2.85

42.57

2.4

1.8

1.48

1.55

g/l

0.42

199

712

Sleep apnoea

2548

12288

1.36

42.56

1.7

1.60

1.53

g/l

2.85

2178

10507

Leukaemia of unspecified cell type

130

7.00

42.38

1.6

2.2

1.57

1.46

g/l

0.32

114

Abnormalities of gait and mobility

451

2286

2.07

42.32

1.5

1.7

1.62

1.54

g/l

1.00

404

1958

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

16.14

42.09

3.2

1.9

1.52

1.67

g/l

0.29

Familial hypercholesterolemia

502

2637

1.97

42.02

1.7

1.6

1.68

1.54

g/l

2.35

416

2228

Neurotic, stress-related and somatoform disorders

2219

11358

1.38

42.01

1.8

1.49

1.50

g/l

0.24

1915

9746

Amyloidosis

120

314

4.29

41.95

1.8

2.1

1.52

1.55

g/l

0.11

105

272

IBD patients in KELA-register

590

3252

1.86

41.93

1.8

1.45

1.48

g/l

0.35

520

2817

Polyuria

729

4291

1.75

41.78

1.7

1.6

1.51

1.54

g/l

0.33

616

3672

Other pulmonary heart/vessel disease

214

797

2.91

41.72

2.1

1.8

1.29

1.54

g/l

3.21

187

680

Pruritus

341

1558

2.28

41.64

1.9

1.8

1.55

1.52

g/l

0.27

284

1342

Acquired absence of limb

125

6.93

41.52

1.8

1.7

1.81

1.52

g/l

1.08

111

Crohn's disease of small intestine

221

832

2.79

41.37

1.7

1.9

1.57

1.48

g/l

0.68

196

732

Fracture of lower leg, including ankle

1482

10141

1.47

41.19

1.6

1.7

1.64

1.53

g/l

4.25

1274

8635

Diabetes mellitus in pregnancy

555

1877

1.92

40.94

2.6

1.9

1.18

1.32

g/l

2.99

494

1629

Polymyalgia rheumatica

495

2621

1.97

40.85

1.7

1.6

1.81

1.55

g/l

6.34

416

2215

Hernia of abdominal wall

1334

9073

1.50

40.73

1.7

1.59

1.54

g/l

1.22

1160

7757

Shoulder lesions

2070

9093

1.40

40.58

1.7

1.59

1.55

g/l

1.20

1775

7698

Intracranial injury

1641

10956

1.44

40.44

1.7

1.50

1.53

g/l

0.43

1373

9338

Anxiety disorders

2239

11500

1.37

40.44

1.8

1.49

1.50

g/l

0.28

1930

9865

Injuries to the shoulder and upper arm

2330

13979

1.36

40.44

1.8

1.7

1.53

1.54

g/l

0.18

1990

11909

Disorders of continuity of bone

286

1229

2.42

40.37

1.6

1.8

1.55

1.51

g/l

0.20

248

1079

Recurrent or chronic depression

935

4089

1.63

40.02

1.7

1.9

1.47

1.48

g/l

0.12

807

3509

Other diseases of pancreas

300

1328

2.38

40.00

1.6

1.7

1.51

1.55

g/l

0.34

272

1147

Special screening examination for infectious and parasitic diseases

478

1800

1.98

40.00

2.0

1.8

1.22

1.41

g/l

4.48

415

1538

Alcohol-induced chronic pancreatitis

240

965

2.64

39.71

1.8

1.58

1.54

g/l

0.28

207

829

Nonalcoholic fatty liver disease

293

1285

2.38

39.55

1.8

1.47

1.54

g/l

0.64

257

1115

1362

8586

1.49

39.21

1.8

1.6

1.48

1.60

g/l

4.83

1175

7236

Infection of intervertebral disc (pyogenic)

198

5.29

38.92

1.9

2.1

1.67

1.55

g/l

0.50

177

Other disorders of veins

1069

6967

1.55

38.88

1.7

1.6

1.48

1.58

g/l

2.94

899

5906

All anxiety disorders

1399

7594

1.47

38.67

1.8

1.46

g/l

0.06

1228

6526

Fentanyl

348

1649

2.19

38.66

1.7

1.6

1.87

1.50

g/l

7.08

287

1394

Ventral hernia

720

4312

1.71

38.57

1.7

1.6

1.60

1.57

g/l

0.33

622

3660

Soft tissue disorders related to use, overuse and pressure

748

4520

1.69

38.51

1.7

1.55

1.56

g/l

0.12

651

3849

Benign neoplasm: Caecum

395

1979

2.10

38.47

1.6

1.7

1.61

1.56

g/l

0.39

356

1697

Chronic myeloid leukaemia, including Hilmo

103

7.28

38.45

1.8

1.24

1.51

g/l

1.26

Seropositive rheumatoid arthritis, strict definition

449

2341

1.99

38.43

1.4

1.7

1.62

1.56

g/l

0.60

382

2000

Non-selective monoamine reuptake inhibitors

1040

6545

1.56

38.33

1.5

1.7

1.66

1.55

g/l

3.13

881

5554

Skin changes due to chronic exposure to nonionizing radiation

1306

8258

1.49

38.28

1.8

1.6

1.47

1.60

g/l

5.63

1135

6960

Other viral hepatitis

178

622

2.99

38.27

1.7

2.0

1.42

1.46

g/l

0.19

146

547

Visual disturbances

1335

9191

1.48

38.20

1.7

1.51

1.53

g/l

0.42

1146

7845

Barrett oesophagus

201

757

2.85

38.19

1.6

1.8

1.61

1.54

g/l

0.45

178

643

Crohn disease (strict definition, require KELA, min 2 HDR)

196

724

2.84

38.10

1.6

2.0

1.45

1.44

g/l

0.08

171

638

Acute gastritis

262

1116

2.46

38.01

1.5

1.7

1.51

1.57

g/l

0.40

225

948

Unspecified acute lower respiratory infection

455

2390

1.97

37.99

2.0

1.7

1.61

1.50

g/l

1.63

405

2039

Other symptoms and signs involving the digestive system and abdomen

455

2387

1.96

37.93

2.0

1.6

1.53

1.54

g/l

0.07

383

2043

L01XE Protein kinase inhibitors

224

895

2.69

37.90

2.0

1.8

1.61

1.53

g/l

0.37

197

774

Covid-19 suspected case

536

2961

1.85

37.84

1.9

1.8

1.55

1.43

g/l

2.02

474

2518

Actinic keratosis

1279

8111

1.50

37.73

1.8

1.6

1.46

1.60

g/l

6.36

1111

6835

Tumor necrosis factor alpha inhibitors

381

1882

2.08

37.71

1.5

1.8

1.56

1.48

g/l

0.83

322

1632

Amyloidosis, other/unspecified

102

257

4.50

37.71

1.9

2.1

1.53

1.57

g/l

0.13

221

Nonorganic sleeping disorders, excluding more controls

461

2430

1.94

37.69

1.9

1.8

1.48

1.44

g/l

0.43

395

2087

Inflammatory bowel disease, strict (require KELA)

590

3360

1.80

37.66

1.8

1.45

1.48

g/l

0.35

520

2907

Non-allergic asthma (mode), excluding more controls

435

2226

1.98

37.61

1.6

1.64

1.45

g/l

3.94

371

1866

Type 1 diabetes, definitions combined

224

883

2.61

37.58

2.4

1.9

1.29

1.35

g/l

0.51

202

760

Other abnormal findings of blood chemistry

174

611

3.04

37.56

2.0

1.9

1.47

1.49

g/l

0.09

148

529

Late syphilis

211

4.91

37.45

2.0

1.61

1.52

g/l

0.36

186

Dependence on enabling machines and devices, not elsewhere classified

129

6.25

37.38

2.6

1.8

1.35

1.43

g/l

0.26

112

Psoriatic and enteropathic arthropathies

308

1410

2.26

37.28

1.5

1.7

1.63

1.49

g/l

1.55

257

1205

Crohn disease (strict definition, require KELA)

196

736

2.79

36.91

1.6

2.0

1.45

1.44

g/l

0.08

171

647

Sciatica+with lumbago

1326

8420

1.47

36.83

1.6

1.7

1.59

1.52

g/l

1.69

1160

7224

Type 1 diabetes, strict (exclude DM2)

222

881

2.59

36.75

2.4

1.9

1.28

1.35

g/l

0.56

200

758

Tubulo-interstitial nephritis, not specified as acute or chronic

214

841

2.66

36.75

1.9

1.6

1.63

1.45

g/l

1.99

182

694

COPD-related respiratory insufficiency

451

2403

1.96

36.64

1.6

1.7

1.74

1.54

g/l

4.23

394

2035

Congenital malformations of heart and great arteries

357

1689

2.12

36.50

1.9

1.8

1.29

1.49

g/l

3.04

268

1468

Pneumonia derived septicemia

150

494

3.29

36.46

2.0

1.63

1.48

g/l

0.96

129

429

Left bundle-branch block

227

922

2.58

36.44

1.5

1.55

1.60

g/l

0.29

188

781

Other disorders of lacrimal gland

936

6053

1.58

36.37

1.7

1.51

1.55

g/l

0.68

799

5150

Other and unspecified types of non-Hodgkin lymphoma, hilmo

184

681

2.93

36.36

2.3

1.7

1.55

1.54

g/l

0.04

151

595

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

348

1697

2.14

36.27

1.6

1.84

1.54

g/l

5.37

296

1449

Malignant neoplasm of urinary organs

334

1606

2.18

36.17

1.7

1.6

1.85

1.54

g/l

5.00

281

1373

Spondylopathies (FG)

340

1636

2.14

36.13

1.7

1.55

1.45

g/l

1.14

284

1406

Other intervertebral disc disorders

2217

9964

1.35

36.12

1.6

1.7

1.57

1.52

g/l

1.83

1911

8515

Postprocedural endocrine and metabolic disorders, not elsewhere classified

300

1376

2.25

36.08

2.1

1.8

1.49

1.50

g/l

0.07

266

1180

Personality disorders

602

3492

1.76

35.88

1.7

1.9

1.56

1.43

g/l

2.65

520

3026

Deforming dorsopathies

740

4541

1.66

35.83

1.9

1.7

1.56

1.53

g/l

0.34

647

3897

Spondylosis

1492

8606

1.43

35.69

1.5

1.7

1.61

1.56

g/l

1.13

1276

7338

Ulcerative colitis, NAS

381

1924

2.04

35.62

1.8

1.7

1.55

1.51

g/l

0.37

333

1658

Other skin changes

585

3390

1.78

35.62

1.8

1.7

1.40

1.57

g/l

4.59

504

2908

Visual impairment including blindness (binocular or monocular)

257

1120

2.42

35.58

1.8

1.59

1.52

g/l

0.58

211

956

Pyothorax

185

694

2.87

35.55

1.6

1.9

1.82

1.54

g/l

2.78

157

595

Ulcer of oesophagus

264

1166

2.39

35.52

1.6

1.7

1.59

1.55

g/l

0.27

226

995

Glucagon-like peptide-1 (GLP-1) analogues

696

4216

1.69

35.47

1.6

1.7

1.80

1.49

g/l

15.79

611

3622

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

696

4216

1.69

35.47

1.6

1.7

1.80

1.49

g/l

15.79

611

3622

Disorders of magnesium metabolism

7.58

35.45

1.5

2.6

1.53

1.54

g/l

0.02

Gingival hyperplasia

143

466

3.31

35.36

2.6

1.9

1.53

g/l

0.02

130

405

Fluid overload

15.91

35.35

1.6

3.7

1.86

1.39

g/l

1.07

Suicide or other Intentional self-harm

580

3346

1.77

35.35

1.7

1.8

1.64

1.46

g/l

4.15

484

2892

Bipolar affective disorders

433

2287

1.94

35.22

1.8

1.55

1.43

g/l

1.69

367

1973

Other viral diseases, not elsewhere classified

476

2588

1.88

35.20

2.3

1.7

1.44

1.46

g/l

0.18

414

2221

Abnormal results of function studies

269

1199

2.34

35.04

1.8

1.40

1.51

g/l

1.06

216

1045

Injuries to the ankle and foot

1688

10897

1.39

34.80

1.8

1.53

1.48

g/l

1.57

1453

9376

Diagnoses used for exclusion with ILD

785

4941

1.63

34.56

1.7

1.61

1.55

g/l

0.98

647

4194

Asthma, hospital admissions , main diagnosis only

2157

14377

1.34

34.35

1.6

1.8

1.58

1.50

g/l

4.17

1836

12274

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

202

799

2.64

34.27

1.6

2.0

1.45

g/l

0.02

176

705

Hypoparathyroidism

148

502

3.19

34.22

2.4

1.7

1.52

g/l

0.00

126

435

Drug-induced neutropenia

244

1058

2.43

34.19

1.9

1.8

1.65

1.56

g/l

0.55

212

921

Open wound of ankle and foot

317

1523

2.16

34.18

1.8

1.61

1.48

g/l

1.37

276

1314

Discitis, unspecified

245

4.40

34.09

1.5

2.0

1.78

1.58

g/l

0.93

213

Late syphilis

173

5.18

34.03

2.0

1.9

1.57

1.53

g/l

0.14

151

Epilepsy

861

5531

1.58

33.95

1.8

1.7

1.54

1.51

g/l

0.34

720

4713

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

433

2324

1.93

33.94

1.9

1.5

1.48

1.52

g/l

0.48

375

1966

Speech therapy

767

4822

1.63

33.93

1.7

1.55

1.56

g/l

0.01

701

4098

Chronic hepatitis, not elsewhere classified

131

415

3.39

33.88

2.0

1.19

1.55

g/l

3.88

118

366

Superficial injury of lower leg

652

3932

1.69

33.85

1.8

1.7

1.49

1.50

g/l

0.06

555

3354

Irritable bowel syndrome

633

3785

1.70

33.79

1.7

1.46

1.49

g/l

0.38

547

3216

Heart failure and hypertrophic cardiomyopathy

102

279

4.15

33.77

2.0

1.9

1.52

1.56

g/l

0.13

252

Acute nephritic syndrome

259

4.17

33.64

2.5

1.9

1.55

1.46

g/l

0.39

227

Colon adenocarcinoma

389

2028

1.99

33.55

1.4

1.5

1.75

1.54

g/l

4.31

335

1723

Abnormal findings on diagnostic imaging of other body structures

401

2112

1.96

33.37

1.8

1.7

1.63

1.55

g/l

0.75

340

1828

Sequelae of other external causes

195

771

2.67

33.36

1.6

1.9

1.65

1.52

g/l

0.87

173

666

Other respiratory disorders and diseases

687

4237

1.67

33.12

1.8

1.6

1.73

1.54

g/l

4.85

575

3579

Other diseases of the respiratory system

687

4237

1.67

33.12

1.8

1.6

1.73

1.54

g/l

4.85

575

3579

Chronic viral hepatitis

145

491

3.09

33.05

1.7

1.9

1.38

1.43

g/l

0.24

117

427

Undetermined asthma

321

1564

2.11

32.98

1.7

1.6

1.66

1.46

g/l

2.89

272

1319

Psoriasis

758

4780

1.62

32.96

1.7

1.61

1.53

g/l

1.23

643

4088

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

262

1189

2.31

32.91

1.8

1.51

1.52

g/l

0.08

238

1028

Other and unspecified immunodeficiencies with predominantly antibody defects

120

5.93

32.53

2.7

2.6

1.34

1.45

g/l

0.30

105

Viral hepatitis

202

819

2.57

32.50

1.7

1.9

1.41

1.48

g/l

0.42

163

715

Disorders of lacrimal system

1121

7692

1.48

32.29

1.7

1.50

1.56

g/l

1.20

954

6524

Thiazolidinediones

372

1938

2.00

32.23

1.5

1.7

1.81

1.49

g/l

8.79

330

1659

Benign neoplasm: Small intestine

175

673

2.82

32.21

1.7

1.9

1.61

1.55

g/l

0.31

149

588

Other obstructive and reflux uropathy

134

441

3.20

32.19

2.2

1.7

1.79

1.41

g/l

4.00

113

379

Myalgia

579

3430

1.72

32.13

1.6

1.7

1.53

1.51

g/l

0.19

494

2913

Use of pramipexole

664

4094

1.67

31.98

1.7

1.52

1.58

g/l

0.82

570

3471

Other or ill-defined heart diseases

161

588

2.86

31.97

1.9

1.7

1.54

1.53

g/l

0.02

135

504

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

381

1995

1.96

31.93

1.7

1.9

1.63

1.44

g/l

3.25

327

1731

Shock, not elsewhere classified

101

6.49

31.89

2.4

1.5

1.59

1.44

g/l

0.45

Congenital malformations of the circulatory system

379

1925

1.97

31.80

2.0

1.8

1.24

1.50

g/l

5.59

294

1671

Persons with potential health hazards related to communicable diseases

809

5165

1.57

31.71

2.2

1.9

1.43

1.40

g/l

0.41

702

4486

Arterial embolism and thrombosis

225

974

2.44

31.70

2.0

1.7

1.78

1.49

g/l

3.92

196

816

Maternal care for other known or suspected fetal problems

400

1308

1.97

31.66

2.7

2.0

1.16

1.32

g/l

2.92

355

1134

Other renal tubulo-interstitial diseases

197

4.46

31.66

3.0

1.8

1.64

1.37

g/l

1.64

168

Disorders of adult personality and behaviour

614

3714

1.68

31.36

1.7

1.9

1.54

1.42

g/l

2.14

530

3226

Haemorrhoids and perianal venous thrombosis

854

5581

1.55

31.32

1.7

1.6

1.53

1.56

g/l

0.37

744

4710

Moderate visual impairment, binocular

139

480

3.14

31.27

2.0

1.6

1.60

1.58

g/l

0.06

120

421

Laparoscopic right hemicolectomy

232

1030

2.41

31.19

1.3

1.8

1.78

1.55

g/l

3.63

200

889

Mucosal proctocolitis

335

1699

2.03

31.01

1.8

1.42

1.49

g/l

0.67

293

1471

Lung transplantation

7.00

30.95

2.1

2.2

1.60

1.50

g/l

0.21

Selective serotonin reuptake inhibitors

2690

10966

1.29

30.86

1.6

1.8

1.54

1.50

g/l

1.50

2249

9384

Fitting and adjustment of other devices

1010

6189

1.50

30.83

1.8

1.6

1.63

1.55

g/l

2.03

843

5171

Phlebitis and thrombophlebitis (not including DVT)

628

3851

1.67

30.77

2.1

1.6

1.64

1.58

g/l

0.98

564

3271

Disorders of the thyroid gland

2552

12964

1.29

30.76

1.8

1.7

1.49

1.51

g/l

0.50

2160

11080

Other and unspecified disorders of skin and subcutaneous tissue

212

906

2.46

30.69

1.9

1.8

1.60

1.52

g/l

0.55

185

783

Neuromuscular dysfunction of bladder

292

1421

2.14

30.62

1.5

1.7

1.53

g/l

0.06

255

1221

Disorders of sclera, cornea, iris and ciliary body

1414

10233

1.40

30.59

1.9

1.7

1.53

g/l

0.02

1213

8748

Malignant neoplasm of kidney, except renal pelvis

297

1457

2.13

30.58

1.6

1.85

1.54

g/l

4.35

250

1249

Colorectal adenocarcinoma

591

3574

1.70

30.42

1.5

1.6

1.73

1.54

g/l

4.95

508

3044

Other blood glucose lowering drugs, excl. Insulins

498

2886

1.78

30.40

1.5

1.7

1.72

1.51

g/l

4.99

428

2447

Oesophagitis

195

807

2.55

30.39

1.8

1.59

1.51

g/l

0.48

175

684

Postprocedural disorders of digestive system, not elsewhere classified

130

439

3.19

30.27

1.4

2.0

1.49

1.53

g/l

0.15

111

387

Squamous cell neoplasms and carcinomas of the skin

306

1526

2.10

30.16

1.9

1.5

1.48

1.52

g/l

0.33

261

1291

Mixed hyperlipidaemia

149

543

2.92

30.11

1.6

1.9

1.78

1.51

g/l

2.45

131

472

Human immunodeficiency virus [HIV] disease resulting in other conditions

172

4.72

30.08

1.4

1.8

1.16

1.47

g/l

2.18

157

Cardiomyopathy, Hypertrophic obstructive

202

4.40

30.06

1.9

1.7

1.57

1.51

g/l

0.19

174

Chronic myeloid leukaemia [CML], BCR/ABL-positive

123

5.84

29.96

1.8

1.27

1.51

g/l

1.04

107

Benign neoplasm: Duodenum

125

419

3.29

29.90

1.8

1.9

1.61

1.56

g/l

0.21

106

369

Other specified/unspecified necrotizing vasculopathies

175

4.78

29.74

2.0

1.5

1.71

1.52

g/l

0.67

158

Crohn's disease of large intestine

155

578

2.81

29.72

1.8

2.0

1.52

1.45

g/l

0.42

140

509

Injuries to unspecified part of trunk, limb or body region

319

1622

2.04

29.60

1.9

1.8

1.55

1.50

g/l

0.31

286

1390

Abnormal serum enzyme levels

959

6361

1.50

29.55

1.6

1.52

1.53

g/l

0.10

839

5424

Pneumococcal septicemia

138

491

3.02

29.34

2.0

1.65

1.47

g/l

1.09

117

427

Sleep apnoea, including avohilmo

2584

12568

1.29

29.32

1.7

1.59

1.53

g/l

2.94

2200

10764

Postpartum care and examination

241

667

2.33

29.25

2.9

1.8

1.07

1.42

g/l

9.05

220

573

Primary biliary cholangitis (PBC)

210

4.22

29.23

1.6

1.5

1.25

1.52

g/l

1.64

177

Carcinoma in situ of skin of other and unspecified parts of face

340

1787

2.01

29.17

1.9

1.6

1.40

1.55

g/l

2.86

302

1514

Other diseases of oesophagus

307

1549

2.06

29.13

1.8

1.7

1.46

1.55

g/l

1.03

266

1327

Papulosquamous disorders

1023

7062

1.47

29.06

1.6

1.7

1.56

1.55

g/l

0.14

863

6054

Persistent mood disorders

495

2894

1.75

28.99

1.7

1.55

1.51

g/l

0.42

426

2458

Infections with a predominantly sexual mode of transmission

617

3815

1.64

28.72

1.9

1.40

1.41

g/l

0.05

536

3309

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

167

656

2.63

28.64

1.6

2.0

1.66

1.42

g/l

2.07

134

567

Sicca syndrome [Sjögren]

242

1124

2.24

28.60

1.9

1.7

1.65

1.56

g/l

0.59

204

960

Vitamin deficiency, wide

167

662

2.66

28.52

1.8

1.9

1.39

1.49

g/l

0.70

140

582

Vitamin deficiency

167

662

2.66

28.52

1.8

1.9

1.39

1.49

g/l

0.70

140

582

Adrenocortical insufficiency

127

437

3.10

28.52

1.8

2.0

1.64

1.47

g/l

1.07

110

383

Familial hypercholesterolemia, with ischemic heart disease

330

1726

2.00

28.47

1.7

1.67

1.57

g/l

1.15

274

1459

Asthma, including avohilmo

3136

14184

1.25

28.17

1.7

1.8

1.56

1.50

g/l

3.14

2681

12107

Hypersplenism

9.24

28.08

2.4

1.8

0.79

1.46

g/l

4.35

Human immunodeficiency virus [HIV] disease

190

4.36

28.07

1.4

1.8

1.17

1.52

g/l

2.75

173

Subjective visual disturbances

668

4252

1.60

28.05

1.7

1.49

1.54

g/l

0.69

577

3657

Other viral diseases, not elsewhere classified

592

3639

1.65

27.85

2.2

1.7

1.42

1.46

g/l

0.51

508

3118

Disorders of skin appendages

1130

7989

1.43

27.82

1.8

1.56

1.47

g/l

2.57

1007

6844

Gangrene, not elsewhere classified

6.33

27.81

2.3

1.8

1.89

1.56

g/l

1.20

Type 1 diabetes, strict definition, subgroup 1

151

570

2.71

27.79

2.3

1.9

1.21

1.26

g/l

0.28

135

496

6-mercaptopurine

272

3.63

27.79

1.6

1.7

1.38

1.36

g/l

0.05

242

Eosinophilic disease (BM)

154

4.78

27.65

1.6

2.0

1.60

1.49

g/l

0.40

131

Symptoms and signs involving the nervous and musculoskeletal systems

1553

11590

1.36

27.63

1.6

1.7

1.56

1.53

g/l

0.90

1342

9879

Other embolism and thrombosis

385

2130

1.87

27.57

2.6

1.6

1.58

1.57

g/l

0.08

336

1806

Left ventricular outflow tract obstruction, narrow definition

155

602

2.71

27.55

2.0

1.26

1.48

g/l

1.65

102

517

Giant cell arteritis

170

696

2.62

27.48

1.5

1.7

2.08

1.56

g/l

5.85

138

593

Maternal care for known or suspected fetal abnormality and damage

270

1123

2.11

27.47

2.2

1.9

1.15

1.34

g/l

2.82

238

967

Reactive arthropathies

237

1109

2.21

27.38

1.9

1.8

1.64

1.48

g/l

1.23

193

953

Other disorders of adrenal gland

143

535

2.82

27.38

1.9

2.0

1.66

1.49

g/l

1.01

125

470

Acquired absence of organs, not elsewhere classified

145

4.97

27.12

2.0

2.2

1.60

1.50

g/l

0.32

126

Hodgkin lymphoma, hilmo

109

355

3.30

27.03

1.9

2.2

1.51

1.45

g/l

0.20

315

Syphilis

105

335

3.39

27.03

1.9

2.0

1.41

1.52

g/l

0.58

296

Syphilis

105

335

3.39

27.03

1.9

2.0

1.41

1.52

g/l

0.58

296

Mental and behavioural disorders due to opioids

103

322

3.35

26.98

1.7

2.1

1.63

1.38

g/l

1.54

287

Small fibre neuropathy

125

443

3.07

26.96

2.8

1.9

1.50

1.56

g/l

0.24

102

388

Kela reimbursement Agammaglobulinemia (D80-84)

6.74

26.89

2.0

2.6

1.31

1.39

g/l

0.17

Other diseases of biliary tract

289

1473

2.04

26.81

1.8

1.6

1.48

1.54

g/l

0.46

248

1246

Retinal vascular occlusion

415

2378

1.81

26.67

1.8

1.7

1.56

1.58

g/l

0.09

352

2017

Specific personality disorders

499

2989

1.70

26.60

1.7

1.9

1.55

1.42

g/l

2.15

437

2591

Fracture of foot, except ankle

575

3575

1.64

26.55

1.8

1.7

1.57

1.49

g/l

1.18

500

3063

Allergic purpura

101

317

3.38

26.48

1.5

2.1

1.63

1.48

g/l

0.66

280

Exclusions for E4_PCOS_BROAD

426

2451

1.78

26.44

1.8

1.7

1.55

1.50

g/l

0.48

370

2111

Injuries to the elbow and forearm

1763

11822

1.32

26.44

1.8

1.7

1.52

g/l

0.03

1507

10106

Disorders of synovium and tendon

1288

8210

1.39

26.43

1.7

1.47

1.51

g/l

0.89

1113

7007

Type 1 diabetes, strict definition

157

620

2.59

26.38

2.3

1.9

1.20

1.27

g/l

0.45

141

535

Total colectomy operation

141

535

2.79

26.36

1.7

2.0

1.61

1.48

g/l

0.86

130

473

Total colectomy

141

535

2.79

26.36

1.7

2.0

1.61

1.48

g/l

0.86

130

473

Other disorders of ear

2434

12608

1.28

26.34

1.6

1.7

1.53

1.55

g/l

0.57

2035

10803

DVT of lower extremities

555

3440

1.65

26.24

1.8

1.6

1.59

g/l

0.02

492

2925

Paralytic ileus

138

521

2.81

26.09

1.7

1.8

1.70

1.49

g/l

1.78

123

446

Other abnormalities of plasma proteins

216

4.08

26.09

2.0

1.9

1.80

1.50

g/l

1.56

187

Retinal vascular disorders

418

2415

1.79

26.09

1.8

1.7

1.56

1.58

g/l

0.12

353

2048

Hypothyroidism, other/unspecified

2339

12137

1.28

25.90

1.8

1.7

1.50

1.51

g/l

0.05

1986

10379

Malnutrition

284

3.58

25.83

1.5

1.8

1.45

1.47

g/l

0.09

251

Poor fetal growth

229

1079

2.17

25.76

3.2

1.9

1.11

1.27

g/l

2.36

206

942

Alcohol abuse, main dg, excluding more controls

370

2062

1.84

25.67

1.6

1.8

1.57

1.47

g/l

1.21

319

1761

Psoriatic arthropathies

257

1271

2.08

25.65

1.5

1.7

1.64

1.52

g/l

1.03

214

1091

Urticaria and erythema

846

5767

1.49

25.60

1.9

1.7

1.46

1.49

g/l

0.44

726

4948

Marginal zone B-cell lymphoma, including Hilmo

196

4.18

25.49

4.0

1.6

1.45

1.52

g/l

0.24

171

Traumatic subdural haemorrhage

438

2468

1.75

25.45

1.9

1.7

1.49

1.56

g/l

0.93

370

2097

Other specified/unspecified bacterial intestinal infections

212

982

2.26

25.43

1.8

1.56

1.53

g/l

0.20

180

851

Superficial injury of hip and thigh

452

2681

1.73

25.38

1.7

1.48

1.53

g/l

0.53

384

2277

Abscess of anal and rectal regions

218

1018

2.21

25.32

1.6

1.8

1.65

1.48

g/l

1.30

189

887

Respiratory disorders in diseases classified elsewhere

184

4.33

25.32

2.2

2.1

1.70

1.50

g/l

0.78

164

Disorders of porphyrin and bilirubin metabolism

120

5.21

25.31

1.9

2.2

0.86

1.49

g/l

6.35

102

Rotator cuff syndrome

1586

8575

1.34

25.27

1.7

1.58

1.56

g/l

0.44

1358

7276

Stomatitis and related lesions

497

3025

1.68

25.15

1.9

1.7

1.43

1.51

g/l

1.06

426

2596

Other and unspecified effects of external causes

632

4072

1.58

25.06

1.7

1.8

1.55

1.47

g/l

1.23

546

3484

Supplementary factors related to causes of morbidity and mortality classified elsewhere

792

5360

1.50

24.99

1.7

1.51

g/l

0.04

680

4572

Herpesviral [herpes simplex] infections

311

1660

1.93

24.94

1.7

1.8

1.51

1.52

g/l

0.10

273

1424

Coeliac disease

313

1675

1.92

24.86

1.7

1.8

1.44

1.52

g/l

0.74

262

1445

Polyarthritis, unspecified

124

454

2.89

24.85

1.6

1.9

1.75

1.52

g/l

1.35

109

392

Other and unspecified vasculitis limited to skin

322

3.33

24.76

1.5

2.0

1.50

1.51

g/l

0.06

279

Injury of unspecified body region

238

1164

2.13

24.74

1.9

1.8

1.59

1.50

g/l

0.69

214

1005

Clear cell adenocarcinoma of kidney

159

662

2.55

24.67

1.6

1.5

1.81

1.51

g/l

2.44

135

570

Hypothyreosis and Thyroxine purchase for inclusion criteria

2409

12591

1.27

24.59

1.8

1.7

1.51

g/l

0.03

2048

10769

Amputation of thigh

137

535

2.77

24.55

2.3

1.9

1.92

1.53

g/l

4.00

118

462

Amenorrhoea

155

635

2.51

24.36

2.4

1.9

1.21

1.35

g/l

1.02

126

566

Complications following infusion, transfusion and therapeutic injection

175

4.28

24.31

2.7

1.9

1.70

1.56

g/l

0.40

155

Retinal detachments and breaks

1011

7208

1.43

24.29

1.8

1.6

1.51

1.57

g/l

1.17

871

6139

Cholecystitis

442

2645

1.72

24.11

1.8

1.6

1.56

g/l

0.06

374

2241

Benign neoplasm: Descending colon

249

1256

2.08

24.06

1.7

1.55

1.56

g/l

0.04

223

1077

Postmenopausal osteoporosis with pathological fracture

218

1048

2.19

23.98

2.0

1.6

1.59

g/l

0.04

194

893

Vasculitis limited to skin, not elsewhere classified

104

355

3.15

23.91

1.5

1.9

1.48

1.54

g/l

0.21

309

Allergic asthma (mode), excluding more controls

419

2410

1.72

23.80

1.6

1.8

1.53

1.35

g/l

3.59

372

2057

Non-allergic asthma (mode)

435

2565

1.71

23.78

1.6

1.64

1.45

g/l

3.88

371

2159

Inflammatory diseases of the central nervous system

239

1187

2.09

23.77

1.9

1.8

1.73

1.52

g/l

2.61

206

1030

Personal history of other diseases and conditions

225

1083

2.12

23.72

2.1

1.8

1.32

1.38

g/l

0.38

194

931

Dermatitis due to substances taken internally

165

708

2.43

23.70

2.1

1.8

1.69

1.50

g/l

1.36

148

617

Operations for atrial fibrillation

247

3.76

23.68

2.2

1.7

1.25

1.54

g/l

1.65

212

Mature T/NK-cell lymphomas, hilmo

203

4.05

23.67

1.7

1.8

1.67

1.55

g/l

0.38

178

Procreative management

646

3509

1.55

23.63

2.2

1.7

1.32

1.52

g/l

5.66

551

3030

L04AC Interleukin inhibitors

156

653

2.48

23.60

1.7

1.9

1.77

1.52

g/l

1.80

126

568

Herpesviral [herpes simplex] infections

555

3523

1.60

23.55

1.8

1.7

1.46

1.48

g/l

0.14

493

3011

Aspergillosis

125

5.14

23.53

1.7

2.3

1.84

1.47

g/l

1.48

108

Combinations of oral blood glucose lowering drugs

765

5219

1.49

23.39

1.5

1.6

1.74

1.49

g/l

10.94

655

4448

Congenital malformations of aortic and mitral valves

130

503

2.72

23.38

2.0

1.25

1.48

g/l

1.68

436

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

808

5568

1.47

23.27

1.8

1.7

1.49

1.54

g/l

0.80

707

4761

Autoimmune hepatitis

6.29

23.22

1.9

1.4

1.31

1.53

g/l

0.57

Maternal care for other conditions predominantly related to pregnancy

339

1856

1.82

23.11

2.2

1.8

1.22

1.37

g/l

2.23

296

1615

Gonarthrosis,primary

2420

11965

1.26

23.07

1.5

1.7

1.61

1.56

g/l

1.48

2063

10191

Adalimumab

225

1104

2.10

22.98

1.5

1.9

1.58

1.51

g/l

0.39

198

954

Pyoderma gangrenosum

5.73

22.98

2.6

2.1

1.31

1.50

g/l

0.59

Psoriasis vulgaris

481

2978

1.65

22.84

1.7

1.8

1.63

1.53

g/l

1.18

409

2574

Pneumonia due to Streptococcus pneumoniae

129

503

2.69

22.79

2.0

1.7

1.74

1.45

g/l

2.41

106

433

Other specified congenital malformation syndromes affecting multiple systems

134

4.57

22.74

1.7

2.3

1.19

1.23

g/l

0.14

122

Asthma/COPD (KELA code 203)

2397

13219

1.25

22.65

1.6

1.8

1.61

1.49

g/l

8.69

2056

11288

Nonorganic sleeping disorders

461

2829

1.66

22.55

1.9

1.8

1.48

1.45

g/l

0.31

395

2441

Osteonecrosis due to drugs

215

3.87

22.51

2.2

1.9

1.78

1.52

g/l

1.03

191

Alcohol withdrawal state with delirium

221

1093

2.11

22.44

1.5

1.7

1.55

1.54

g/l

0.08

189

948

Scoliosis

223

1102

2.08

22.40

1.8

1.55

1.46

g/l

0.70

194

958

Adverse effects, not elsewhere classified

453

2774

1.66

22.38

1.8

1.54

1.48

g/l

0.68

396

2365

Generalized skin eruption due to drugs and medicaments

129

510

2.67

22.28

2.1

1.9

1.63

1.49

g/l

0.75

116

446

Infections with a predominantly sexual mode of transmission

751

4779

1.48

22.20

2.1

1.9

1.37

1.39

g/l

0.22

650

4143

Cholecystectomy

1855

12579

1.28

22.19

1.9

1.7

1.50

1.54

g/l

1.14

1584

10713

Other crystal arthropathies

282

3.38

22.05

1.7

1.8

1.67

1.56

g/l

0.39

239

Acute generalized exanthematous pustulosis

142

590

2.53

22.05

2.1

1.9

1.61

1.50

g/l

0.65

128

508

Thyroiditis, ILD-related definition

266

1405

1.94

21.99

2.0

1.8

1.43

1.53

g/l

0.98

221

1215

Mental and behavioural disorders due to tobacco

236

1203

2.03

21.85

1.7

1.8

1.74

1.52

g/l

2.55

212

1036

Malignant neoplasm of small intestine

278

3.35

21.78

1.4

1.6

1.63

1.52

g/l

0.43

242

Reactive arthropathies, FINNGEN

184

855

2.22

21.77

1.9

1.8

1.68

1.45

g/l

1.93

152

733

Viral warts

254

1328

1.97

21.76

2.1

1.8

1.53

1.47

g/l

0.42

229

1153

Other degenerative diseases of the nervous system

772

3963

1.48

21.67

1.5

1.7

1.55

1.56

g/l

0.11

618

3388

Olecranon bursitis

198

954

2.17

21.55

1.7

1.58

1.52

g/l

0.32

175

814

therapeutic use

119

463

2.75

21.44

1.6

1.7

1.74

1.55

g/l

1.14

406

Iridocyclitis

576

3773

1.56

21.44

1.8

1.7

1.51

1.53

g/l

0.11

500

3236

Iron deficiency

233

3.47

21.38

1.7

2.4

1.35

1.23

g/l

0.50

205

Schizophrenia or delusion, excluding more controls

636

4204

1.52

21.35

1.6

1.8

1.70

1.46

g/l

7.25

538

3591

Neovascular glaucoma

146

625

2.47

21.33

2.0

1.8

1.61

1.53

g/l

0.38

126

538

Other and unspecified haemorrhagic conditions

192

3.86

21.32

1.8

1.59

1.47

g/l

0.36

171

Smoking dependency

236

1216

2.01

21.20

1.7

1.8

1.74

1.52

g/l

2.54

212

1046

Polycystic ovarian syndrome, consortium definition

1477

6668

1.32

21.06

1.8

1.50

1.49

g/l

0.13

1260

5726

Drug-induced osteoporosis

162

4.19

21.04

2.2

1.61

1.57

g/l

0.10

141

Localized swelling, mass and lump of skin and subcutaneous tissue

801

5621

1.45

21.03

1.9

1.7

1.51

1.54

g/l

0.41

689

4796

Abscess of lung

209

3.73

20.99

1.6

2.0

1.92

1.50

g/l

1.92

183

Thyrotoxicosis, other and/or unspecified

480

3031

1.61

20.98

1.7

1.6

1.49

1.53

g/l

0.40

415

2583

Etanercept

164

739

2.30

20.97

1.4

1.9

1.52

1.51

g/l

0.04

132

644

Crystal arthropathies, rheuma endpoint

291

3.27

20.94

1.7

1.67

1.50

g/l

0.69

249

Colitis, primary sclerosing

122

4.61

20.90

1.7

2.1

1.25

1.50

g/l

1.03

109

Colitis, primary sclerosing, strict definition

5.26

20.89

1.7

2.2

1.15

1.51

g/l

1.86

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

6.32

20.84

2.0

2.1

1.67

1.59

g/l

0.14

Fall on and from stairs and steps

666

4526

1.50

20.77

1.7

1.51

1.54

g/l

0.34

566

3860

Right hemicolectomy

211

1060

2.09

20.70

1.6

1.7

1.74

1.52

g/l

2.44

182

916

Hypertrophic cardiomyopathy

153

679

2.39

20.67

1.8

1.51

1.55

g/l

0.25

133

595

Other hammer toe(s) (acquired)

435

2479

1.65

20.63

1.4

1.7

1.55

1.60

g/l

0.46

370

2073

Maternal care for known or suspected abnormality of pelvic organs

405

1647

1.70

20.48

2.7

2.0

1.13

1.41

g/l

9.34

358

1423

Umbilical hernia

694

4769

1.48

20.45

1.6

1.7

1.57

1.54

g/l

0.36

608

4117

Other diseases of lip and oral mucosa

960

6983

1.39

20.42

1.7

1.52

1.54

g/l

0.33

821

6008

Disturbances of skin sensation

613

4108

1.51

20.38

1.8

1.46

1.50

g/l

0.52

514

3531

Pulmonary oedema

301

3.19

20.37

2.4

1.7

1.61

1.55

g/l

0.22

263

Intracranial and intraspinal abscess and granuloma

157

4.21

20.35

1.8

2.0

2.06

1.49

g/l

3.19

136

Malignant neoplasm of bladder, including Hilmo

370

2199

1.72

20.33

1.7

1.5

1.74

1.52

g/l

3.99

325

1866

Hypothyroidism, strict autoimmune, 3 medication purchases required

2137

11609

1.25

20.27

1.8

1.7

1.51

g/l

0.13

1809

9925

Other symptoms and signs involving the circulatory and respiratory systems

176

829

2.19

20.16

1.8

1.6

1.57

1.55

g/l

0.09

154

712

Temporal arteritis

143

625

2.44

20.13

1.5

1.7

2.10

1.57

g/l

5.40

122

538

Unspecified human immunodeficiency virus [HIV] disease

106

4.94

20.03

1.5

1.6

1.24

1.61

g/l

1.72

Donors of organs and tissues

109

4.71

20.02

1.5

2.2

1.71

1.27

g/l

1.35

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

629

4209

1.50

19.97

1.4

1.6

1.99

1.55

g/l

14.57

527

3566

Type of accident

718

4990

1.46

19.89

1.7

1.51

g/l

0.04

616

4262

Special screening examination for other diseases and disorders

249

1330

1.91

19.84

1.9

1.6

1.57

1.54

g/l

0.16

225

1121

Cardiac murmurs and other cardiac sounds

217

1097

2.00

19.73

1.8

1.53

1.47

g/l

0.37

184

944

ILD-related respiratory insufficiency

136

588

2.48

19.71

2.4

1.9

1.62

1.56

g/l

0.32

119

510

Crohn disease (strict definition, all UC cases excluded)

137

588

2.42

19.71

1.6

2.0

1.47

1.45

g/l

0.07

124

518

Arterial embolism and thrombosis of lower extremity artery

132

561

2.49

19.65

2.0

1.9

1.74

1.47

g/l

2.37

115

481

Coxarthrosis, primary

1687

11282

1.28

19.60

1.5

1.7

1.63

1.58

g/l

1.40

1442

9556

Other disorders of bone

436

2735

1.62

19.59

1.6

1.8

1.46

1.49

g/l

0.25

371

2356

Sarcoidosis

343

2030

1.73

19.56

1.8

1.7

1.53

1.56

g/l

0.26

287

1749

Emotionally unstable personality disorder

240

1275

1.92

19.46

1.6

2.0

1.47

1.35

g/l

1.09

209

1106

Glaucoma secondary to other eye disorders

146

652

2.36

19.39

2.0

1.8

1.61

1.51

g/l

0.50

126

568

Single delivery by caesarean section

329

1072

1.79

19.30

2.7

2.1

1.13

1.40

g/l

6.66

299

923

Hypertension, Pulmonary Arterial

5.27

19.29

2.2

2.1

1.12

1.51

g/l

1.60

Other and unspecified psoriasis

200

1008

2.06

19.29

1.7

1.9

1.77

1.53

g/l

1.99

163

877

Heartburn

269

1491

1.85

19.20

1.6

1.7

1.46

1.52

g/l

0.52

237

1284

Alcohol-induced acute pancreatitis

123

512

2.54

19.18

1.7

1.9

1.72

1.55

g/l

1.16

106

439

Somatoform disorder

372

2257

1.68

19.17

1.6

1.8

1.53

1.50

g/l

0.24

310

1935

Conductive and sensorineural hearing loss

2121

11581

1.25

19.17

1.6

1.7

1.54

1.57

g/l

0.86

1749

9913

Juvenile arthritis (FINNGEN)

100

374

2.76

19.08

1.8

2.2

1.51

1.28

g/l

1.46

335

Exclusion endpoint for clefts

171

3.78

19.08

1.7

2.2

1.23

1.29

g/l

0.19

152

Cerebral palsy and other paralytic syndromes

297

1702

1.79

19.02

1.7

1.8

1.56

1.53

g/l

0.29

255

1461

Mental and behavioural disorders due to sedatives or hypnotics

164

769

2.20

19.02

1.4

1.9

1.67

1.50

g/l

1.45

130

671

961

6159

1.38

18.99

1.6

1.56

1.59

g/l

0.45

802

5194

Abnormal findings in nipple discharge synovial fluid wound secretions

178

3.79

18.99

2.0

2.4

1.50

1.46

g/l

0.09

156

Disorders of vitreous body and globe

1335

9894

1.31

18.98

1.8

1.6

1.50

1.58

g/l

3.00

1156

8409

Other ulcerative colitis

154

706

2.26

18.97

1.6

1.9

1.53

1.48

g/l

0.32

137

623

IBD (strict) with PSC

5.13

18.95

1.7

2.5

1.23

1.39

g/l

0.51

Giant cell arteritis with polymyalgia rheumatica

143

642

2.37

18.95

1.5

1.8

2.10

1.57

g/l

5.40

122

558

Thyrotoxicosis

600

4072

1.50

18.86

1.8

1.7

1.54

g/l

0.02

518

3456

Early onset COPD

586

3965

1.51

18.82

1.6

1.7

1.71

1.53

g/l

4.58

504

3389

Exclusions for E4_PCOS_CONSORTIUM

1540

7517

1.29

18.82

1.7

1.8

1.52

1.48

g/l

0.68

1301

6458

Gestational diabetes (for exclusion)

552

2526

1.53

18.79

2.5

2.0

1.23

1.31

g/l

1.30

487

2200

COPD, hospital admissions 1, only main diagnosis

1064

6815

1.36

18.76

1.5

1.6

1.72

1.55

g/l

6.99

909

5758

Carcinoma in situ of skin

291

1676

1.81

18.67

1.7

1.47

1.54

g/l

0.65

246

1430

Bacterial, viral and other infectious agents

209

1080

1.99

18.61

1.8

1.9

1.53

1.50

g/l

0.19

179

939

Corns and callosities

187

933

2.08

18.53

1.7

1.8

1.69

1.51

g/l

1.50

161

801

Ankylosing spondylitis

225

1194

1.94

18.50

1.6

1.8

1.62

1.50

g/l

0.90

184

1033

Bullous disorders

191

966

2.07

18.38

1.8

1.47

1.51

g/l

0.21

163

831

Attention to artificial openings

133

584

2.39

18.36

1.5

1.6

1.68

1.43

g/l

2.32

111

514

Common variable immunodeficiency

6.37

18.32

1.6

2.5

1.35

1.41

g/l

0.13

Mantle cell lymphoma, including Hilmo

188

3.68

18.31

1.9

1.5

1.54

1.52

g/l

0.04

163

Later onset COPD

961

5661

1.38

18.31

1.5

1.6

1.72

1.54

g/l

7.58

824

4764

Type1 diabetes, definitions combined, early onset

127

541

2.40

18.24

2.4

2.0

1.20

1.29

g/l

0.57

115

481

Other disorders of the musculoskeletal system and connective tissue

395

2470

1.64

18.23

1.7

1.56

g/l

0.01

339

2115

Malignant neoplasm of small intestine, including Hilmo

103

405

2.70

18.15

1.4

1.6

1.65

1.52

g/l

0.62

350

Transport accidents

1008

6451

1.36

18.10

1.8

1.49

g/l

0.03

855

5563

Portal vein thrombosis

209

3.49

18.10

2.3

2.0

1.31

1.61

g/l

1.25

182

Meniscus derangement

1289

6660

1.32

18.09

1.6

1.7

1.52

1.53

g/l

0.27

1091

5656

Adult respiratory distress syndrome

190

3.66

18.06

1.8

2.2

1.79

1.50

g/l

1.10

161

Polyarteritis nodosa and related conditions

160

3.87

18.05

1.7

2.2

1.62

1.45

g/l

0.58

144

Other overlap syndromes

219

3.40

18.05

2.4

2.0

1.65

1.48

g/l

0.57

191

Gilbert syndrome

5.40

17.89

1.9

2.0

0.85

1.42

g/l

3.59

Eosinophilia

216

3.43

17.85

1.6

2.1

1.58

1.52

g/l

0.22

187

Drug-induced hypoglycaemia without coma

221

3.39

17.85

1.7

1.9

1.60

1.48

g/l

0.46

195

Disorders of vitreous body

1287

9630

1.31

17.81

1.9

1.6

1.49

1.59

g/l

3.69

1112

8192

Special screening examination for neoplasms

152

713

2.20

17.68

1.7

1.6

1.49

1.56

g/l

0.36

129

605

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

5.14

17.68

2.0

2.1

1.65

1.45

g/l

0.50

Infarction of spleen

5.17

17.67

1.9

1.38

1.59

g/l

0.63

Supervision of high-risk pregnancy

300

1027

1.78

17.65

2.1

1.8

1.18

1.50

g/l

7.37

256

888

Chronic hepatitis NAS

144

4.01

17.62

1.7

1.9

1.35

1.50

g/l

0.51

127

Congenital malformations of cardiac septa

165

773

2.13

17.58

2.1

2.0

1.21

1.44

g/l

2.65

137

675

Benign neoplasm of other and unspecified endocrine glands

345

2106

1.68

17.57

1.5

1.7

1.67

1.55

g/l

1.34

299

1808

Keratitis

840

6131

1.39

17.57

1.9

1.7

1.52

1.51

g/l

0.06

721

5228

Mixed and other personality disorders

170

833

2.09

17.54

1.7

1.9

1.61

1.46

g/l

1.08

141

720

Other bursopathies

344

2100

1.68

17.47

1.8

1.6

1.53

1.58

g/l

0.42

300

1789

Rheumatism, unspecified

314

1870

1.72

17.46

1.8

1.7

1.60

1.61

g/l

0.07

274

1586

Sensorineural hearing loss

2033

11236

1.24

17.45

1.6

1.7

1.53

1.57

g/l

1.13

1679

9615

Bicuspidal aortic valve syndrome

110

454

2.54

17.43

1.9

2.0

1.33

1.50

g/l

0.92

393

Fissure and fistula of anal and rectal regions

538

3630

1.50

17.40

1.9

1.6

1.56

1.53

g/l

0.25

456

3082

Unspecified misadventure during surgical and medical care

169

834

2.11

17.40

1.8

1.9

1.36

1.54

g/l

1.84

138

718

Other congenital malformations

278

1602

1.77

17.36

1.7

1.9

1.37

1.46

g/l

0.94

229

1406

Dermatophytosis

363

2254

1.65

17.32

1.9

1.7

1.55

g/l

0.01

309

1939

Other juvenile arthritis

336

2.77

17.29

1.9

2.3

1.49

1.28

g/l

1.16

303

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

129

4.29

17.26

2.1

2.2

1.42

1.52

g/l

0.21

111

Assault

267

1524

1.78

17.22

1.7

1.9

1.48

1.44

g/l

0.25

226

1320

Bacterial, viral and other infectious agents

216

1160

1.91

17.15

1.8

1.9

1.56

1.50

g/l

0.41

186

1012

Fall on same level involving ice and snow

1395

10973

1.28

17.12

1.7

1.52

1.54

g/l

0.26

1174

9365

Other problems related to primary support group, including family circumstances

218

1139

1.90

17.09

2.2

1.9

1.34

1.38

g/l

0.22

192

1001

Melanocytic naevi of trunk

301

1786

1.73

17.07

1.9

1.8

1.43

1.52

g/l

0.98

263

1545

Melanocytic naevi

677

4791

1.43

17.05

2.1

1.7

1.37

1.52

g/l

4.50

595

4110

Excessive, frequent and irregular menstruation

823

3242

1.41

17.05

1.8

1.9

1.47

g/l

0.06

706

2761

Diseases of male genital organs

1360

5312

1.31

17.03

1.8

1.7

1.50

1.55

g/l

1.00

1174

4528

Benign neoplasm: Adrenal gland

224

1227

1.89

16.92

1.5

1.7

1.74

1.57

g/l

1.99

195

1058

Recurrent aphthous stomatitis , including avohilmo

352

2179

1.65

16.91

1.9

1.8

1.41

1.52

g/l

1.21

305

1869

malignant neoplasm of male genital organs

811

3571

1.41

16.87

1.7

1.6

1.61

1.52

g/l

1.80

694

3038

Other arterial embolism and thrombosis

101

408

2.62

16.86

1.9

2.0

1.80

1.45

g/l

2.90

351

Ulcerative colitis (strict) with PSC

5.44

16.86

1.8

2.1

1.28

1.39

g/l

0.30

Artificial joint operation, meniscal resection

2380

12815

1.21

16.84

1.6

1.7

1.60

1.55

g/l

1.59

2019

10930

Diseases of external ear

852

6287

1.37

16.73

1.8

1.7

1.57

1.53

g/l

0.52

723

5341

Organic, including symptomatic, mental disorders

1541

8724

1.27

16.68

1.5

1.7

1.60

1.58

g/l

0.51

1248

7452

Cyst of kidney

223

1228

1.89

16.64

2.0

1.7

1.68

1.52

g/l

1.80

190

1056

Allergic asthma (mode)

419

2643

1.57

16.63

1.6

1.8

1.53

1.36

g/l

3.27

372

2250

Fracture of forearm

1298

9288

1.29

16.62

1.8

1.7

1.55

1.54

g/l

0.21

1109

7921

Disorders of muscles

250

1418

1.81

16.62

1.9

1.7

1.61

1.52

g/l

0.73

222

1213

Other and unspecified injuries of head

199

1055

1.95

16.58

1.5

1.8

1.53

g/l

0.02

168

907

Chronic rhinitis, nasopharyngitis and pharyngitis

723

5198

1.41

16.58

1.6

1.7

1.52

1.51

g/l

0.05

614

4470

Extreme obesity with alveolar hypoventilation

129

585

2.31

16.56

1.3

1.8

1.79

1.54

g/l

2.03

104

504

KRA_PSY_EATING, excluding more controls

145

679

2.16

16.53

2.2

2.1

1.20

1.15

g/l

0.27

125

604

Atrial septal defect

101

407

2.57

16.53

2.4

2.1

1.17

1.44

g/l

2.24

361

Other congenital malformations

191

997

1.96

16.49

1.6

1.9

1.33

1.45

g/l

1.06

158

878

Arthropathic psoriasis

279

1638

1.75

16.47

1.5

1.7

1.60

1.55

g/l

0.30

233

1420

Unspecified urinary incontinence

238

1337

1.83

16.47

1.8

1.7

1.80

1.54

g/l

3.20

196

1153

Other peripheral vascular diseases

203

1085

1.93

16.43

2.0

1.8

1.45

1.49

g/l

0.19

173

933

Right bundle-branch block

108

454

2.49

16.43

1.5

1.57

g/l

0.02

390

Ulcerative colitis (strict definition, require KELA)

371

2340

1.61

16.42

1.9

1.8

1.45

1.48

g/l

0.27

327

2023

Dissection of aorta

118

519

2.41

16.38

1.5

1.9

1.56

1.44

g/l

0.69

445

Open wound of forearm

255

1463

1.79

16.37

1.9

1.7

1.47

1.49

g/l

0.19

210

1250

Pneumonitis due to solids and liquids

270

1582

1.76

16.25

1.6

1.7

1.74

1.53

g/l

2.67

223

1337

Dermatophytosis

1480

11787

1.27

16.22

1.7

1.50

1.52

g/l

0.35

1250

10097

Alcohol abuse, main dg

370

2342

1.61

16.19

1.6

1.8

1.57

1.50

g/l

0.77

319

2026

Acute and subacute iridocyclitis

460

3057

1.53

16.16

1.9

1.7

1.51

1.52

g/l

0.10

399

2627

Symptoms and signs involving speech and voice

825

6092

1.37

16.16

1.8

1.7

1.53

1.55

g/l

0.24

706

5189

Fall involving bed

121

542

2.37

16.15

1.8

1.56

1.57

g/l

0.04

105

468

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

525

3533

1.49

16.13

2.0

1.8

1.40

1.39

g/l

0.14

448

3065

Irregular menses

848

4933

1.37

16.09

1.9

1.42

1.44

g/l

0.19

729

4264

Carcinoma in situ of skin of scalp and neck

116

515

2.44

16.07

1.9

1.42

1.53

g/l

0.61

455

Paracetamol or NSAID medication

415

1319

1.60

16.02

1.9

1.8

1.48

1.32

g/l

2.51

366

1111

Primary hyperparathyroidism

297

1791

1.71

15.99

2.0

1.7

1.68

1.59

g/l

0.77

264

1534

Other disorders of bladder

348

2184

1.64

15.97

1.7

1.53

1.54

g/l

0.13

293

1867

Carcinoma in situ of skin of upper limb, including shoulder

109

472

2.50

15.95

1.9

1.51

1.56

g/l

0.23

413

Lung cancer and mesothelioma

485

2787

1.52

15.92

1.6

1.5

1.91

1.49

g/l

13.61

413

2330

Other retinal artery occlusion

410

2.60

15.89

1.7

1.9

1.62

1.59

g/l

0.10

360

Lung diseases due to external agents

430

2835

1.55

15.87

1.7

1.67

1.55

g/l

1.83

350

2410

Urticaria

624

4410

1.43

15.81

1.9

1.7

1.47

1.48

g/l

0.18

535

3793

Lumbar disc prolapse

1511

9251

1.26

15.80

1.6

1.7

1.61

1.53

g/l

2.46

1321

7910

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

360

2277

1.61

15.77

1.9

1.8

1.45

1.49

g/l

0.28

317

1968

Other headache syndromes

907

6803

1.35

15.76

1.7

1.8

1.45

1.50

g/l

0.77

770

5850

Acute alcohol intoxication, ICD10

473

3179

1.51

15.73

1.5

1.8

1.58

1.50

g/l

0.95

403

2751

Respiratory insufficiency

223

1242

1.84

15.71

1.6

1.5

1.71

1.50

g/l

2.44

189

1046

Other encephalitis

345

2.69

15.61

2.5

2.1

1.72

1.46

g/l

1.57

301

Pregnancy examination and test

222

745

1.87

15.61

2.1

1.9

1.16

1.43

g/l

4.60

199

639

Lichen simplex chronicus and prurigo

174

901

2.00

15.61

1.7

1.8

1.66

1.53

g/l

1.07

144

786

Personal history of medical treatment

124

4.08

15.55

1.7

2.2

1.80

1.47

g/l

0.99

113

Systemic sclerosis (FG)

266

2.94

15.53

2.0

1.7

1.52

1.47

g/l

0.17

230

Embolic stroke with flimmer

382

2.60

15.51

1.5

1.8

1.63

1.62

g/l

0.05

323

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

394

2554

1.57

15.50

1.9

1.8

1.45

1.48

g/l

0.30

349

2215

Ankylosing spondylitis, ICD10

215

1193

1.85

15.47

1.6

1.8

1.60

1.53

g/l

0.50

177

1042

Encephalitis

366

2.61

15.31

2.4

2.1

1.69

1.48

g/l

1.20

321

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

277

2.84

15.30

1.7

2.2

1.34

1.33

g/l

0.04

242

Other specified disorders of kidney and ureter

106

458

2.44

15.30

2.8

1.9

1.53

1.56

g/l

0.14

407

Malignant neoplasm of stomach, including Hilmo

179

943

1.97

15.28

1.4

1.6

1.56

1.51

g/l

0.29

160

792

Restrictive cardiomyopathy

6.64

15.27

2.2

1.9

1.36

1.52

g/l

0.33

Ulcerative enterocolitis

348

2.64

15.27

1.6

2.1

1.33

1.45

g/l

0.62

303

Post-traumatic stress disorder

153

759

2.06

15.25

1.9

2.0

1.33

1.29

g/l

0.23

130

674

Other postsurgical states

165

845

2.01

15.23

1.5

1.7

1.57

1.54

g/l

0.11

148

727

Anterior Iridocyclitis

486

3308

1.49

15.22

1.9

1.7

1.50

1.53

g/l

0.20

420

2832

Other other unspecified disorders of the circulatory system

119

542

2.30

15.17

1.6

1.8

1.47

1.50

g/l

0.12

474

Prurigo nodularis

335

2.69

15.01

1.6

1.9

1.59

1.53

g/l

0.25

294

Superficial injury of abdomen, lower back and pelvis

361

2316

1.59

14.94

1.7

1.46

1.50

g/l

0.37

297

2000

Viral warts

452

3045

1.51

14.84

1.9

1.8

1.47

1.48

g/l

0.10

399

2623

Presence of other devices

637

4563

1.41

14.78

1.9

1.6

1.55

1.59

g/l

0.61

552

3868

Follow-up examination after treatment for malignant neoplasms

259

1536

1.73

14.77

1.6

1.5

1.69

1.60

g/l

0.70

218

1299

Hyperplasia of prostate

1045

4541

1.32

14.77

1.8

1.7

1.53

1.57

g/l

0.71

903

3876

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

133

3.73

14.61

3.1

2.1

1.30

1.37

g/l

0.18

116

Other disorders of eyelid

1198

8989

1.28

14.58

1.6

1.7

1.53

1.58

g/l

1.39

1043

7604

Memory loss

283

1733

1.69

14.51

1.7

1.8

1.53

g/l

0.02

233

1502

Migraine

959

5930

1.32

14.50

1.9

1.8

1.40

1.44

g/l

0.64

831

5157

Carcinoma in situ of skin of ear and external auricular canal

292

2.87

14.48

2.1

1.7

1.49

1.56

g/l

0.22

250

Abnormal involuntary movements

341

2179

1.60

14.46

1.7

1.53

1.54

g/l

0.05

294

1868

Myocardial infarction, with ST-elevation

544

3830

1.45

14.44

1.6

1.68

1.54

g/l

2.74

468

3236

Rash and other nonspecific skin eruption

243

1428

1.75

14.39

1.7

1.8

1.59

1.54

g/l

0.27

208

1236

Psoriatic arthropathies, ICD10

253

1504

1.72

14.35

1.5

1.7

1.65

1.56

g/l

0.70

211

1294

Acute alcohol intoxication

628

4527

1.41

14.34

1.6

1.8

1.59

1.51

g/l

1.38

540

3891

Chronic laryngitis and laryngotracheitis

354

2288

1.58

14.27

1.7

1.65

1.57

g/l

0.80

295

1966

Acute pharyngitis

284

1722

1.66

14.25

1.8

2.0

1.43

1.39

g/l

0.38

248

1504

Diseases of the ear and mastoid process

2876

12314

1.18

14.19

1.8

1.49

1.52

g/l

0.68

2446

10577

Tobacco use

137

675

2.10

14.16

1.9

1.73

1.48

g/l

2.43

126

585

Progressive vascular leukoencephalopathy

147

751

2.07

14.06

1.5

1.7

1.61

1.53

g/l

0.51

120

645

Other shoulder lesions

212

1205

1.80

14.06

1.7

1.8

1.58

1.54

g/l

0.22

189

1029

Speech and linguistic disorders, excluding more controls

155

747

1.99

14.02

2.0

2.1

1.55

1.30

g/l

2.19

135

644

Toxic liver disease

183

3.28

14.02

1.9

2.0

1.31

1.52

g/l

0.83

164

Intentional self-harm by unspecified means

109

4.00

13.98

1.5

2.6

1.47

1.27

g/l

0.56

Other aneurysm

170

911

1.94

13.89

2.0

1.7

1.56

1.48

g/l

0.46

150

771

severe traumatic brain injury, does not include concussion

635

4619

1.40

13.87

1.8

1.6

1.50

1.54

g/l

0.61

530

3913

Trigger finger

324

2064

1.60

13.86

1.7

1.42

1.57

g/l

2.27

287

1757

Malignant melanoma, including Hilmo

431

2924

1.50

13.83

1.8

1.6

1.48

1.54

g/l

0.63

370

2492

Focal epilepsy

520

3653

1.45

13.80

1.9

1.7

1.47

1.52

g/l

0.48

426

3141

Other noninfective disorders of lymphatic vessels and lymph nodes

100

441

2.36

13.72

1.8

1.7

1.78

1.59

g/l

0.80

379

Pain associated with micturition

280

1729

1.66

13.71

2.2

1.7

1.47

1.54

g/l

0.73

239

1493

Other epidermal thickening

129

631

2.13

13.70

1.5

1.9

1.50

g/l

0.01

116

546

Other disorders of nervous system

187

1037

1.86

13.66

1.8

1.64

1.54

g/l

0.72

158

901

Inflammatory diseases of female pelvic organs

1183

6869

1.28

13.51

1.7

1.8

1.48

1.49

g/l

0.18

997

5915

Phobic anxiety disorders

232

1363

1.72

13.51

1.9

1.45

1.36

g/l

0.62

208

1184

Atrial septal defect, secundum type

262

2.77

13.47

2.0

2.1

1.21

1.38

g/l

0.85

231

Disorders of myoneural junction and muscle in diseases classified elsewhere

4.32

13.45

2.2

2.3

1.75

1.67

g/l

0.11

Panic disorder

272

1672

1.65

13.41

1.9

1.53

1.40

g/l

1.36

245

1448

Neuroendocrine tumor and carcinoma of small intestine

152

3.48

13.40

1.5

1.6

1.56

1.59

g/l

0.06

131

Synovial cyst of popliteal space [Baker]

194

1093

1.83

13.39

1.7

1.54

1.58

g/l

0.20

167

929

Abnormality of red blood cells

5.22

13.37

1.6

2.4

1.48

1.49

g/l

0.01

Background retinopathy and retinal vascular changes

307

2.67

13.36

2.0

2.1

1.55

1.50

g/l

0.17

273

Hallux valgus (acquired)

705

3737

1.37

13.33

1.6

1.7

1.56

1.55

g/l

0.06

602

3147

Artrosis, including avohilmo

2059

9406

1.21

13.33

1.6

1.8

1.57

1.52

g/l

1.23

1739

8018

Other extrapyramidal and movement disorders in other diseases

604

4389

1.40

13.27

1.6

1.7

1.51

1.57

g/l

0.77

509

3760

Volvulus

355

2.51

13.26

2.8

1.9

1.66

1.50

g/l

0.66

308

Coxibs

813

3203

1.35

13.25

1.7

2.0

1.52

1.44

g/l

1.76

690

2729

Mental and behavioural disorders due to use of other stimulants, including caffeine

215

2.94

13.17

1.5

2.1

1.50

1.33

g/l

0.61

195

Myositis

351

2.52

13.12

1.5

1.8

1.71

1.54

g/l

0.86

301

Periapical abscess

1007

7880

1.29

13.05

1.7

1.57

1.52

g/l

0.83

863

6754

Benign neoplasm: Rectosigmoid junction

136

693

2.06

13.04

1.5

1.8

1.69

1.57

g/l

0.76

116

598

Malignant neoplasm of prostate

779

3493

1.35

12.99

1.6

1.5

1.63

1.52

g/l

2.34

665

2972

Disorders of purine and pyrimidine metabolism

4.80

12.99

2.1

1.8

1.69

1.46

g/l

0.53

Campylobacter enteritis

322

2.57

12.98

2.1

2.0

1.59

1.50

g/l

0.25

279

Malignant melanoma

357

2363

1.54

12.97

1.9

1.6

1.46

1.54

g/l

0.94

308

2011

Nonalcoholic steatohepatitis

4.42

12.94

2.7

2.1

1.16

1.55

g/l

1.38

Faecal incontinence

226

1345

1.72

12.83

1.6

1.61

1.58

g/l

0.21

191

1149

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

158

846

1.92

12.82

1.6

1.9

1.58

1.47

g/l

0.74

132

741

Varicose veins

1543

9556

1.23

12.71

1.7

1.6

1.59

1.57

g/l

0.21

1300

8086

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

5.29

12.64

2.0

1.8

1.70

1.41

g/l

0.72

Gonarthrosis, primary, with knee surgery

1552

10162

1.23

12.63

1.5

1.7

1.64

1.57

g/l

1.88

1316

8641

Systemic sclerosis

297

2.62

12.60

2.0

1.8

1.52

g/l

0.00

259

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

705

5254

1.35

12.58

1.7

1.9

1.50

1.43

g/l

1.16

603

4523

Conotruncal defects

108

3.83

12.57

2.6

2.4

1.01

1.21

g/l

0.83

Focal epilepsy, strict definition

482

3401

1.44

12.56

1.9

1.7

1.50

1.53

g/l

0.19

391

2926

Assault by bodily force

150

794

1.93

12.54

1.9

2.0

1.47

1.44

g/l

0.16

131

690

Other specified and unspecified personality disorders

185

1046

1.81

12.54

1.6

1.9

1.66

1.47

g/l

1.54

164

907

Carcinoma in situ of skin of trunk

124

624

2.11

12.47

1.8

1.41

1.53

g/l

0.80

107

546

Other and unspecified nonorganic psychotic disorders

359

2395

1.52

12.42

1.6

1.8

1.61

1.44

g/l

2.41

303

2077

Other psoriatic arthropathies

240

1465

1.68

12.38

1.6

1.7

1.64

1.56

g/l

0.60

199

1258

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

290

2.65

12.31

2.1

1.8

1.47

1.62

g/l

0.71

256

Other/unspecified reactive arthropathies

161

881

1.88

12.27

2.0

1.9

1.70

1.53

g/l

1.07

131

774

Other and unspecified urticaria

407

2794

1.48

12.26

2.0

1.7

1.44

1.50

g/l

0.55

345

2389

Fibromyalgia

172

958

1.83

12.24

1.6

1.8

1.51

1.56

g/l

0.20

150

826

Other general symptoms and signs

102

469

2.21

12.24

1.8

1.7

1.30

1.43

g/l

0.83

399

Cardiomyopathy in other diseases

4.79

12.22

1.4

1.8

1.27

1.66

g/l

1.43

Other immunodeficiencies

106

3.85

12.19

2.0

2.4

1.24

1.49

g/l

0.81

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

163

896

1.86

12.14

2.4

1.8

1.36

1.60

g/l

2.69

145

768

Injury of intra-abdominal organs

284

2.61

12.14

1.7

2.2

1.67

1.45

g/l

0.85

254

Malignant neoplasm of prostate, including Hilmo

789

3558

1.34

12.11

1.5

1.6

1.61

1.52

g/l

1.93

673

3026

Carcinoma in situ of colon

311

2.59

12.11

1.8

2.0

1.68

1.54

g/l

0.69

270

Erosion of teeth , including avohilmo

490

3487

1.42

12.11

1.9

1.8

1.34

1.46

g/l

2.40

432

3007

Adenocarcinoma and Papillary adenocarcinoma of kidney

142

3.46

12.08

1.9

1.6

1.94

1.52

g/l

1.32

125

Spontaneous rupture of synovium and tendon

207

1225

1.73

12.05

1.7

1.6

1.64

1.60

g/l

0.27

174

1042

Hepatocellular carcinoma, including Hilmo

429

2.30

12.04

1.7

1.6

1.16

1.48

g/l

2.63

360

Spondylolisthesis/Spondylolysis

418

2897

1.47

12.04

1.8

1.7

1.62

1.58

g/l

0.42

371

2484

Sequelae of injuries, of poisoning and of other consequences of external causes

511

3669

1.41

12.03

1.6

1.8

1.63

1.54

g/l

1.38

437

3155

Drug-induced adrenocortical insufficiency

211

2.92

12.03

1.8

2.1

1.71

1.49

g/l

0.66

188

Use of disulfiram, acamprosate or naltrexone

194

1128

1.76

12.00

1.5

1.8

1.74

1.50

g/l

2.81

165

974

Migraine with aura

449

3149

1.44

11.99

1.7

1.9

1.44

1.41

g/l

0.19

391

2741

Trochanteric bursitis

314

2058

1.55

11.93

1.8

1.7

1.57

1.59

g/l

0.13

274

1740

Deficiency of other B group vitamins

294

2.59

11.89

1.7

1.8

1.37

1.50

g/l

0.50

260

Injuries to the neck

490

3501

1.42

11.87

1.7

1.8

1.50

1.48

g/l

0.19

424

3007

Internal derangement of knee

789

6027

1.31

11.87

1.6

1.7

1.53

1.50

g/l

0.25

660

5140

Hyphaema and other vascular disorders of iris and ciliary body

301

2.58

11.86

1.8

2.1

1.83

1.50

g/l

1.93

263

Striking against or struck by other objects

700

5283

1.34

11.86

1.8

1.48

g/l

0.09

603

4543

Fracture of skull and facial bones

480

3420

1.42

11.83

1.7

1.8

1.49

1.52

g/l

0.26

418

2931

Septal defects

140

724

1.94

11.83

1.8

2.0

1.27

1.43

g/l

1.35

116

633

!Aliquae complicationes praecoces traumatis

120

604

2.06

11.82

1.9

2.0

1.63

1.51

g/l

0.63

107

525

Early complications of trauma

120

604

2.06

11.82

1.9

2.0

1.63

1.51

g/l

0.63

107

525

Other benign neoplasms of skin

926

7273

1.29

11.79

1.9

1.6

1.50

1.56

g/l

1.37

757

6210

Oter anti-inflammatory and antirheumatic agents, non-steroids

674

2763

1.36

11.79

1.7

1.8

1.57

1.49

g/l

1.31

573

2343

Ulcerative ileocolitis

437

2.25

11.78

1.9

2.0

1.40

1.49

g/l

0.41

383

Bronchiectasis

232

1427

1.67

11.78

1.6

1.66

1.54

g/l

1.12

195

1216

Chronic sinusitis

954

7509

1.28

11.75

1.8

1.7

1.55

1.52

g/l

0.42

813

6441

Systemic sclerosis, icd10

302

2.54

11.70

2.0

1.9

1.54

1.56

g/l

0.05

264

Carcinoma in situ of other and unspecified digestive organs

114

569

2.11

11.67

1.8

1.9

1.60

1.58

g/l

0.09

105

495

Wet age-related macular degeneration

556

3958

1.39

11.65

1.5

1.6

1.59

1.58

g/l

0.13

464

3353

Conjunctivitis (acute, non atopic)

586

4308

1.37

11.64

2.0

1.7

1.51

g/l

0.02

529

3685

Redundant prepuce, phimosis and paraphimosis

476

3363

1.42

11.63

1.6

1.7

1.55

1.52

g/l

0.21

402

2862

Convalescence

114

565

2.07

11.62

1.8

1.7

1.55

1.50

g/l

0.24

496

Rheumatic fever incl heart disease

101

482

2.19

11.56

2.4

1.9

1.35

1.53

g/l

0.86

418

Eating disorders

192

1121

1.74

11.56

2.0

2.1

1.28

1.32

g/l

0.21

167

984

Haemorrhagic disorder due to circulating anticoagulants

229

2.84

11.55

1.7

1.5

1.58

1.64

g/l

0.20

206

Orchitis and epididymitis

257

1626

1.62

11.54

1.6

1.66

1.53

g/l

1.44

231

1398

Malignant neoplasm of stomach

146

792

1.90

11.52

1.3

1.5

1.55

1.50

g/l

0.28

130

665

Nail disorders

187

1090

1.76

11.50

2.3

1.8

1.64

1.51

g/l

0.95

167

948

Other disorders of optic [2nd] nerve and visual pathways

159

887

1.84

11.43

2.0

1.9

1.40

1.51

g/l

0.75

138

772

Enteropathic arthropathies

239

2.71

11.43

1.5

2.3

1.55

1.45

g/l

0.41

213

Orthopaedic devices associated with adverse incidents

289

2.60

11.43

1.4

1.9

1.70

1.56

g/l

0.61

254

Infective dermatitis

275

1771

1.58

11.39

1.5

1.7

1.52

1.54

g/l

0.08

228

1535

Open wound of abdomen, lower back and pelvis

367

2.35

11.38

1.9

2.1

1.67

1.43

g/l

1.35

323

Central retinal artery occlusion

403

2.32

11.34

1.8

1.57

1.50

g/l

0.24

350

Malignant neoplasm of bladder

204

1226

1.71

11.28

1.5

1.82

1.49

g/l

4.63

178

1040

Other diseases of upper respiratory tract

2862

12966

1.16

11.24

1.8

1.7

1.54

1.52

g/l

0.57

2437

11069

Disorders of conjunctiva

1878

12745

1.19

11.24

1.9

1.7

1.49

1.51

g/l

0.27

1638

10880

Carpal tunnel syndrome

1424

10365

1.22

11.23

1.7

1.57

1.54

g/l

0.59

1235

8827

Rheumatic valve diseases

346

2.40

11.20

2.5

1.8

1.21

1.58

g/l

2.15

302

Follow-up care involving plastic surgery

388

2.29

11.20

1.5

1.7

1.75

1.51

g/l

1.20

338

Menorrhagia

704

2943

1.34

11.13

1.8

1.47

1.52

g/l

0.71

595

2488

Primary gonarthrosis, bilateral

1344

9470

1.23

11.07

1.5

1.7

1.63

1.57

g/l

1.68

1130

8045

Marfan's syndrome

5.23

11.04

1.6

1.9

1.18

1.41

g/l

0.40

Pure hyperglyceridaemia

280

2.55

11.01

1.8

2.2

1.72

1.53

g/l

0.82

246

Complications of other internal prosthetic devices, implants and grafts

116

593

2.03

10.99

1.6

1.7

1.42

1.54

g/l

0.76

103

516

Congenital malformations of pulmonary and tricuspid valves

4.89

10.95

2.8

1.6

1.10

1.28

g/l

0.43

Disorders of iron metabolism

166

3.06

10.93

1.6

2.4

1.21

1.48

g/l

1.10

144

Viral haemorrhagic fevers, not elsewhere classified/unspecified

375

2596

1.47

10.92

1.6

1.7

1.45

1.53

g/l

1.03

336

2238

Overexertion and strenuous or repetitive movements

222

1373

1.65

10.92

1.5

1.8

1.57

1.52

g/l

0.35

185

1193

Other chondrocalcinosis

207

2.89

10.91

1.7

2.1

1.65

1.57

g/l

0.17

186

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

176

1027

1.76

10.90

1.7

1.6

1.40

1.53

g/l

1.03

144

877

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

182

2.93

10.90

1.7

2.4

1.66

1.41

g/l

0.85

159

Other predominantly sexually transmitted diseases, not elsewhere classified

293

1928

1.54

10.89

1.8

1.9

1.42

g/l

0.01

248

1671

Superficial injury of thorax

360

2477

1.48

10.87

1.8

1.7

1.42

1.51

g/l

1.10

308

2113

Speech disturbances, not elsewhere classified

247

1573

1.61

10.86

1.8

1.7

1.59

1.54

g/l

0.38

207

1342

Exposure to other and unspecified inanimate mechanical forces

168

967

1.78

10.84

1.8

1.50

1.53

g/l

0.12

144

845

Generalized anxiety disorder

274

1779

1.56

10.82

1.8

1.9

1.37

1.40

g/l

0.22

242

1557

Malignant neoplasm of oral cavity, including Hilmo

118

612

1.99

10.70

1.5

1.65

1.52

g/l

0.94

101

530

Carcinoma in situ of skin of lower limb, including hip

381

2.33

10.69

1.9

1.8

1.40

1.62

g/l

1.60

339

Schizophrenia or delusion

636

4817

1.33

10.64

1.6

1.8

1.70

1.49

g/l

6.16

538

4121

Extrapyramidal and movement disorders

979

7844

1.26

10.62

1.6

1.54

1.56

g/l

0.29

813

6697

Other disorders of amino-acid metabolism

5.10

10.61

6.6

2.6

0.90

1.55

g/l

2.70

Other predominantly sexually transmitted diseases, not elsewhere classified

343

2343

1.48

10.61

2.0

1.38

1.40

g/l

0.13

288

2032

Postprocedural musculoskeletal disorders, not elsewhere classified

192

1158

1.71

10.56

1.9

1.7

1.68

1.56

g/l

0.87

159

1004

Seborrhoeic keratosis

557

4151

1.36

10.55

1.8

1.6

1.47

1.57

g/l

1.90

498

3537

Status epilepticus

103

513

2.08

10.51

1.6

1.9

1.54

1.48

g/l

0.20

444

Marginal zone B-cell lymphoma

103

3.69

10.48

3.4

1.6

1.64

1.53

g/l

0.21

Lesion of ulnar nerve

317

2143

1.50

10.48

1.6

1.7

1.55

1.54

g/l

0.04

279

1844

Other primary thrombocytopenia

5.27

10.42

2.0

1.27

1.42

g/l

0.27

Cutaneous lupus erythematosus

294

2.46

10.39

2.3

2.0

1.49

1.56

g/l

0.23

258

Acute suppurative otitis media

454

3051

1.40

10.39

2.0

1.9

1.40

1.37

g/l

0.38

396

2656

Visual field defects

223

1402

1.63

10.36

1.6

1.7

1.55

1.54

g/l

0.10

196

1210

Blindness, monocular

119

3.47

10.35

1.8

2.4

1.68

1.52

g/l

0.29

107

Other and unspecified mood [affective] disorders

131

708

1.88

10.35

1.8

2.0

1.55

1.37

g/l

1.46

109

632

Personal history of certain other diseases

138

3.16

10.34

1.5

2.1

1.53

1.26

g/l

1.12

123

Other disorders of eye and adnexa

302

2027

1.51

10.33

1.9

1.8

1.47

1.52

g/l

0.50

268

1739

Focal epilepsy, mode (most common among epilepsy diagnosis)

442

3184

1.41

10.32

1.7

1.47

1.52

g/l

0.52

359

2739

Leisure time condition

422

3019

1.42

10.29

1.7

1.47

1.51

g/l

0.46

357

2594

Mantle cell lymphoma

125

3.42

10.28

1.5

1.6

1.60

1.50

g/l

0.21

107

Degenerative macular diseases

342

2362

1.48

10.27

1.7

1.6

1.60

1.58

g/l

0.10

291

2011

Selective deficiency of immunoglobulin G [IgG] subclasses

4.39

10.24

2.7

2.2

1.52

g/l

0.01

Congenital iodine-deficiency syndrome/hypothyroidism

418

2.20

10.24

1.9

1.7

1.56

1.52

g/l

0.14

361

Other disorders of iris and ciliary body

393

2.24

10.18

1.7

2.0

1.79

1.53

g/l

1.59

349

Benign neoplasm of mouth and pharynx

265

1739

1.56

10.17

1.5

1.7

1.55

1.54

g/l

0.05

214

1491

Chorioretinal inflammation

360

2.29

10.17

1.7

2.0

1.68

1.58

g/l

0.36

311

Hypopituitarism

152

867

1.79

10.13

2.1

1.9

1.43

1.50

g/l

0.42

137

759

Other symptoms and signs involving the urinary system

269

1774

1.55

10.11

1.7

1.60

1.54

g/l

0.50

230

1524

Degeneration of nervous system due to alcohol

363

2.30

10.11

1.6

1.8

1.61

1.58

g/l

0.08

306

Schizophrenia, schizotypal and delusional disorders

636

4854

1.32

10.10

1.6

1.8

1.70

1.49

g/l

6.01

538

4152

Other condition

313

2127

1.50

10.09

1.7

1.57

1.51

g/l

0.42

276

1831

Acute lymphadenitis

120

638

1.92

10.04

2.0

1.52

1.50

g/l

0.05

112

556

Eating disorder

145

815

1.80

10.02

2.2

2.3

1.20

1.21

g/l

0.05

125

715

Necrotizing fasciitis

4.67

10.00

1.3

1.6

1.80

1.55

g/l

0.61

Other congenital malformations of the digestive system

117

614

1.94

9.99

2.0

1.9

1.40

1.45

g/l

0.27

101

539

Other congenital malformations of the digestive system

102

513

2.03

9.89

2.1

2.0

1.39

1.43

g/l

0.18

450

Organ-limited amyloidosis

4.37

9.83

1.6

2.6

1.37

1.65

g/l

0.70

Arthropod-borne viral fevers and viral haemorrhagic fevers

412

2960

1.41

9.80

1.6

1.7

1.47

1.52

g/l

0.47

370

2548

Necrobiosis lipoidica, not elsewhere classified

4.99

9.77

2.4

2.5

1.46

1.34

g/l

0.19

Lesion of lateral popliteal nerve

128

704

1.87

9.74

1.9

1.53

1.54

g/l

0.05

110

614

Ingrowing nail

122

660

1.90

9.73

1.8

1.9

1.69

1.48

g/l

1.53

108

577

Unspecified mental disorder

823

6522

1.27

9.73

1.6

1.8

1.62

1.48

g/l

3.73

703

5577

Degeneration of the brain due to alcohol

369

2.27

9.73

1.6

1.8

1.61

1.59

g/l

0.08

314

Other misadventures during surgical and medical care

310

2.37

9.71

1.8

2.0

1.70

1.49

g/l

0.81

273

Impacted cerumen

271

1808

1.53

9.71

1.5

1.7

1.55

1.53

g/l

0.13

211

1548

Otitis externa

481

3551

1.37

9.68

1.9

1.7

1.54

1.51

g/l

0.27

425

3043

Other specified/unspecified soft tissue disorders

124

677

1.88

9.64

1.6

1.7

1.60

1.59

g/l

0.02

103

582

Adhesive capsulitis of shoulder

373

2643

1.43

9.64

1.6

1.7

1.63

1.58

g/l

0.48

326

2232

Pemphigoid

464

2.11

9.62

1.9

1.51

1.57

g/l

0.21

404

conjunctival haemorrhage

208

1313

1.63

9.58

2.2

1.7

1.49

1.54

g/l

0.33

185

1122

Pain in thoracic spine

318

2191

1.47

9.54

1.9

1.7

1.51

1.52

g/l

0.11

270

1882

Cervicalgia

458

3363

1.38

9.54

1.7

1.50

1.54

g/l

0.51

385

2882

Other congenital malformations of urinary system

5.32

9.54

1.8

2.8

1.63

1.38

g/l

0.50

Iridocyclitis in diseases classified elsewhere

232

2.58

9.53

1.5

2.1

1.37

1.48

g/l

0.38

204

Other specified and unspecified retinal disorders

103

533

2.01

9.52

2.1

1.9

1.48

1.61

g/l

0.57

459

Other follicular disorders

153

891

1.75

9.52

1.7

1.9

1.67

1.47

g/l

1.77

141

782

Congenital malformations of cardiac chambers and connections

5.25

9.50

2.2

2.6

1.04

1.09

g/l

0.09

Follicular lymphoma, hilmo

126

698

1.88

9.48

1.6

1.9

1.81

1.55

g/l

1.37

606

Other and unspecified vascular occlusions

272

1827

1.53

9.47

1.8

1.6

1.54

1.57

g/l

0.24

228

1549

Postzoster neuralgia

234

2.59

9.45

1.6

1.8

1.39

1.59

g/l

0.77

211

Emphysema

215

1376

1.60

9.36

1.5

1.7

1.72

1.53

g/l

1.97

181

1170

Acute and transient psychotic disorders

227

1465

1.57

9.35

1.6

1.8

1.66

1.51

g/l

1.44

191

1272

Malignant melanoma of skin, including Hilmo

341

2394

1.45

9.34

1.8

1.6

1.47

1.54

g/l

0.79

298

2041

Fracture of neck

171

1036

1.70

9.33

1.7

1.8

1.51

1.53

g/l

0.10

147

894

Diplopia

313

2164

1.47

9.32

1.6

1.7

1.61

1.55

g/l

0.55

263

1864

Ankylosing spondylitis, strict definition

460

2.05

9.26

1.3

2.0

1.51

1.50

g/l

0.01

399

Benign neoplasm of urinary organs

132

746

1.83

9.25

2.0

1.9

1.62

1.51

g/l

0.59

113

650

Other specified and unspecified disorders of eye and adnexa

503

2.01

9.23

1.9

1.51

1.49

g/l

0.09

438

Ulcerative colitis (strict definition, all Crohn cases excluded)

293

2001

1.49

9.23

1.8

1.41

1.49

g/l

0.77

258

1733

Other abnormal uterine and vaginal bleeding

482

2550

1.37

9.22

1.7

1.56

g/l

0.01

400

2142

Disorders of optic nerve and visual pathways

206

1307

1.61

9.20

1.9

1.41

1.49

g/l

0.58

177

1141

Rare circulating lymphoid malignancy

3.91

9.19

1.5

1.7

1.48

1.45

g/l

0.04

Artificial joint re-operation

193

1211

1.64

9.17

1.5

1.7

1.73

1.57

g/l

1.21

158

1044

Inflammatory disease of uterus

239

1566

1.55

9.17

2.0

1.8

1.43

1.45

g/l

0.09

204

1348

Abdominal aortic aneurysm (AAA)

310

2132

1.47

9.15

1.8

1.7

1.67

1.51

g/l

2.00

267

1783

Voice disturbances

594

4563

1.32

9.13

1.8

1.7

1.51

1.55

g/l

0.63

513

3894

Other specified/unspecified inflammatory spondylopathies

491

2.00

9.05

1.8

2.0

1.45

1.48

g/l

0.14

426

Nummular dermatitis

204

1299

1.61

9.04

1.6

1.7

1.60

1.52

g/l

0.61

173

1116

Other erythematous conditions

452

2.06

9.04

1.9

2.0

1.34

1.51

g/l

1.11

395

Malignant neoplasm of head and neck

200

1267

1.61

9.04

1.7

1.6

1.74

1.53

g/l

2.37

171

1087

CR(E)ST syndrome

179

2.77

9.02

2.0

1.51

1.61

g/l

0.33

155

Other bacterial agents as the cause of diseases classified to other chapters

124

3.20

9.01

2.1

2.2

1.71

1.56

g/l

0.43

106

Coxarthrosis, primary, with hip surgery

1261

9867

1.21

9.01

1.5

1.6

1.62

1.58

g/l

0.84

1070

8340

Senility

123

3.16

9.00

1.4

1.49

1.60

g/l

0.24

107

Viral infections of the central nervous system

158

944

1.71

8.99

1.6

1.9

1.52

1.51

g/l

0.04

133

824

Other surgical follow-up care

345

2.21

8.98

1.9

1.8

1.40

1.42

g/l

0.08

307

Speech and linguistic disorders

158

905

1.70

8.90

1.9

2.1

1.57

1.30

g/l

2.48

137

793

Migraine without aura

318

2221

1.44

8.84

1.9

1.31

1.38

g/l

0.66

267

1938

Anorexia (incl.atypical)

115

629

1.86

8.82

2.0

2.1

1.31

1.37

g/l

0.28

103

551

Other abnormal immunological findings in serum

204

2.60

8.81

1.6

2.2

1.58

1.47

g/l

0.37

177

Carrier of infectious disease

265

2.39

8.81

2.8

2.3

1.43

1.40

g/l

0.10

232

Autoimmune hyperthyroidism

112

609

1.88

8.78

1.8

1.5

1.44

1.54

g/l

0.55

526

Cushing syndrome

126

3.12

8.74

1.8

2.1

1.99

1.46

g/l

1.71

110

Abnormal findings on antenatal screening of mother

112

609

1.86

8.71

2.0

1.14

1.20

g/l

0.29

534

Embolic stroke

150

896

1.73

8.67

1.5

1.7

1.58

1.52

g/l

0.34

133

766

Contact with heat and hot substances

119

664

1.84

8.65

1.8

2.0

1.35

1.50

g/l

0.99

576

Disorders of tooth development and eruption

307

1724

1.46

8.63

1.6

1.7

1.48

1.46

g/l

0.21

271

1466

Macular pucker

420

3104

1.38

8.61

1.5

1.6

1.52

1.59

g/l

0.93

353

2660

Other/unspecified synovitis and tenosynovitis

247

1656

1.52

8.59

1.8

1.7

1.43

1.57

g/l

1.62

214

1408

Vitamin D deficiency

183

2.68

8.59

1.9

2.4

1.47

g/l

0.01

161

Post-traumatic wound infection, not elsewhere classified

327

2.22

8.53

1.7

2.1

1.62

1.46

g/l

0.71

291

Alcohol induced polyneuropathy

151

2.93

8.52

1.9

1.5

1.62

1.56

g/l

0.15

131

Nonsuppurative otitis media

443

2843

1.36

8.49

2.3

2.0

1.48

1.38

g/l

1.54

390

2488

Behavioural syndromes associated with physiological disturbances and physical factors

2081

12853

1.15

8.49

1.7

1.8

1.46

1.51

g/l

1.78

1775

11004

Ectropion of eyelid

135

790

1.77

8.49

1.8

1.7

1.57

1.51

g/l

0.33

115

662

Preterm labour and delivery

399

2920

1.38

8.47

2.5

1.8

1.22

1.54

g/l

10.56

342

2528

Malignant neoplasm of rectum, including Hilmo

297

2073

1.46

8.46

1.6

1.5

1.74

1.54

g/l

2.91

257

1756

Implicit parasitic Sepsis

4.33

8.46

2.9

1.9

1.59

1.46

g/l

0.23

Impetigo

434

2.03

8.45

2.3

2.1

1.26

1.40

g/l

0.90

380

Fibroblastic disorders

567

4379

1.31

8.43

1.5

1.6

1.47

1.56

g/l

1.67

489

3696

Primary adrenocortical insufficiency

129

3.05

8.41

1.9

2.4

1.40

1.41

g/l

0.01

113

Twin gestation

122

690

1.79

8.37

2.5

1.8

1.09

1.43

g/l

4.43

110

591

Infection due to other mycobacteria

186

2.66

8.37

2.2

1.8

1.60

1.55

g/l

0.16

156

Conjunctivitis

1588

11354

1.17

8.35

1.8

1.49

1.50

g/l

0.09

1384

9718

Juvenile rheumatoid arthirtis

156

2.77

8.35

1.4

2.2

1.60

1.31

g/l

1.00

142

Erythema intertrigo

312

2.24

8.28

1.7

1.8

1.62

1.51

g/l

0.41

277

Fracture at wrist and hand level

727

5785

1.26

8.28

1.7

1.8

1.49

1.50

g/l

0.10

617

4955

Complications of genitourinary prosthetic devices, implants and grafts

325

2.21

8.27

2.0

1.8

1.80

1.57

g/l

1.16

283

Intrahepatic Cholestasis of Pregnancy (ICP)

104

563

1.88

8.26

2.3

1.9

1.11

1.34

g/l

1.77

485

Other operation for atrial fibrillation

3.67

8.24

1.7

1.9

1.44

1.55

g/l

0.19

Other and unspecified injuries of lower leg

157

959

1.67

8.23

1.8

2.0

1.52

1.50

g/l

0.11

135

841

Malignant melanoma of skin

256

1748

1.49

8.21

1.7

1.6

1.45

1.54

g/l

0.88

223

1497

Restless leg syndrome

300

2110

1.45

8.20

1.7

1.46

1.55

g/l

1.00

257

1807

Symptoms and signs involving emotional state

312

2.21

8.19

2.0

2.1

1.43

1.51

g/l

0.25

270

Other and unspecified erythematous conditions

407

2.06

8.17

1.8

2.0

1.36

1.52

g/l

0.94

356

Ulcerative proctitis

127

735

1.76

8.15

1.6

1.9

1.59

1.49

g/l

0.60

110

641

Other mycoses, not elsewhere classified/unspecified

201

2.56

8.11

2.1

2.0

1.52

1.47

g/l

0.14

175

Other disorders of conjunctiva

349

2527

1.40

8.10

2.1

1.6

1.50

1.58

g/l

0.88

307

2165

Varicella [chickenpox]

102

554

1.88

8.06

2.7

2.0

1.45

1.40

g/l

0.18

474

Viral infections of the central nervous system

164

1019

1.64

8.06

1.7

1.9

1.53

1.52

g/l

0.03

139

889

Malignant neoplasm of renal pelvis, including Hilmo

161

2.78

8.05

2.2

1.7

1.79

1.59

g/l

0.59

138

Erythema nodosum

355

2.13

8.04

1.8

1.9

1.59

1.53

g/l

0.20

311

Multiple gestation

124

714

1.76

8.02

2.5

1.8

1.10

1.43

g/l

4.35

112

611

Other congenital malformations of skin

437

2.00

7.99

1.5

2.2

1.35

1.48

g/l

0.67

386

Other/unspecified crystal arthropathies

3.59

7.97

1.7

1.8

1.67

1.66

g/l

0.01

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1171

9555

1.20

7.97

1.8

1.7

1.57

1.53

g/l

0.65

986

8219

Psychotic depression

127

740

1.75

7.95

1.7

1.9

1.58

1.47

g/l

0.60

112

645

Diseases of tongue

138

824

1.71

7.94

1.6

1.58

1.52

g/l

0.30

117

692

Other bullous disorders

371

2.10

7.94

1.9

2.0

1.32

1.47

g/l

0.79

331

Diseases of salivary glands

676

5377

1.27

7.92

1.9

1.7

1.54

1.53

g/l

0.11

583

4589

Migraine with aura and triptan purchases

253

1732

1.48

7.90

1.6

1.9

1.53

1.40

g/l

1.13

212

1518

Other bacterial agents as the cause of diseases classified to other chapters

145

2.85

7.89

2.1

1.73

1.53

g/l

0.67

124

Ovarian cyst

686

3124

1.28

7.85

1.7

1.8

1.53

1.48

g/l

0.56

596

2661

Other keratitis

232

1569

1.50

7.79

2.0

1.8

1.61

1.51

g/l

0.73

202

1358

Superficial injury of wrist and hand

387

2862

1.37

7.78

1.5

1.8

1.52

1.47

g/l

0.55

334

2473

Other maternal disorders predominantly related to pregnancy

904

4627

1.23

7.75

2.0

1.8

1.33

1.50

g/l

6.81

778

3998

Focal brain injury

158

983

1.64

7.75

1.7

1.51

g/l

0.04

133

846

Varicella [chickenpox]

498

1.91

7.74

2.8

2.0

1.39

1.42

g/l

0.08

429

Asthma and allergy, excluding more controls

177

1112

1.58

7.73

1.6

1.9

1.52

1.29

g/l

3.27

158

953

Traction detachment of retina

114

3.12

7.70

2.8

2.2

1.68

1.48

g/l

0.57

Necrosis of pulp, including avohilmo

1173

9864

1.19

7.66

1.8

1.49

1.50

g/l

0.22

998

8499

Abnormal findings on diagnostic imaging of central nervous system

105

587

1.83

7.64

2.1

2.0

1.44

1.52

g/l

0.35

515

Caries of enamel

1896

11934

1.15

7.63

1.9

1.7

1.43

1.51

g/l

4.06

1659

10230

Traumatic subarachnoid haemorrhage

538

1.88

7.62

1.7

1.46

1.54

g/l

0.33

464

Other and specified injuries of hip and thigh

330

2.15

7.61

1.4

2.0

1.59

1.53

g/l

0.17

294

Paraplegia, diplegia of upper limbs

290

2.23

7.61

1.7

1.9

1.79

1.49

g/l

1.36

255

Somnolence, stupor and coma

109

618

1.81

7.60

1.7

1.9

1.57

1.53

g/l

0.16

533

Other noninflammatory disorders of uterus, except cervix

463

2360

1.34

7.59

1.7

1.71

1.61

g/l

1.31

386

1980

Oesophageal obstruction

100

556

1.86

7.51

1.7

1.8

1.61

1.56

g/l

0.26

480

Inguinal hernia

1438

8232

1.17

7.44

1.6

1.7

1.41

1.55

g/l

6.92

1213

7016

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

133

799

1.69

7.44

2.1

1.9

1.18

1.44

g/l

2.79

115

689

Injuries to the wrist and hand

2344

14393

1.13

7.38

1.7

1.8

1.52

1.51

g/l

0.08

2019

12313

Mental and behavioural disorders due to cannabinoids

215

2.38

7.37

1.4

2.2

1.62

1.37

g/l

0.92

195

Cervical disc disorders

807

6600

1.23

7.37

1.7

1.6

1.55

1.56

g/l

0.01

667

5649

Hidradenitis suppurativa

319

2.12

7.35

1.4

2.2

1.72

1.41

g/l

2.19

281

Chondrocostal junction syndrome [Tietze]

451

1.94

7.34

1.6

2.0

1.46

1.50

g/l

0.13

401

Other and unspecified visual disturbances

223

1517

1.50

7.33

1.8

1.7

1.53

1.54

g/l

0.06

197

1312

Other female pelvic inflammatory diseases

297

2127

1.41

7.33

1.6

1.7

1.62

1.57

g/l

0.35

244

1811

All dysplastic lesions of the vulva

458

1.93

7.32

2.5

1.9

1.59

1.52

g/l

0.24

401

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

189

1243

1.55

7.31

1.4

1.7

1.60

1.54

g/l

0.32

169

1058

Surgical ablation of atrial fibrillation

3.56

7.29

2.5

1.8

1.18

1.71

g/l

1.82

Other symptoms and signs involving general sensations and perceptions

102

575

1.82

7.28

1.6

1.9

1.50

1.58

g/l

0.40

495

Atopic dermatitis, strict definition with reimbursement

495

3692

1.30

7.28

2.3

1.9

1.46

1.38

g/l

1.07

425

3219

Other disorders of patella

293

2095

1.41

7.26

1.6

1.7

1.64

1.45

g/l

2.27

255

1778

Malignant neoplasm of oral cavity

446

1.94

7.26

1.5

1.6

1.71

1.52

g/l

1.18

390

Pediculosis, acariasis and other infestations

124

738

1.72

7.26

1.8

1.9

1.50

1.51

g/l

0.04

100

644

Other inflammation of eyelid

297

2134

1.41

7.24

1.8

1.7

1.60

1.54

g/l

0.49

248

1822

Disorders of psychological development

194

1187

1.53

7.23

1.9

2.1

1.55

1.29

g/l

2.85

171

1031

Idiopathic pulmonary fibrosis

229

1576

1.49

7.22

1.8

1.7

1.66

1.52

g/l

1.25

186

1333

Hydrocele

318

2315

1.40

7.21

2.1

1.6

1.43

1.53

g/l

1.47

271

1973

Follicular cysts of skin and subcutaneous tissue

390

2927

1.35

7.20

1.7

1.59

1.52

g/l

0.69

344

2518

Ventricular septal defect, a heart condition

205

2.41

7.20

1.5

2.3

1.29

1.27

g/l

0.05

180

Hyperhidrosis

256

2.24

7.18

1.8

1.9

1.27

1.40

g/l

0.51

221

Myocardial infarction, unclassifiable

662

4745

1.26

7.18

1.6

1.67

1.55

g/l

2.87

562

3978

Other eating disorders

432

1.93

7.14

2.0

2.2

1.04

1.19

g/l

1.13

380

Viral encephalitis, not elsewhere classified/unspecified

265

2.24

7.13

1.5

2.0

1.74

1.50

g/l

0.96

234

Kela-code for severe mental illness

723

5866

1.24

7.12

1.5

1.8

1.67

1.49

g/l

5.30

615

5010

Alzheimer disease, excluding more controls

476

2408

1.32

7.10

1.5

1.7

1.59

g/l

0.03

373

2046

Other congenital malformations of skin

157

997

1.60

7.09

1.6

1.9

1.41

1.50

g/l

0.57

126

872

Toxic effects of substances chiefly nonmedicinal as to source

234

1617

1.47

7.09

1.7

1.8

1.53

1.49

g/l

0.24

201

1411

Implicit parasitic Sepsis

3.73

7.07

2.9

2.1

1.59

1.39

g/l

0.45

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

523

1.85

7.04

3.1

1.8

1.52

1.53

g/l

0.03

465

Corneal ulcer

375

2808

1.35

7.03

1.8

1.7

1.50

1.51

g/l

0.03

317

2428

Left hemicolectomy

376

2.03

7.01

1.5

1.9

1.68

1.59

g/l

0.32

331

Event of undetermined intent

131

799

1.67

7.00

1.5

2.0

1.54

1.51

g/l

0.11

105

693

Retinal detachment with retinal break

317

2319

1.39

6.99

1.9

1.7

1.48

1.58

g/l

1.10

279

1983

Sequelae of injuries of lower limb

190

1264

1.53

6.97

1.6

1.8

1.60

1.54

g/l

0.37

160

1095

Guillain-Barre syndrome

210

2.40

6.97

1.6

2.2

1.63

1.53

g/l

0.34

183

Complications of the puerperium, not elsewhere classified

312

2.09

6.97

3.4

2.1

0.96

1.33

g/l

4.40

272

Postmenopausal bleeding

569

2378

1.29

6.96

1.6

1.7

1.61

1.62

g/l

0.13

483

1994

Intentional self-harm by sharp object

215

2.34

6.95

1.5

2.4

1.35

1.32

g/l

0.07

193

Malignant neoplasm, without specification of site, including Hilmo

119

710

1.72

6.94

1.6

1.5

1.87

1.51

g/l

2.20

599

Other orthopaedic follow-up care

111

649

1.75

6.94

1.7

1.60

1.49

g/l

0.57

559

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

389

1.98

6.93

1.7

2.1

1.58

1.49

g/l

0.32

344

Secondary parkinsonism, excluding more controls

335

2.07

6.91

1.3

1.7

1.62

1.53

g/l

0.29

286

Asthma and opportunity respiratory infection

128

782

1.69

6.91

1.4

1.7

1.79

1.54

g/l

2.31

105

674

Unspecified event, undetermined intent

281

2.17

6.91

1.6

2.2

1.50

1.40

g/l

0.25

251

Suppurative and unspecified otitis media

653

4651

1.25

6.89

1.9

1.40

g/l

0.02

568

4022

Agoraphobia

254

2.21

6.89

1.8

2.2

1.53

1.28

g/l

1.04

225

Biomechanical lesions, not elsewhere classified

121

728

1.71

6.88

1.6

1.8

1.43

1.52

g/l

0.53

108

633

Calculus of kidney and ureter

738

6031

1.24

6.88

1.7

1.54

g/l

0.03

643

5139

Dementia in Alzheimer disease

327

3714

0.73

6.86

1.6

1.7

1.60

1.55

g/l

0.43

230

3147

Medical treatment for female infertility

269

1902

1.42

6.86

2.1

2.0

1.12

1.30

g/l

3.31

249

1636

Seborrhoeic dermatitis

218

1498

1.48

6.85

1.6

1.7

1.64

1.53

g/l

0.78

184

1294

Benign neoplasm: Kidney

529

1.84

6.82

2.2

1.9

1.63

1.50

g/l

0.61

463

Disorders of ocular muscles, binocular movement, accommodation and refraction

938

7773

1.20

6.82

1.9

1.8

1.50

1.47

g/l

0.31

802

6695

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

410

3127

1.33

6.82

1.4

1.6

1.93

1.55

g/l

7.95

340

2669

Superficial injury of forearm

195

1311

1.51

6.80

1.8

1.9

1.41

1.45

g/l

0.25

170

1140

Systemic sclerosis,strict definition

3.21

6.79

2.0

2.1

1.80

1.62

g/l

0.37

Malignant neoplasm of tongue, including Hilmo

338

2.05

6.77

1.4

1.5

1.64

1.50

g/l

0.71

297

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

104

601

1.76

6.74

2.3

2.0

1.11

1.25

g/l

0.82

526

Dislocation of lens

220

2.34

6.71

1.7

1.45

1.64

g/l

0.69

192

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

133

822

1.64

6.71

2.1

2.0

1.18

1.34

g/l

1.28

115

714

Malignant neoplasm of larynx, including Hilmo

272

2.18

6.70

1.6

1.85

1.53

g/l

1.69

231

Social phobias

130

799

1.65

6.68

2.1

1.9

1.38

1.33

g/l

0.21

114

699

Colonic or urogenital fistula

585

4676

1.26

6.68

1.9

1.7

1.58

1.54

g/l

0.37

497

3992

Benign neoplasm: Other and unspecified parts of small intestine

234

2.29

6.67

1.6

1.9

1.62

1.54

g/l

0.26

203

Disorders of orbit

546

1.80

6.66

1.8

1.9

1.53

g/l

0.01

476

Retinal haemorrhage

411

1.95

6.66

2.1

1.7

1.37

1.57

g/l

1.28

360

Anorexia

146

2.64

6.66

1.4

2.1

1.39

g/l

0.00

123

Hyperosmolality and hypernatraemia

183

2.47

6.66

1.5

1.9

1.62

1.52

g/l

0.29

160

Dislocation, sprain and strain of joint and ligaments of hip

570

1.79

6.65

1.7

1.9

1.49

1.53

g/l

0.18

502

Other hearing loss

759

6110

1.23

6.64

1.9

1.6

1.52

1.58

g/l

1.28

633

5207

Palmar fascial fibromatosis [Dupuytren]

406

3107

1.33

6.63

1.5

1.6

1.43

1.57

g/l

2.49

345

2627

Acne

155

994

1.57

6.63

2.3

2.1

1.27

1.25

g/l

0.12

141

865

Antepartum haemorrhage, not elsewhere classified

112

664

1.71

6.61

2.4

1.9

1.27

1.38

g/l

0.69

101

577

Manic episode

320

2.05

6.58

1.8

2.2

1.46

1.43

g/l

0.08

282

Other secondary gonarthrosis

131

815

1.65

6.56

1.5

1.8

1.76

1.57

g/l

1.47

108

710

Benign neoplasm: Oesophagus

154

2.61

6.55

1.9

1.8

1.38

1.56

g/l

0.55

132

Mental disorders, not otherwise specified

148

945

1.59

6.55

1.9

2.0

1.35

1.42

g/l

0.48

129

827

Unspecified visual impairment (binocular)

197

2.39

6.53

1.3

2.2

1.45

1.55

g/l

0.25

177

Other acute viral hepatitis

136

2.69

6.52

1.6

2.3

1.65

1.41

g/l

0.60

122

Arthropathy in ulcerative colitis

136

2.69

6.52

1.6

2.3

1.60

1.42

g/l

0.61

115

Raynaud syndrome

170

1122

1.54

6.52

2.1

1.9

1.31

1.51

g/l

2.10

143

979

Panniculitis, unspecified

119

2.84

6.51

1.5

1.7

1.41

1.55

g/l

0.43

103

Sacroiliitis, not elsewhere classified

461

1.86

6.51

1.7

2.1

1.65

1.39

g/l

1.26

403

Anogenital herpesviral [herpes simplex] infection

104

608

1.74

6.50

2.0

2.1

1.32

1.36

g/l

0.15

534

Carbimazole or st.post thyroidectomy, condition for graves disease

404

3094

1.32

6.50

1.8

1.7

1.52

1.54

g/l

0.24

350

2647

Urolithiasis

806

6686

1.22

6.49

1.7

1.53

1.54

g/l

0.03

701

5711

Superficial injury of shoulder and upper arm

245

1739

1.43

6.47

1.6

1.8

1.51

g/l

0.01

200

1498

Monoarthritis, not elsewhere classified

515

1.81

6.43

1.6

1.9

1.83

1.48

g/l

1.54

444

623

4740

1.25

6.42

1.7

1.6

1.53

1.59

g/l

0.78

520

4010

Other puerperal infections

115

693

1.68

6.41

3.0

2.1

1.20

1.23

g/l

0.11

107

604

Use of donepezil

380

4733

0.76

6.40

1.5

1.6

1.60

1.56

g/l

0.34

306

3985

Ptosis of eyelid

272

1973

1.40

6.39

1.4

1.7

1.53

1.57

g/l

0.34

235

1673

Disorders of optic nerve, not elsewhere classified

305

2.09

6.38

2.3

2.1

1.44

1.53

g/l

0.28

271

Other prurigo

132

2.72

6.38

1.5

2.0

1.51

1.45

g/l

0.14

116

Burns and corrosions

271

1961

1.40

6.37

1.5

1.8

1.51

1.48

g/l

0.22

222

1697

Prepatellar bursitis

104

614

1.73

6.36

1.6

1.7

1.65

1.52

g/l

0.63

520

Nontraumatic intracranial haemmorrhage

511

4048

1.28

6.36

1.6

1.51

1.55

g/l

0.50

433

3425

Neuralgia and neuritis, unspecified

107

636

1.72

6.36

1.7

1.8

1.65

1.53

g/l

0.63

548

Other and unspecified follicular disorders

488

1.83

6.35

1.8

2.0

1.65

1.47

g/l

0.86

424

Otitis externa, unspecified

221

1546

1.45

6.32

2.0

1.8

1.44

1.49

g/l

0.40

201

1343

Pneumothorax

178

1198

1.52

6.29

1.7

1.69

1.50

g/l

1.56

152

1019

Other and unspecified mononeuropathies, also in other diseases

412

1.90

6.24

1.6

1.9

1.64

1.58

g/l

0.23

353

Primary coxarthrosis, bilateral

738

6100

1.22

6.23

1.5

1.6

1.61

1.58

g/l

0.35

632

5170

Other maltreatment syndromes

306

2.04

6.23

1.8

1.9

1.39

1.47

g/l

0.26

269

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

203

1406

1.47

6.19

1.6

1.8

1.52

1.56

g/l

0.20

178

1217

Diseases of middle ear and mastoid

1165

8169

1.17

6.18

2.1

1.8

1.43

1.46

g/l

0.41

1003

7007

Acetic acid derivatives and related substances

746

3173

1.23

6.17

1.8

2.0

1.49

1.44

g/l

0.80

637

2705

Other and unspecified epidermal thickening

350

1.98

6.16

1.3

2.2

1.55

1.51

g/l

0.14

312

Cerebral palsy

122

2.71

6.15

1.9

2.7

1.19

1.21

g/l

0.06

106

Hyperkinetic disorders, excluding more controls

141

862

1.58

6.14

1.8

2.2

1.25

1.15

g/l

0.68

119

753

Other sleep disorders

240

1714

1.42

6.14

1.5

1.8

1.52

1.51

g/l

0.02

201

1484

Other infective otitis externa

132

836

1.61

6.14

2.0

1.9

1.65

1.51

g/l

1.01

118

730

Migraine without aura and triptan purchases

240

1711

1.41

6.12

1.8

1.9

1.33

1.40

g/l

0.52

198

1490

Viral agents as the cause of diseases classified to other chapters

255

2.15

6.11

1.6

2.2

1.53

1.49

g/l

0.11

222

Lactose intolerance

302

2.04

6.07

2.0

2.1

1.34

1.49

g/l

0.67

266

Injury of other and unspecified intrathoracic organs

157

1038

1.54

6.06

1.6

1.8

1.68

1.51

g/l

1.15

138

891

Hypertrophic disorders of skin

103

615

1.70

6.02

1.9

2.0

1.36

1.46

g/l

0.47

543

Parkinson's disease, excluding more controls

337

2399

1.34

6.01

1.5

1.7

1.57

1.58

g/l

0.01

278

2044

Bullous pemphigoid

362

1.96

6.00

1.4

2.0

1.57

g/l

0.01

319

Corneal scars and opacities

383

1.92

5.95

1.9

2.0

1.56

1.52

g/l

0.10

338

Other secondary coxarthrosis

492

1.80

5.94

1.5

1.9

1.65

1.55

g/l

0.39

428

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

603

4906

1.24

5.91

1.8

1.7

1.50

1.52

g/l

0.27

518

4215

Malignant neoplasm of other connective and soft tissue, including Hilmo

575

1.73

5.89

1.4

1.7

1.93

1.51

g/l

2.46

491

Outcome of delivery

191

801

1.48

5.89

1.9

1.8

1.12

1.45

g/l

5.91

166

684

Enthesopathies of lower limb, excluding foot

429

3357

1.29

5.89

1.6

1.7

1.54

1.53

g/l

0.04

364

2874

All dysplastic lesions of the vagina

265

2.10

5.89

2.1

2.0

1.40

1.55

g/l

0.57

232

Blood alcohol or alcohol intoxication level

245

2.14

5.88

2.0

2.1

1.36

1.43

g/l

0.27

217

Radiculopathy

373

2872

1.31

5.85

1.9

1.6

1.62

1.57

g/l

0.37

319

2451

Other and unspecified nonscarring hair loss

3.64

5.85

1.7

2.2

1.60

1.37

g/l

0.48

Use of anticholinesterases

736

6962

0.83

5.84

1.4

1.6

1.59

1.57

g/l

0.16

594

5874

N06DA Anticholinesterases

736

6962

0.83

5.84

1.4

1.6

1.59

1.57

g/l

0.16

594

5874

Other disorders starting during childhood or adolecense, excluding more controls

332

1.93

5.82

2.0

2.2

1.27

1.09

g/l

0.90

289

Blepharochalasis

687

5679

1.22

5.81

1.5

1.7

1.53

1.61

g/l

1.32

596

4817

Other specified/unspecified dorsopathies

436

1.83

5.80

1.5

1.9

1.47

1.56

g/l

0.39

371

Gastrojejunal ulcer

157

2.47

5.80

1.7

2.0

1.56

1.55

g/l

0.03

138

Otalgia

157

1047

1.52

5.79

1.5

1.9

1.47

1.52

g/l

0.26

125

913

Complications peculiar to reattachment and amputation

3.00

5.77

2.4

1.7

2.07

1.62

g/l

0.81

Dermatopolymyositis, unspecified

3.66

5.75

1.6

1.5

1.17

1.63

g/l

2.03

Metatarsalgia

182

1252

1.47

5.74

1.6

1.7

1.61

1.57

g/l

0.20

154

1069

Cerebral cysts

118

740

1.62

5.73

2.1

1.9

1.23

1.45

g/l

1.91

101

647

Exfoliative dermatitis

146

2.53

5.72

1.6

2.3

1.60

1.46

g/l

0.35

129

Bronchitis, not specified as acute or chronic

187

1295

1.47

5.71

1.8

1.7

1.36

1.53

g/l

1.83

155

1089

Hyperaldosteronism

396

1.88

5.70

1.7

1.9

1.56

1.57

g/l

0.02

345

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

120

759

1.62

5.67

1.6

1.5

1.38

1.51

g/l

0.79

101

637

Disorders of vestibular function (Vertigo)

1094

9270

1.17

5.67

1.5

1.7

1.54

1.56

g/l

0.38

919

7869

Malignant neoplasm of floor of mouth, including Hilmo

3.01

5.66

1.5

1.6

1.79

1.44

g/l

0.87

LSIL lesion of the vulva

269

2.06

5.66

2.9

2.1

1.35

1.50

g/l

0.58

239

Impotence

146

967

1.55

5.66

1.6

1.46

1.55

g/l

0.62

127

825

Disorders of speech understanding and production

467

1.78

5.63

1.8

2.1

1.71

1.36

g/l

2.01

407

Parkinson's disease, strict definition, excluding more controls

315

2269

1.34

5.62

1.5

1.7

1.54

1.57

g/l

0.27

259

1933

Panniculitis affecting regions of neck and back

470

1.79

5.61

2.2

2.0

1.53

1.52

g/l

0.05

404

Viral agents as the cause of diseases classified to other chapters

291

2.02

5.61

1.6

2.2

1.60

1.49

g/l

0.38

254

Papilloedema, unspecified

250

2.10

5.61

2.5

2.3

1.30

1.42

g/l

0.34

220

Other bursitis of hip

264

2.08

5.61

1.6

1.8

1.45

1.52

g/l

0.20

227

Disorders of lysine and hydroxylysine metabolism

+∞

5.59

21.8

0.0

0.47

—

g/l

—

Other salmonella infections

530

1.73

5.59

1.8

1.9

1.69

1.51

g/l

0.75

459

Burns and corrosions of external body surface, specified by site

214

1525

1.42

5.58

1.5

1.8

1.50

1.49

g/l

0.04

175

1326

Specific development disorders of speech and language

107

634

1.65

5.57

1.7

2.1

1.71

1.35

g/l

2.62

556

Asthma and allergy

177

1200

1.47

5.55

1.6

1.8

1.52

1.31

g/l

2.93

158

1026

Other disorders of penis

220

1579

1.41

5.54

1.7

1.61

1.52

g/l

0.69

183

1353

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1027

8570

1.17

5.51

1.7

1.8

1.49

1.50

g/l

0.05

884

7352

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

259

2.08

5.51

1.5

1.55

1.52

g/l

0.10

223

Thyrotoxicosis with toxic multinodular goitre

141

932

1.55

5.50

1.5

1.7

1.70

1.58

g/l

0.95

121

801

Other bursitis of elbow

113

2.73

5.48

3.1

1.8

1.41

1.57

g/l

0.40

Antenatal screening

266

1088

1.38

5.47

2.0

1.8

1.26

1.49

g/l

3.49

234

941

Other nonscarring hair loss

2.99

5.46

1.8

2.2

1.53

1.44

g/l

0.21

Other disorders of pigmentation

580

1.69

5.45

1.9

1.49

1.54

g/l

0.16

499

Car occupant injured in noncollision transport accident

408

1.83

5.44

2.3

2.1

1.43

1.42

g/l

0.05

356

Other and unspecified rosacea

170

1168

1.48

5.44

1.5

1.8

1.53

1.55

g/l

0.06

149

1008

Other specified/unspecified disorders of bone/cartilage

337

1.92

5.43

1.7

2.0

1.45

1.59

g/l

0.64

300

Cramp and spasm

100

612

1.67

5.40

1.6

1.9

1.47

1.50

g/l

0.12

531

Superficial injury of ankle and foot

208

1484

1.42

5.38

1.8

1.9

1.49

1.43

g/l

0.59

185

1289

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

295

1.97

5.35

2.7

2.1

1.26

1.31

g/l

0.13

261

Atopic dermatitis

1054

7436

1.17

5.35

1.9

1.8

1.46

1.45

g/l

0.16

890

6426

Labour and delivery complicated by fetal stress [distress]

286

1392

1.35

5.35

2.1

2.0

1.15

1.28

g/l

1.81

248

1211

Unknown and unspecified causes of morbidity

125

808

1.57

5.33

1.6

1.60

1.49

g/l

0.51

113

693

226

1644

1.40

5.32

1.7

1.21

1.54

g/l

6.97

182

1397

Thyroiditis

134

882

1.54

5.29

1.7

1.8

1.53

1.52

g/l

0.06

112

769

Injuries involving multiple body regions

449

1.78

5.28

1.4

2.1

1.74

1.47

g/l

1.46

396

HSIL lesion of the vagina

139

2.47

5.25

1.8

2.4

1.52

1.54

g/l

0.03

123

Hypertrophic scar

562

1.68

5.25

1.9

2.0

1.38

1.47

g/l

0.31

496

Vulvovaginal ulceration/inflammation in other diseases

585

1.67

5.23

1.9

2.1

1.33

1.39

g/l

0.19

517

Other and unspecified glaucoma

191

1355

1.44

5.23

1.5

1.7

1.69

1.53

g/l

1.66

163

1159

Chondropathies

292

2210

1.34

5.22

1.5

1.8

1.49

g/l

0.01

251

1926

Other proliferative retinopathy

3.43

5.22

1.3

2.5

1.66

1.48

g/l

0.43

Separation of retinal layers (serosa)

550

1.69

5.19

2.0

1.9

1.47

1.59

g/l

0.51

473

Other and unspecified abdominal hernia

100

620

1.65

5.18

1.5

1.8

1.61

1.58

g/l

0.13

540

Malignant neoplasm of tongue

238

2.09

5.18

1.5

1.69

1.52

g/l

0.64

206

Postpartum haemorrhage

321

2065

1.32

5.18

2.3

1.9

1.12

1.40

g/l

8.19

279

1802

Other mental disorders due to brain damage and dysfunction and to physical disease

303

2315

1.33

5.16

1.5

1.7

1.57

1.53

g/l

0.27

245

1993

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

263

1963

1.35

5.15

1.8

1.35

1.44

g/l

0.78

224

1688

LSIL lesion of the vagina

134

2.47

5.15

2.5

2.3

1.47

1.48

g/l

0.01

113

Sequelae of injuries of head

109

690

1.61

5.15

1.6

1.9

1.72

1.55

g/l

0.92

594

Other salmonella infections

468

1.75

5.14

1.8

1.9

1.76

1.52

g/l

0.95

406

Other and unspecified paralytic syndromes

166

2.32

5.13

1.8

2.3

1.13

1.50

g/l

1.64

149

Congenital malformations of great arteries

194

2.19

5.13

1.6

2.1

1.31

1.33

g/l

0.04

169

Other and unspecified iridocyclitis

590

1.66

5.12

2.0

1.9

1.51

1.48

g/l

0.11

515

Other enthesopathy of foot (+metatarsalgia)

191

1356

1.43

5.12

1.6

1.7

1.60

1.57

g/l

0.18

163

1160

Coarctation of the aorta

2.80

5.10

1.6

1.8

1.43

1.30

g/l

0.15

False labour

358

1725

1.30

5.08

2.0

1.07

1.37

g/l

12.84

312

1490

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

100

2.77

5.06

1.5

1.6

1.99

1.57

g/l

1.00

Allergic conjunctivitis

1071

9053

1.16

5.05

1.7

1.8

1.49

g/l

0.01

920

7792

Meningitis

101

631

1.63

5.04

1.5

2.0

1.63

1.54

g/l

0.37

552

Maternal care for known or suspected malpresentation of fetus

219

1146

1.39

5.02

2.2

2.0

1.17

1.31

g/l

1.81

196

986

Lack of expected normal physiological development

106

2.52

5.01

2.8

2.3

1.04

1.10

g/l

0.14

Ocular pain

156

1072

1.48

5.01

1.9

1.44

1.51

g/l

0.39

139

933

Causalgia

142

2.40

5.00

1.3

2.1

1.22

1.48

g/l

0.99

125

Specific development disorders of scholastic skills

333

1.86

5.00

2.2

2.0

1.31

1.26

g/l

0.19

298

Hyperfunction of pituitary gland

486

1.72

4.99

1.6

1.9

1.49

1.45

g/l

0.10

427

Allergic urticaria

151

1032

1.48

4.99

1.7

1.9

1.55

1.49

g/l

0.43

136

906

Viral meningitis

361

1.84

4.97

2.0

2.1

1.40

g/l

0.01

322

Osteomyelitis of vertebra

3.79

4.95

2.0

2.1

1.67

1.57

g/l

0.11

Melanocytic naevi of upper limb, including shoulder

284

1.96

4.93

1.7

2.0

1.37

1.52

g/l

0.70

250

Dissociative [conversion] disorders

362

1.83

4.91

1.5

2.1

1.63

1.36

g/l

1.48

318

Family history of certain disabilities and chronic diseases leading to disablement

414

1.76

4.88

2.0

1.23

1.42

g/l

1.17

362

Acne vulgaris

116

753

1.56

4.87

2.2

2.1

1.30

1.24

g/l

0.33

105

660

Algoneurodystrophy

299

1.91

4.85

1.6

2.1

1.38

1.44

g/l

0.21

265

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

126

2.47

4.82

1.3

2.7

1.79

1.44

g/l

0.92

111

Benign neoplasm: Liver/bile ducts

279

1.95

4.82

1.8

2.2

1.46

1.48

g/l

0.06

242

Other factor of the environment

158

2.31

4.82

1.3

2.1

1.87

1.44

g/l

1.57

137

Personal history of malignant neoplasm

114

741

1.56

4.80

1.8

1.7

1.55

1.56

g/l

0.02

644

Car occupant injured in other and unspecified transport accidents

347

2721

1.29

4.79

2.0

1.8

1.52

1.48

g/l

0.39

300

2343

Strabismus

506

4130

1.23

4.78

1.8

1.7

1.50

1.49

g/l

0.08

438

3547

Hypothermia

267

1.98

4.77

1.5

2.0

1.50

1.55

g/l

0.13

229

Polyp of the female genital tract

579

2738

1.22

4.77

1.7

1.54

1.56

g/l

0.24

493

2311

Hepatocellular carcinoma

317

1.89

4.76

1.7

1.6

1.11

1.46

g/l

2.32

266

Lesion of radial nerve

502

1.69

4.75

1.6

1.9

1.47

1.55

g/l

0.36

430

Rosacea

218

1605

1.37

4.75

1.6

1.8

1.51

1.53

g/l

0.12

189

1380

Ulcerative rectosigmoiditis

154

1068

1.46

4.74

1.8

1.53

1.52

g/l

0.06

139

943

Hallux rigidus

269

2044

1.33

4.74

1.5

1.7

1.48

1.58

g/l

1.13

229

1739

Other and unspecified nerve root and plexus disorders, also in other diseases

383

3046

1.27

4.72

1.6

1.7

1.55

1.54

g/l

0.10

335

2616

Golimumab

309

1.88

4.72

1.5

2.0

1.60

1.48

g/l

0.42

276

D07AA Corticosteroids, weak (group I)

275

2093

1.32

4.71

1.6

1.8

1.50

1.44

g/l

0.60

244

1797

Erectile dysfunction

226

1683

1.37

4.69

1.9

1.7

1.54

1.55

g/l

0.04

189

1446

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

135

2.39

4.63

2.3

1.6

1.33

1.50

g/l

0.52

118

Anuria and oliguria

2.75

4.62

1.6

1.9

1.64

1.54

g/l

0.11

Abnormal blood-pressure reading, without diagnosis

536

1.65

4.62

2.8

1.7

1.45

1.55

g/l

0.46

460

Toxic effect of other and unspecified substances

104

2.58

4.62

1.5

2.0

1.74

1.37

g/l

1.36

Measles

2.89

4.62

1.5

2.2

1.44

1.43

g/l

0.02

Behavioural disorders, excluding more controls

128

2.38

4.59

1.7

2.3

1.70

1.19

g/l

1.55

117

Disease of hard tissues of teeth, NOS

1283

5907

1.14

4.58

1.6

1.47

1.57

g/l

2.90

1084

5052

Inflammatory disorders of male genital organs, not elsewhere classified

202

2.12

4.57

1.6

1.9

1.54

1.49

g/l

0.15

175

Contusion of other and unspecified parts of foot

514

1.66

4.57

2.0

2.1

1.54

1.40

g/l

0.81

449

Schizoaffective disorder

129

872

1.50

4.54

1.4

1.9

1.70

1.49

g/l

1.80

101

758

Other specified/unspecified spondylopathies

381

1.79

4.53

1.5

1.8

1.47

1.52

g/l

0.16

332

Open wound of hip and thigh

395

1.76

4.52

1.7

2.2

1.50

1.45

g/l

0.16

346

Other enthesopathies

551

4574

1.21

4.52

1.6

1.7

1.60

1.54

g/l

0.80

471

3904

HSIL lesion of the vulva

189

2.13

4.51

1.6

2.3

1.77

1.51

g/l

0.77

169

Aneurysms, operations, SAH

353

2800

1.27

4.50

1.8

1.6

1.59

1.57

g/l

0.10

310

2389

Eustachian salpingitis and obstruction

117

776

1.53

4.50

2.2

2.0

1.42

1.41

g/l

0.05

674

Malignant neoplasm of larynx

210

2.08

4.49

1.6

1.7

1.95

1.53

g/l

2.12

179

Acute laryngitis and tracheitis

174

1225

1.41

4.47

1.8

2.0

1.52

1.35

g/l

1.42

152

1065

Malignant neoplasm of other connective and soft tissue

309

1.87

4.46

1.5

1.7

1.94

1.52

g/l

1.32

272

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

218

1624

1.36

4.46

1.6

1.5

1.72

1.55

g/l

1.73

187

1392

Diseases of inner ear

1261

10808

1.13

4.42

1.5

1.7

1.55

1.56

g/l

0.19

1064

9202

Benign neoplasm: Skin of trunk

575

1.62

4.41

1.9

1.50

1.51

g/l

0.04

506

Malignant neoplasm of breast

679

3738

1.19

4.38

1.5

1.7

1.68

1.57

g/l

1.54

556

3184

Carcinoma in situ of skin of lip

3.63

4.38

2.7

2.0

1.76

1.69

g/l

0.11

Open wound of wrist and hand

930

7899

1.16

4.38

1.7

1.8

1.53

1.50

g/l

0.38

802

6786

HSIL lesion of the cervix uteri, vagina or vulva

274

2110

1.31

4.37

2.2

1.9

1.47

1.37

g/l

0.94

235

1830

Paralytic strabismus

162

1155

1.43

4.37

1.6

1.8

1.62

1.52

g/l

0.63

138

992

Oligomenorrhoea

354

1.78

4.36

2.2

2.0

1.22

1.39

g/l

0.75

313

Burns and corrosions of multiple and unspecified body regions

268

1.92

4.35

1.6

1.8

1.53

1.49

g/l

0.13

236

Pyoderma

219

2.02

4.35

1.7

2.0

1.65

1.47

g/l

0.53

192

Protein-energy malnutrition of moderate and mild degree

127

2.41

4.34

1.4

2.1

1.40

1.59

g/l

0.49

112

Hemiplegia

109

720

1.54

4.33

1.9

1.55

1.52

g/l

0.16

631

Other disorders of the genitourinary system

268

2065

1.31

4.33

1.7

1.59

g/l

0.01

225

1767

Scabies

522

1.64

4.33

1.8

2.0

1.55

1.50

g/l

0.20

455

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

5.92

4.33

1.5

1.8

1.32

1.76

g/l

0.55

All dysplastic lesions of the cervix uteri, vagina or vulva

408

3250

1.24

4.32

2.0

1.9

1.46

1.40

g/l

0.64

350

2805

Other fall from one level to another

446

3647

1.23

4.29

1.8

1.43

1.49

g/l

0.74

398

3130

Atopic dermatitis, strict definition

457

3666

1.23

4.29

2.4

1.9

1.45

1.39

g/l

0.72

396

3191

Malignant neoplasm of rectum

209

1557

1.36

4.29

1.6

1.5

1.72

1.55

g/l

1.62

180

1340

Sleep disorders

1905

12474

1.11

4.28

1.7

1.8

1.47

1.51

g/l

0.95

1625

10679

Evidence of alcohol involvement determined by blood alcohol level

153

2.23

4.26

2.1

2.6

1.46

1.45

g/l

0.02

132

Malignant neoplasm of breast, including Hilmo

687

3768

1.19

4.25

1.5

1.7

1.68

1.57

g/l

1.71

561

3208

Childhood asthma (age<16), excluding more controls

158

879

1.42

4.24

2.3

1.23

1.08

g/l

1.51

139

774

Benign neoplasm: Anus and anal canal

442

1.70

4.24

1.6

1.9

1.65

1.52

g/l

0.53

391

Alcoholic gastritis

201

2.07

4.24

1.5

1.9

1.56

g/l

0.01

173

Adenocarcinoma and papilloma adenocarcinoma of rectum

207

1545

1.36

4.20

1.6

1.5

1.72

1.55

g/l

1.49

178

1325

Malignant neoplasm of breast, HER2-negative, including Hilmo

686

3768

1.18

4.19

1.5

1.7

1.68

1.57

g/l

1.72

560

3208

Benign paroxysmal vertigo

642

5450

1.19

4.18

1.5

1.7

1.51

1.57

g/l

0.99

548

4650

Burn and corrosion of trunk

375

1.75

4.17

1.5

2.1

1.49

1.51

g/l

0.05

328

Scleritis and episcleritis

110

734

1.52

4.17

2.1

1.9

1.56

1.51

g/l

0.18

638

Glucosamine medication

1211

8571

1.13

4.17

1.6

1.58

1.59

g/l

0.17

1028

7265

Other menopausal disorders

316

2256

0.78

4.16

1.7

1.50

1.59

g/l

0.80

269

1909

Malignant neoplasm of rectosigmoid junction, including Hilmo

429

1.70

4.16

1.7

1.6

1.78

1.54

g/l

1.16

369

Carcinoma in situ of vulva

2.68

4.16

1.3

2.4

2.11

1.49

g/l

1.15

Acute bronchiolitis

508

1.60

4.15

2.0

2.2

1.42

1.27

g/l

0.74

436

Sleep disorders, other/unspecified

330

1.79

4.15

1.4

2.1

1.50

1.42

g/l

0.27

287

Other protozoal intestinal diseases

155

2.20

4.14

1.5

2.4

1.21

1.35

g/l

0.44

137

Contact with other hot metals

182

2.10

4.14

1.8

1.7

1.43

1.44

g/l

0.03

158

Other specific arthropathies, wide

237

1.95

4.14

1.6

1.7

1.36

1.46

g/l

0.27

202

Other noninflammatory disorders of vulva and perineum

161

1156

1.41

4.13

1.7

1.52

1.51

g/l

0.07

137

989

Perforation of tympanic membrane

206

1542

1.35

4.11

1.9

1.8

1.46

1.52

g/l

0.54

176

1337

Anankastic personality disorder

361

1.75

4.10

2.3

2.1

1.43

1.40

g/l

0.09

317

Benign neoplasm: Liver

245

1.92

4.09

1.9

2.1

1.44

1.46

g/l

0.06

211

Glaucoma

1417

10930

1.12

4.08

1.6

1.7

1.55

1.57

g/l

0.57

1183

9271

Malignant cancer of tonsil and base of tongue

246

1.93

4.07

2.2

1.5

1.61

1.47

g/l

0.52

213

Thyrotoxicosis with diffuse goitre

243

1863

1.32

4.07

1.9

1.7

1.46

1.55

g/l

0.77

208

1603

Helminthiases

423

1.68

4.06

2.9

2.1

1.17

1.43

g/l

2.00

372

Unspecified parasitic disease

112

2.45

4.05

1.7

1.8

1.54

1.64

g/l

0.28

Alzheimer’s disease (Early onset)

849

0.55

4.05

1.3

1.6

1.58

1.55

g/l

0.08

715

Other intracranial haemorrhages

574

1.59

4.03

1.8

1.9

1.44

1.54

g/l

0.44

502

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

274

1895

1.29

4.03

1.7

2.2

1.34

1.21

g/l

1.47

236

1658

Poisoning by narcotics and psychodysleptics [hallucinogens]

150

2.19

4.03

1.3

2.3

2.04

1.32

g/l

3.09

135

Toxic effect of ethanol

447

1.66

4.02

1.5

2.0

1.47

1.50

g/l

0.14

391

Melanocytic naevi, other sites/unspecified

153

1096

1.41

4.02

2.3

1.8

1.36

1.52

g/l

1.59

145

954

Malignant neoplasm of other and unspecified parts of tongue

164

2.15

4.02

1.5

1.46

1.53

g/l

0.16

138

Monoamine oxidase A inhibitors

225

1711

1.33

4.02

1.5

1.8

1.57

1.56

g/l

0.06

189

1472

Pedestrian injured in collision with car, pick-up truck or van

305

1.82

4.01

1.7

1.9

1.74

1.53

g/l

0.92

270

Malignant neoplasm of endocrine gland

119

814

1.48

4.00

2.0

1.6

1.54

1.51

g/l

0.12

101

705

Female infertility, associated with anovulation

103

683

1.52

3.99

2.5

2.0

1.12

1.22

g/l

0.72

598

Benign neoplasm: Skin of other and unspecified parts of face

240

1845

1.32

3.99

2.4

1.7

1.54

1.55

g/l

0.04

184

1582

Benign neoplasm of middle ear and respiratory system

177

1302

1.38

3.99

1.7

1.8

1.68

1.52

g/l

1.41

149

1120

Flat foot [pes planus] (acquired)

164

1190

1.39

3.97

1.9

1.8

1.48

1.54

g/l

0.34

140

1017

Maltreatment syndromes

495

1.62

3.95

1.6

2.0

1.56

1.40

g/l

0.87

435

Excessive vomiting in pregnancy

109

734

1.50

3.94

2.9

1.9

1.18

1.47

g/l

3.03

633

Other demyelinating diseases of the central nervous system

336

1.75

3.92

1.4

1.9

1.43

1.42

g/l

0.05

293

Crushed, pushed or stepped on by crowd or human stampede

119

818

1.47

3.90

1.9

1.47

1.45

g/l

0.09

719

Infective bursitis

406

1.69

3.90

2.3

1.9

1.44

1.56

g/l

0.57

354

Benign neoplasm: Skin of eyelid, including canthus

342

2756

1.25

3.88

1.4

1.7

1.51

1.58

g/l

0.68

288

2357

Malignant neoplasm of liver and intrahepatic bile ducts

415

1.68

3.86

1.6

1.20

1.44

g/l

1.45

347

Malignant neoplasm, without specification of site

477

1.63

3.85

1.9

1.5

1.77

1.53

g/l

0.83

396

Malignant cancer of tonsil and base of tongue, including Hilmo

317

1.78

3.84

2.1

1.5

1.60

1.49

g/l

0.44

278

Tuberculosis, IBD comorbidity

176

1303

1.37

3.83

1.6

1.48

1.53

g/l

0.30

151

1096

Malignant neoplasm of breast, HER2-negative

665

3716

1.18

3.79

1.5

1.7

1.68

1.57

g/l

1.53

543

3167

Bulimia nervosa (incl. atypical)

280

1.81

3.79

2.4

2.2

1.35

1.18

g/l

0.73

245

Demyelinating diseases of the central nervous system

137

973

1.42

3.78

1.5

1.9

1.37

1.48

g/l

0.84

118

845

Other specified/unspecified hearing loss

194

1461

1.35

3.77

1.7

1.46

1.55

g/l

0.82

176

1249

Urethral stricture

149

1078

1.41

3.77

1.4

1.7

1.67

1.49

g/l

1.55

125

919

Combined immunodeficiencies

122

2.30

3.76

1.9

2.1

1.77

1.50

g/l

0.62

107

Female infertility

465

2336

1.21

3.75

2.3

1.9

1.30

1.42

g/l

2.31

423

2011

Dislocation, sprain and strain of joints and ligaments at neck level

248

1929

1.30

3.75

1.6

1.9

1.46

1.45

g/l

0.03

217

1669

Acute inflammation of orbit

2.82

3.74

2.4

1.9

1.39

1.35

g/l

0.05

malignant neoplasm of female genital organs

273

2139

1.28

3.73

1.8

1.6

1.74

1.62

g/l

0.92

216

1817

Impingement syndrome of shoulder

476

3980

1.20

3.73

1.8

1.7

1.58

1.57

g/l

0.01

408

3403

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

100

660

1.51

3.71

2.4

2.0

1.37

1.34

g/l

0.11

573

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

471

1.60

3.70

2.0

2.3

1.26

1.19

g/l

0.25

420

Herpesviral keratitis and keratoconjunctivitis

617

1.54

3.70

1.9

1.55

1.48

g/l

0.27

537

Other endocrine disorders

543

1.56

3.70

2.4

2.0

1.23

1.42

g/l

1.03

483

Melanocytic naevi of lower limb, including hip

561

1.56

3.69

2.6

2.0

1.21

1.47

g/l

2.11

490

Testicular dysfunction

467

1.62

3.67

1.4

1.8

1.50

1.54

g/l

0.17

397

Sequelae of injuries of neck and trunk

382

1.69

3.67

1.4

2.2

1.53

1.51

g/l

0.03

328

Other abnormal findings in urine

234

1.90

3.67

2.2

2.0

1.61

1.56

g/l

0.14

206

Other noninflammatory disorders of vagina

140

1005

1.41

3.66

2.0

1.7

1.39

1.54

g/l

1.26

121

859

Renal cell carcinoma of kidney

484

1.61

3.64

1.7

1.5

1.82

1.52

g/l

1.70

406

Generalized epilepsy

444

1.62

3.63

1.7

2.1

1.21

1.39

g/l

0.75

397

Chronic Coagulation defects

241

1.87

3.62

1.5

2.1

1.38

1.46

g/l

0.24

209

114

789

1.46

3.62

2.2

2.0

1.25

1.21

g/l

0.16

693

Childhood asthma (age<16)

158

907

1.38

3.61

2.3

1.23

1.10

g/l

1.31

139

799

Other diseases of spinal cord

392

1.67

3.59

1.4

2.1

1.77

1.55

g/l

0.74

344

HSIL lesion of the cervix uteri

236

1836

1.29

3.57

2.3

1.9

1.43

1.35

g/l

0.52

206

1598

Contact with other hot fluids

339

1.71

3.56

1.6

2.1

1.34

1.40

g/l

0.22

299

Achalasia of cardia

236

1.88

3.56

1.6

2.1

1.61

1.57

g/l

0.09

207

Postpartum hemorraghe, all women as controls

321

2550

1.24

3.54

2.3

2.1

1.12

1.32

g/l

4.50

279

2224

Benign neoplasm: Other and unspecified parts of mouth

480

1.60

3.54

1.7

2.0

1.55

1.51

g/l

0.19

423

Other and unspecified injuries of ankle and foot

432

1.62

3.52

1.6

2.0

1.42

1.48

g/l

0.25

381

Excessive attrition of teeth

1080

9632

1.13

3.51

1.7

1.8

1.41

1.50

g/l

2.47

924

8302

Certain conditions originating in the perinatal period

110

673

1.46

3.51

2.7

2.1

1.23

1.22

g/l

0.06

100

587

Psoriasis (vulgaris), strict definition

402

1.65

3.51

1.8

2.2

1.53

g/l

0.01

351

Urethritis and urethral syndrome

244

1.84

3.50

1.5

2.0

1.63

1.44

g/l

0.41

208

Other acquired deformities of musculoskeletal system and connective tissue

617

1.52

3.49

1.4

1.8

1.51

1.55

g/l

0.14

536

Inguinal hernia, bilateral

261

2069

1.28

3.49

1.5

1.7

1.44

1.55

g/l

1.06

219

1779

Family history of other specific disorders

100

2.36

3.48

2.5

2.6

1.23

1.33

g/l

0.21

Insomnia

1825

12161

1.10

3.47

1.7

1.8

1.47

1.51

g/l

0.98

1556

10418

Malignant neoplasm of other and ill-defined sites, including Hilmo

195

1.96

3.47

1.8

1.5

1.87

1.58

g/l

0.71

170

Infliximab

146

2.10

3.46

1.8

2.3

1.49

1.36

g/l

0.27

129

Sudden idiopathic hearing loss

221

1717

1.30

3.46

1.7

1.8

1.55

1.57

g/l

0.09

189

1476

Noninflammatory disorders of female genital tract

751

3266

1.16

3.45

1.9

1.42

1.47

g/l

0.76

651

2782

Anogenital herpesviral [herpes simplex] infection

157

1160

1.36

3.44

2.2

2.1

1.28

1.35

g/l

0.49

136

1013

Idiopathic hypoparathyroidism

3.20

3.44

2.1

2.8

1.42

1.45

g/l

0.07

Perioral dermatitis

195

1.94

3.44

1.7

2.3

1.39

1.38

g/l

0.01

171

Carcinoma in situ of other and unspecified genital organs

217

1.90

3.44

1.6

2.2

1.73

1.54

g/l

0.48

191

Superficial injuries involving multiple body regions

305

1.74

3.43

1.6

2.1

1.62

1.43

g/l

0.62

270

Alzheimer’s disease (Late onset), excluding more controls

393

2125

1.22

3.42

1.5

1.7

1.59

g/l

0.04

307

1808

Inguinal or femoral hernia, bilateral

265

2110

1.27

3.42

1.5

1.7

1.44

1.55

g/l

1.10

222

1815

Intracerebral haemorrhage

320

2601

1.24

3.42

1.5

1.6

1.49

1.56

g/l

0.61

268

2204

Optic neuritis

420

1.62

3.41

1.4

2.1

1.51

1.44

g/l

0.26

368

Other/unspecified disorders of vestibular function

613

1.51

3.41

1.5

1.9

1.62

1.54

g/l

0.42

530

Thyroiditis, unspecified

161

2.04

3.41

2.1

1.9

1.76

1.50

g/l

0.67

141

Melanoma in situ

108

755

1.46

3.38

2.3

1.8

1.40

1.54

g/l

0.84

650

Other and unspecified injuries of shoulder and upper arm

391

1.64

3.37

1.4

2.1

1.53

1.50

g/l

0.10

342

Other disorders of cornea

193

1479

1.32

3.35

1.6

1.8

1.56

1.53

g/l

0.12

170

1286

Scleritis

135

2.14

3.35

3.5

2.2

1.86

1.47

g/l

0.65

117

Tongue abnormality

127

914

1.41

3.34

1.6

1.8

1.58

1.56

g/l

0.08

108

786

Leiomyoma of uterus

1107

5596

1.12

3.34

1.7

1.57

1.56

g/l

0.06

935

4777

Other disorders starting during childhood or adolescence

410

1.61

3.33

2.0

2.3

1.27

1.21

g/l

0.22

366

Unspecified/other endometriosis

127

912

1.40

3.32

1.9

1.8

1.37

1.41

g/l

0.20

110

782

Benign neoplasm: Tongue

409

1.63

3.32

1.8

1.9

1.62

1.52

g/l

0.37

357

Other and unspecified tonsillitis

526

3761

1.18

3.32

1.7

1.9

1.40

1.39

g/l

0.10

465

3271

Other sexually transmitted chlamydial diseases

582

1.51

3.31

1.9

2.1

1.15

1.25

g/l

0.64

519

Lichen simplex chronicus

440

1.60

3.31

1.9

1.80

1.53

g/l

1.66

389

Injury of blood vessels at abdomen, lower back and pelvis level

3.05

3.29

1.1

2.1

1.61

1.53

g/l

—

Recurrent dislocation and subluxation of joint

681

1.47

3.29

2.2

1.9

1.78

1.45

g/l

2.04

596

Use of galantamine

126

1725

0.72

3.28

1.5

1.6

1.69

1.53

g/l

0.98

102

1450

Postpartum haemorrhage due to anatomy

147

1085

1.37

3.27

2.5

2.3

1.08

1.13

g/l

0.36

131

966

Malignant neoplasm of mesothelium and soft tissue

562

1.52

3.26

1.3

1.6

2.08

1.50

g/l

3.35

477

Cysts of oral region, not elsewhere classified

117

834

1.42

3.26

1.6

1.9

1.40

1.55

g/l

0.98

103

726

Family history of malignant neoplasm

153

1137

1.36

3.25

1.6

1.8

1.46

1.52

g/l

0.36

125

972

L02BX Other hormone antagonists and related agents

156

1170

1.36

3.25

1.4

1.7

1.86

1.52

g/l

2.83

125

1003

Polyhydramnios

332

1.68

3.24

1.9

2.0

1.18

1.30

g/l

0.42

286

Other/unspecified enthesopathies, not elsewhere classified

170

1286

1.34

3.24

1.7

1.57

g/l

0.01

144

1091

Obsessive-compulsive disorder

618

1.49

3.23

1.8

2.1

1.43

1.27

g/l

0.97

544

Secondary parkinsonism

428

1.60

3.23

1.3

2.0

1.62

1.54

g/l

0.27

374

Optic atrophy

200

1.90

3.23

1.6

2.1

1.58

1.51

g/l

0.15

175

Injury of nerves and spinal cord at neck level

312

1.71

3.21

1.6

1.9

1.52

1.54

g/l

0.06

273

Female infertility, cervical, vaginal, other or unspecified origin

420

2279

1.20

3.21

2.3

1.9

1.29

1.42

g/l

2.64

383

1964

All dysplastic lesions of the cervix uteri

337

2745

1.22

3.20

2.1

1.9

1.40

1.35

g/l

0.41

292

2371

Optic atrophy

208

1.88

3.19

1.6

2.1

1.60

1.49

g/l

0.25

183

Poisoning by medicine, drug-induced

131

2.12

3.18

1.3

2.2

1.51

1.44

g/l

0.14

116

Acute nasopharyngitis (common cold)

184

1400

1.32

3.18

1.6

1.8

1.52

1.53

g/l

0.01

161

1195

Disorders of refraction and accommodation

456

3843

1.19

3.17

2.0

1.8

1.47

g/l

0.02

386

3317

Short stature, not elsewhere classified

133

2.05

3.17

4.0

2.0

0.80

1.17

g/l

2.27

122

Malignant neoplasm of respiratory system and intrathoracic organs

468

3300

1.19

3.17

1.5

1.93

1.53

g/l

11.62

396

2792

Astigmatism

110

778

1.43

3.16

1.7

1.9

1.62

1.45

g/l

1.13

687

Testicular hypofunction

398

1.61

3.16

1.5

1.8

1.48

1.54

g/l

0.20

341

Other contact dermatitis

144

1067

1.36

3.16

1.7

1.8

1.66

1.52

g/l

0.82

119

930

Dermatitis herpetiformis

246

1.80

3.15

1.6

2.0

1.26

1.49

g/l

1.01

217

Other acute skin changes due to ultraviolet radiation

486

1.55

3.15

1.6

1.7

1.65

1.56

g/l

0.41

428

Embedded teeth, including avohilmo

131

956

1.38

3.14

1.9

2.1

1.33

1.32

g/l

0.03

114

841

424

1.60

3.14

1.4

1.9

1.86

1.52

g/l

2.24

368

Malignant neoplasm of oesophagus, including Hilmo

527

1.53

3.13

1.3

1.5

1.60

1.51

g/l

0.49

453

Tooth agenesis EXCLUDE clefts and syndromes

313

1.68

3.12

1.8

2.4

1.07

1.26

g/l

0.96

283

Malignant neoplasm of bronchus and lung, including Hilmo

479

3409

1.18

3.11

1.6

1.5

1.90

1.53

g/l

10.52

406

2885

Pustular psoriasis

592

1.49

3.11

1.3

1.9

1.83

1.56

g/l

1.65

517

Single spontaneous delivery

608

3721

0.86

3.09

1.7

1.8

1.45

1.58

g/l

2.91

530

3185

Malignant neoplasm of ovary, including Hilmo

109

775

1.42

3.09

1.5

1.6

1.89

1.60

g/l

1.56

662

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

113

808

1.41

3.07

2.2

1.9

1.78

1.44

g/l

2.35

707

Lagophthalmos

190

1.91

3.06

1.5

2.0

1.67

1.46

g/l

0.53

167

Bursitis of shoulder

293

1.71

3.06

1.5

1.8

1.93

1.57

g/l

1.55

252

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

197

1.88

3.05

1.4

1.6

2.27

1.55

g/l

2.60

172

Scar conditions and fibrosis of skin

433

1.57

3.05

1.5

1.9

1.50

1.48

g/l

0.04

380

Respiratory conditions due to other external agents

318

1.68

3.02

2.1

1.8

1.59

1.57

g/l

0.08

280

Other congenital malformations of heart

2.64

3.01

2.4

2.1

1.12

1.30

g/l

0.48

Other/unspecified soft tissue disorders related to use, overuse and pressure

317

1.67

3.01

1.5

1.8

1.22

1.62

g/l

3.05

273

Assault by blunt object

148

2.01

3.00

2.5

2.0

1.43

g/l

0.01

132

Disorder of external ear, unspecified

436

1.57

2.99

1.9

2.1

1.64

1.55

g/l

0.31

382

Cervicocranial syndrome

197

1540

1.29

2.97

1.7

1.59

1.55

g/l

0.22

171

1317

Procedures for purposes other than remedying health state

220

1.81

2.97

1.6

1.7

1.34

1.48

g/l

0.42

194

Other and unspecified acute skin changes due to ultraviolet radiation

382

1.61

2.96

1.6

1.7

1.67

1.57

g/l

0.38

333

Mastocytosis

2.82

2.96

1.4

2.7

1.09

1.48

g/l

1.04

Malignant neoplasm of rectosigmoid junction

214

1.83

2.95

1.4

1.5

1.88

1.53

g/l

1.28

184

Foreign body in alimentary tract

110

792

1.41

2.93

1.9

1.50

1.53

g/l

0.09

692

Secondary parkinsonism+Parkinsonism in other disease

447

1.56

2.93

1.3

2.0

1.63

1.54

g/l

0.32

392

Tuberculosis, wide

179

1388

1.31

2.92

1.6

1.7

1.48

1.53

g/l

0.29

154

1174

Panhypopituitarism

237

1.78

2.92

1.4

2.0

1.38

1.46

g/l

0.25

211

Chromosomal abnormalities, not elsewhere classified

163

1.93

2.91

2.1

2.3

1.57

1.28

g/l

0.60

136

Other disorders of choroid

208

1.84

2.91

1.9

1.60

g/l

0.00

183

Pilonidal cyst

126

928

1.37

2.89

1.8

1.9

1.50

1.43

g/l

0.38

107

804

Recurrent dislocation of patella

446

1.54

2.89

2.0

2.2

1.58

1.29

g/l

1.31

399

Gonococcal infection

360

1.61

2.88

1.5

1.9

1.54

1.57

g/l

0.11

319

Epiphora

299

1.68

2.87

1.8

1.46

1.52

g/l

0.18

261

Carcinoma in situ of skin of eyelid, including canthus

3.60

2.86

1.8

2.3

1.22

1.46

g/l

0.61

Sexual dysfunction

165

1.93

2.86

1.6

2.2

1.46

g/l

0.00

146

Other diseases of gallbladder

687

1.44

2.86

1.9

1.7

1.37

1.50

g/l

0.65

596

Pustulosis palmaris et plantaris

522

1.50

2.84

1.3

1.9

1.84

1.61

g/l

1.17

457

Other symptoms and signs involving the nervous and musculoskeletal systems

854

7623

1.12

2.83

1.5

1.7

1.54

1.52

g/l

0.30

724

6522

Problems related to social environment

362

1.60

2.83

1.4

2.0

1.77

1.48

g/l

0.94

322

Inflammatory disorders of breast

679

1.43

2.82

1.8

2.0

1.27

1.43

g/l

1.25

595

Other otitis externa (chronic)

124

917

1.37

2.81

1.7

1.9

1.59

1.51

g/l

0.36

108

798

Burns and corrosions confined to eye and internal organs

277

1.69

2.81

1.3

2.3

1.58

1.46

g/l

0.33

245

Viral haemorrhagic fevers, not elsewhere classified/unspecified

155

1185

1.32

2.81

1.6

1.8

1.43

1.51

g/l

0.42

139

1028

Other disorders of binocular movement

202

1.81

2.81

1.4

2.3

1.41

1.32

g/l

0.20

177

Other and unspecified injuries of wrist and hand

418

1.55

2.81

2.1

1.60

1.45

g/l

0.70

368

Episcleritis

597

1.46

2.80

1.8

1.9

1.45

1.50

g/l

0.21

521

Other inflammation of vagina/vulva

308

1.65

2.79

1.8

2.3

1.47

1.39

g/l

0.19

267

Varicose veins of other sites

126

936

1.36

2.78

1.8

1.7

1.26

1.55

g/l

3.17

108

808

Benign neoplasm of other and unspecified intrathoracic organs

132

2.04

2.77

2.0

1.9

1.75

1.46

g/l

0.52

115

Bacterial meningitis

436

1.54

2.77

1.5

2.1

1.77

1.52

g/l

1.18

380

Ovarian dysfunction, other/unspecified

2.70

2.76

1.6

2.6

1.78

1.36

g/l

0.55

Spinal instabilities

341

1.61

2.76

1.5

1.9

1.62

1.50

g/l

0.38

293

Mental retardation, wide definition

433

1.54

2.75

1.6

2.1

1.56

1.42

g/l

0.50

380

Exposure to other and unspecified animate mechanical forces

294

1.66

2.75

1.8

2.0

1.53

1.44

g/l

0.25

260

Bitten or struck by other mammals

183

1433

1.29

2.75

2.0

1.9

1.57

1.47

g/l

0.67

162

1249

Phantom limb syndrome with pain

3.41

2.75

1.7

2.3

2.09

1.51

g/l

1.31

Haemangioma and lymphangioma, any site

166

1285

1.31

2.74

1.7

1.9

1.50

1.55

g/l

0.27

150

1121

Myasthenia gravis

242

1.74

2.74

1.7

2.0

1.53

1.52

g/l

0.01

212

Ganglion

351

2947

1.20

2.73

1.5

1.7

1.42

1.50

g/l

1.09

300

2510

Other protozoal intestinal diseases

219

1.77

2.73

1.6

2.3

1.19

1.41

g/l

0.84

195

Convergent concomitant strabismus

592

1.45

2.72

2.2

2.0

1.36

1.43

g/l

0.33

526

Atypical mycobacterium lung infection

176

1.88

2.72

1.9

1.79

1.56

g/l

0.73

154

Malignant neoplasm of breast, ER-positive, including Hilmo

514

3425

1.16

2.72

1.4

1.6

1.70

1.59

g/l

1.33

418

2920

Exophthalmic conditions

126

2.05

2.72

1.9

2.2

1.59

1.43

g/l

0.23

113

Vascular dementia (other)

134

2.05

2.72

1.3

1.7

1.49

1.66

g/l

0.58

122

Gonococcal infection

382

1.57

2.70

1.5

2.0

1.52

1.55

g/l

0.08

339

Behavioural disorders

161

1.89

2.69

1.7

2.2

1.70

1.29

g/l

1.16

147

Brain meningioma, including Hilmo

653

1.43

2.69

1.8

1.6

1.63

1.56

g/l

0.23

561

Other, unspecified and serous retinal detachments

497

1.50

2.68

1.9

1.8

1.41

1.60

g/l

1.06

429

Mixed conductive and sensorineural hearing loss

274

2256

1.23

2.68

1.7

1.60

1.56

g/l

0.23

222

1941

Congenital malformations and deformations of the musculoskeletal system

162

1246

1.30

2.68

2.1

1.9

1.39

1.42

g/l

0.15

137

1080

Tuberculosis of other organs

337

1.61

2.67

1.6

1.7

1.48

1.60

g/l

0.41

299

Disorders of synovium and tendon in diseases classified elsewhere

251

1.71

2.67

1.5

1.8

1.55

1.60

g/l

0.09

216

Carcinoma in situ of skin, other sites/unspecified

261

1.71

2.64

1.8

1.57

1.61

g/l

0.12

232

Third [oculomotor] nerve palsy

260

1.70

2.64

1.7

2.0

1.57

1.46

g/l

0.28

232

Schizophrenia

264

2166

1.23

2.64

1.5

1.8

1.85

1.50

g/l

6.37

223

1884

Unspecified abortion

432

1.52

2.64

2.3

1.7

1.41

1.59

g/l

0.79

370

Infectious mononucleosis

110

806

1.37

2.63

2.0

1.35

1.31

g/l

0.15

712

Vascular dementia

260

2058

1.23

2.63

1.5

1.6

1.57

1.51

g/l

0.55

213

1735

LSIL lesion of the cervix uteri, vagina or vulva

184

1450

1.28

2.63

2.1

1.8

1.42

1.45

g/l

0.14

162

1255

Postpartum hemorraghe, parous women as controls

321

2280

1.20

2.63

2.3

2.1

1.12

1.29

g/l

3.38

279

1999

Trigeminal neuralgia

104

757

1.39

2.63

1.5

1.8

1.59

1.56

g/l

0.15

652

Ulcer of vagina/vulva

283

1.66

2.62

1.5

2.2

1.50

1.45

g/l

0.12

247

Prolonged pregnancy

1139

0.72

2.61

1.6

2.0

1.13

1.32

g/l

1.43

983

Entropion and trichiasis of eyelid

212

1706

1.26

2.60

1.6

1.7

1.50

1.53

g/l

0.20

189

1441

Any dementia, excluding more controls

967

6004

1.11

2.60

1.5

1.7

1.61

1.56

g/l

0.77

773

5092

Polycystic ovarian syndrome, broad definition

135

1023

1.33

2.59

2.6

2.1

1.20

1.19

g/l

0.03

121

898

Universal erythroderma, KELA reimbursement

186

1.83

2.59

1.8

1.7

1.60

1.53

g/l

0.13

162

Benign neoplasm: Appendix

150

1.93

2.59

1.4

2.0

1.48

1.53

g/l

0.11

134

Flatulence and related conditions

101

2.14

2.58

2.1

2.3

1.52

1.44

g/l

0.13

Myopia

192

1526

1.27

2.57

2.1

1.8

1.38

1.46

g/l

0.56

167

1336

Subacute thyroiditis

428

1.52

2.56

1.5

2.0

1.38

1.52

g/l

0.62

373

Salpingitis and oophoritis

273

2256

1.22

2.55

1.7

1.54

1.58

g/l

0.28

236

1926

Dependent personality disorder

224

1.73

2.55

2.1

2.2

1.59

1.49

g/l

0.27

197

Bell's palsy

224

1816

1.24

2.54

1.9

1.7

1.55

1.54

g/l

0.08

194

1563

Dysplasia of cervi uteri

367

2247

1.19

2.54

2.1

1.9

1.44

1.43

g/l

0.05

317

1925

Other/unspecified enthesopathies of lower limb, excluding foot

118

881

1.35

2.54

1.6

1.8

1.64

1.56

g/l

0.35

757

Achilles tendinitis

188

1495

1.27

2.53

1.7

1.56

1.53

g/l

0.14

160

1298

Non-small cell lung cancer, squamous, helper endpoint

959

0.68

2.52

1.4

1.7

1.95

1.54

g/l

2.70

803

Endometriosis

593

3046

1.15

2.52

1.7

1.8

1.47

1.49

g/l

0.23

504

2592

Chronic diseases of tonsils and adenoids

1356

9330

0.92

2.52

1.9

1.8

1.49

g/l

0.05

1173

8046

Abscess of external ear

144

1.92

2.51

1.7

2.2

1.41

1.37

g/l

0.08

129

Dronedarone medication

374

1.55

2.51

1.6

1.36

1.60

g/l

1.34

322

Adenocarcinoma and papillary adenocarcinoma of stomach

382

1.55

2.50

1.4

1.6

1.44

1.54

g/l

0.37

325

Burn and corrosion of wrist and hand

414

1.52

2.49

1.2

2.2

1.47

1.46

g/l

0.04

363

Haemangioma, any site

155

1207

1.30

2.49

1.7

1.9

1.51

1.55

g/l

0.16

139

1052

Abnormal spermatozoa

212

2606

0.80

2.49

1.6

1.7

1.56

1.54

g/l

0.11

180

2233

Malignant neoplasm of oropharynx

196

1.78

2.49

2.4

1.5

1.33

1.43

g/l

0.32

168

Patent foramen ovale

241

1.69

2.48

1.6

2.2

1.41

1.40

g/l

0.02

218

Cluster headache, strict

366

1.55

2.48

1.3

2.0

1.40

1.49

g/l

0.39

315

Subarachnoid haemorrhage

220

1787

1.24

2.48

1.7

1.6

1.51

1.55

g/l

0.23

189

1525

Use of biperiden

698

1.39

2.47

1.5

1.9

1.76

1.55

g/l

1.26

604

Vascular dementia (subcortical)

658

1.41

2.47

1.4

1.7

1.48

1.53

g/l

0.21

567

Perineal laceration during delivery

192

1280

1.26

2.45

2.0

2.1

1.10

1.30

g/l

3.04

168

1121

Other strabismus

363

3079

1.18

2.45

1.8

1.44

1.48

g/l

0.29

314

2646

Malignant neoplasm of eye and adnexa, including Hilmo

197

1.77

2.45

2.0

1.7

1.48

1.55

g/l

0.16

173

Atypical facial pain

640

1.41

2.44

1.5

1.8

1.41

1.57

g/l

1.07

555

Complications predominantly related to the puerperium

355

3017

1.18

2.44

2.3

1.8

1.37

1.44

g/l

0.68

322

2595

Hirsprung

6.90

2.44

1.2

1.9

2.04

1.25

g/l

—

Cerebral aneurysm, nonruptured

161

1264

1.29

2.44

1.8

1.7

1.68

1.55

g/l

0.92

145

1091

Pediculosis, acariasis and other infestations

261

2159

1.22

2.43

1.6

1.8

1.49

1.44

g/l

0.37

212

1881

Congenital malformations of uterus and cervix

167

1.83

2.43

1.3

2.4

1.36

1.31

g/l

0.11

145

Severe visual impairment, monocular

125

1.99

2.42

1.9

2.3

1.57

1.51

g/l

0.14

109

MS-disease / Multiple Sclerosis

106

785

1.36

2.42

1.5

1.9

1.33

1.46

g/l

1.02

681

Fourth [trochlear] nerve palsy

322

1.59

2.41

1.7

2.0

1.66

1.47

g/l

0.84

285

Alzheimer’s disease (Atypical or mixed)

195

2389

0.80

2.40

1.7

1.6

1.60

1.52

g/l

0.54

147

2018

Other deformities of toe(s)

443

1.49

2.39

1.7

1.9

1.47

1.56

g/l

0.36

381

Asthma mixed form (mode), excluding more controls

517

1.44

2.37

1.4

1.7

1.57

1.47

g/l

0.45

444

Macular cyst

495

1.47

2.37

1.7

1.8

1.58

1.63

g/l

0.19

432

Conduct disorder

176

1.79

2.36

1.7

2.3

1.77

1.27

g/l

1.52

160

Chronic conjunctivitis

355

1.55

2.36

1.9

1.8

1.57

1.52

g/l

0.11

314

Exposure to unspecified smoke, fire and flames

119

2.00

2.36

1.5

2.0

1.53

1.55

g/l

0.02

101

Sequelae of injuries of upper limb

172

1367

1.27

2.36

1.6

1.8

1.63

1.55

g/l

0.67

151

1193

2.25

2.36

1.2

2.6

1.70

1.45

g/l

0.28

Malignant neoplasm of tonsil

177

1.80

2.36

2.6

1.5

1.32

1.47

g/l

0.46

150

Malignant neoplasm of oropharynx, including Hilmo

253

1.66

2.35

2.3

1.5

1.38

1.48

g/l

0.30

218

Transient global amnesia

126

1634

0.76

2.35

1.8

1.7

1.34

1.57

g/l

1.99

102

1416

Delayed milestone in childhood

106

1.98

2.34

2.7

1.8

1.09

1.12

g/l

0.05

Ovarian dysfunction

704

1.37

2.33

2.3

2.1

1.41

1.26

g/l

0.79

614

Major anomalies of jaw size

253

1.65

2.33

1.5

2.2

1.25

1.42

g/l

0.45

219

Papillary adenocarcinoma of thyroid gland

553

1.43

2.33

1.7

1.36

1.51

g/l

0.76

484

Benign neoplasm: Skin of upper limb, including shoulder

254

1.65

2.32

2.6

2.0

1.42

1.51

g/l

0.28

224

Certain zoonotic bacterial diseases

406

1.50

2.31

2.1

2.0

1.42

1.46

g/l

0.13

361

Benign neoplasm: Skin of scalp and neck

350

1.54

2.29

2.9

2.0

1.34

1.54

g/l

1.24

308

Chronic suppurative otitis media, including avohilmo

149

1169

1.29

2.29

1.8

1.49

1.47

g/l

0.06

131

1019

Other disorders of Eustachian tube

350

1.54

2.28

1.7

2.1

1.42

1.52

g/l

0.38

307

Meralgia paraesthetica

415

1.49

2.28

1.9

1.46

1.56

g/l

0.32

357

Tinnitus

464

4054

1.15

2.27

1.6

1.7

1.54

1.56

g/l

0.22

396

3478

Dislocation, sprain and strain of joints and ligaments of head

415

1.49

2.27

1.7

2.1

1.50

1.45

g/l

0.18

365

Other congenital malformations of intestine

128

1.93

2.26

1.5

2.3

1.69

1.46

g/l

0.40

113

Other peripheral vertigo

187

1511

1.25

2.25

1.5

1.8

1.50

1.55

g/l

0.27

149

1300

Other specified disorders of muscle

376

1.51

2.24

2.2

1.8

1.44

1.55

g/l

0.43

318

Toxic effect of contact with venomous animals

534

1.42

2.22

1.5

2.1

1.48

1.45

g/l

0.09

471

Malignant neoplasm of thyroid gland, including Hilmo

114

867

1.33

2.21

1.9

1.6

1.52

1.53

g/l

0.02

749

Sequelae of infectious and parasitic diseases

135

1052

1.30

2.20

1.9

1.8

1.39

1.54

g/l

0.93

116

901

Benign neoplasm: Skin of ear and external auricular canal

663

1.38

2.20

1.9

1.27

1.52

g/l

2.30

581

Tooth eruption problems

190

1501

1.24

2.19

1.9

2.1

1.32

1.26

g/l

0.41

170

1327

Cerebral atherosclerosis

205

1.70

2.15

1.5

1.9

1.60

1.65

g/l

0.12

180

Other diseases of peritoneum

631

1.38

2.15

1.6

1.8

1.36

1.53

g/l

0.87

555

Nonspecific lymphadenitis

647

1.37

2.14

1.5

1.8

1.51

1.56

g/l

0.22

560

Meretoja disease

2.71

2.14

1.5

2.2

1.32

1.56

g/l

0.60

Other sexually transmitted chlamydial diseases

119

914

1.31

2.14

2.0

2.2

1.14

1.22

g/l

0.55

107

804

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

160

1.79

2.14

1.4

1.9

1.60

1.63

g/l

0.06

138

Deviated nasal septum

690

6197

1.12

2.13

1.6

1.7

1.53

1.54

g/l

0.01

583

5316

Disorders of pituitary gland, other and/or unspecified

2.35

2.12

1.1

2.2

1.69

1.50

g/l

0.25

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

482

4243

1.14

2.12

1.5

1.9

1.50

1.49

g/l

0.04

420

3645

Appendectomy

1258

11116

1.08

2.12

1.7

1.8

1.55

1.50

g/l

1.37

1071

9572

Pedestrian injured in transport accident

126

979

1.30

2.12

1.7

1.9

1.56

1.51

g/l

0.24

103

857

Hordeolum and other deep inflammation of eyelid

735

1.35

2.11

2.3

1.9

1.18

1.50

g/l

3.35

645

Contusion of ankle

397

1.48

2.11

1.8

2.2

1.52

1.46

g/l

0.25

351

Oxicams

585

2949

1.13

2.11

1.6

1.9

1.54

1.47

g/l

1.10

481

2502

Non-small cell lung cancer, including Hilmo

322

2595

1.18

2.11

1.5

1.93

1.54

g/l

8.15

274

2196

Malignant neoplasm of breast, HER-positive

496

3404

1.14

2.11

1.4

1.6

1.71

1.59

g/l

1.46

401

2901

Laparoscopic left hemicolectomy

254

1.62

2.09

1.3

1.9

1.85

1.57

g/l

1.09

221

Other disorders of bone density and structure

269

1.59

2.09

1.4

2.3

1.51

1.43

g/l

0.23

237

Hypotension due to drugs

239

1.64

2.08

1.5

1.9

1.55

1.56

g/l

0.04

211

Congenital malformations and deformations of the musculoskeletal system

122

940

1.30

2.08

2.3

2.0

1.39

1.40

g/l

0.02

105

823

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

278

1.58

2.08

1.6

1.5

1.63

1.57

g/l

0.13

236

Other and unspecified trigeminal disorders

169

1.75

2.08

1.3

2.3

1.48

1.51

g/l

0.07

150

Oral lichen planus and hypothyroidism or thyroxine medication

223

1.65

2.07

2.6

2.0

1.48

1.59

g/l

0.24

191

Other and unspecified injuries of thorax

215

1.66

2.07

1.7

2.2

1.32

1.48

g/l

0.58

190

Arthropod-borne viral fevers and viral haemorrhagic fevers

181

1473

1.24

2.07

1.6

1.8

1.49

1.52

g/l

0.15

162

1268

Use of antiglaucoma preparations and miotics

196

1610

1.23

2.07

1.7

1.55

1.52

g/l

0.14

165

1374

Malignant neoplasm of tonsil, including Hilmo

208

1.67

2.05

2.4

1.5

1.35

1.46

g/l

0.35

180

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

611

1.38

2.05

2.0

1.8

1.69

1.56

g/l

0.56

535

Radial styloid tenosynovitis [de Quervain]

610

1.37

2.04

1.4

1.8

1.40

1.54

g/l

0.72

531

Brain meningioma

629

1.37

2.02

1.9

1.6

1.63

1.55

g/l

0.26

541

Presbycusis

374

3223

1.16

2.01

2.0

1.6

1.52

1.57

g/l

0.49

295

2736

Other and unspecified corneal deformities and disorders

394

1.47

2.01

1.5

1.9

1.69

1.48

g/l

0.93

344

Premature separation of placenta [abruptio placentae]

148

1.78

2.00

2.0

1.31

1.40

g/l

0.16

127

Small kidney of unknown cause

2.93

2.00

1.6

1.5

1.22

1.50

g/l

—

Cluster headache, wide

411

1.45

1.99

1.3

2.0

1.37

1.48

g/l

0.55

353

Malignant neoplasm of cervix uteri, including Hilmo

233

1.61

1.98

1.9

1.8

1.38

1.50

g/l

0.43

205

Juvenile osteochondrosis

321

1.51

1.98

1.9

2.0

1.38

1.42

g/l

0.10

287

Toxic effect of other noxious substances eaten as food

2.84

1.97

2.2

2.3

1.69

1.75

g/l

—

Malignant neoplasm of ureter, including Hilmo

128

1.86

1.96

2.6

1.9

1.60

1.52

g/l

0.17

108

Other melanin hyperpigmentation

307

1.53

1.95

2.1

1.9

1.46

1.53

g/l

0.19

272

Benign neoplasm: Pharynx, unspecified

2.02

1.94

1.2

2.7

1.74

1.40

g/l

0.56

Lichen planus

246

2077

1.19

1.94

1.6

1.7

1.45

1.58

g/l

1.37

206

1776

Inflammatory diseases of prostate (prostatitis)

280

2391

1.18

1.94

1.4

1.6

1.53

1.55

g/l

0.09

229

2036

Vascular dementia (mixed)

349

1.50

1.94

2.2

1.7

1.43

1.52

g/l

0.31

301

Endometriosis diagnosis and infertility diagnosis occurring together

126

991

1.28

1.93

2.2

1.8

1.32

1.44

g/l

0.85

115

849

Contact with sharp glass

397

1.45

1.93

1.7

2.2

1.42

g/l

0.00

354

Malignant neoplasm of corpus uteri, including Hilmo

165

1342

1.24

1.92

1.9

1.6

1.72

1.62

g/l

0.47

124

1152

Persistent delusional disorders

141

1127

1.26

1.92

1.4

1.8

1.79

1.53

g/l

2.38

127

966

Fenamates

341

2000

1.16

1.91

1.6

2.0

1.53

1.43

g/l

1.29

298

1727

Dermatographic urticaria

739

1.32

1.91

2.0

1.9

1.44

1.49

g/l

0.20

642

Use of rivastigmine

304

3511

0.86

1.91

1.3

1.6

1.55

g/l

0.02

243

2951

Benign neoplasm: Larynx

483

1.41

1.90

1.5

1.9

1.71

1.51

g/l

0.94

427

Anisometropia and aniseikonia

382

1.46

1.90

2.7

1.9

1.46

1.53

g/l

0.23

343

Non-small cell lung cancer, adenocarcinoma

125

987

1.28

1.90

1.6

1.91

1.50

g/l

3.33

107

843

Atrophic disorders of skin

243

2053

1.19

1.90

1.6

1.7

1.60

1.57

g/l

0.17

200

1751

Juvenile Open Angle Glaucoma

2.28

1.88

2.2

1.9

1.25

1.41

g/l

0.36

Tuberculosis of other organs, strict

401

1.45

1.87

1.7

1.48

1.57

g/l

0.29

355

Placenta praevia

325

1.49

1.87

2.8

1.9

1.14

1.32

g/l

0.77

273

Pleural plaque

255

2171

1.19

1.87

1.6

1.7

1.50

1.53

g/l

0.23

214

1843

Malignant neoplasm of ovary

561

1.37

1.86

1.5

1.6

2.04

1.60

g/l

2.10

479

Postmenopausal atrophic vaginitis

368

2328

0.87

1.85

1.7

1.51

1.62

g/l

1.32

317

1958

Benign neoplasm of ovary

293

2520

1.17

1.85

1.9

1.6

1.58

1.60

g/l

0.12

254

2133

Examination and encounter for administrative purposes

605

1.35

1.84

1.6

1.43

1.55

g/l

0.58

513

Chronic iridocyclitis

666

1.34

1.84

1.5

1.8

1.47

1.52

g/l

0.18

582

Otitis media, unspecified

162

1215

1.23

1.83

1.7

2.0

1.34

1.39

g/l

0.33

142

1068

Haemorrhage in early pregnancy

361

3069

1.15

1.82

1.9

1.8

1.35

1.48

g/l

1.91

308

2641

Hereditary motor and sensory neuropathy

102

1.92

1.80

1.7

1.8

1.22

1.53

g/l

0.69

Acute alcohol intoxication ICD-9

497

1.39

1.79

1.6

1.9

1.54

1.55

g/l

0.05

423

Alzheimer’s disease (Early onset), excluding more controls

649

0.69

1.79

1.3

1.6

1.58

1.52

g/l

0.14

550

Other bursitis, not elsewhere classified

117

1.84

1.78

1.4

1.8

1.69

1.59

g/l

0.19

106

Sequelae of other and unspecified infectious and parasitic diseases

600

1.35

1.78

2.0

1.9

1.31

1.52

g/l

1.21

522

Additional codes for the location of defect, injury or illness

105

819

1.30

1.77

1.7

1.9

1.44

1.53

g/l

0.43

717

Other specified and unspecified disorders of lens

148

1.75

1.76

2.5

1.8

1.72

1.74

g/l

0.03

129

Other neurotic disorders

671

1.33

1.76

1.9

1.8

1.52

1.54

g/l

0.06

577

Vascular syndromes of brain in cerebrovascular disorders

108

848

1.29

1.76

1.4

1.8

1.56

1.52

g/l

0.15

734

Diffuse brain injury

448

1.40

1.74

1.8

1.41

1.51

g/l

0.39

382

Malignant neoplasm of thyroid gland

750

1.30

1.74

2.0

1.6

1.52

1.51

g/l

0.03

651

Other congenital malformations of female genitalia

2.17

1.73

2.5

2.9

1.54

1.18

g/l

0.86

Other superficial mycoses

161

1322

1.23

1.73

1.7

1.9

1.53

1.46

g/l

0.44

134

1152

Other osteochondropathies

116

919

1.27

1.73

1.5

1.8

1.54

1.53

g/l

0.05

102

803

Residual foreign body in soft tissue

612

1.34

1.72

1.4

1.8

1.53

1.52

g/l

0.04

524

Burn and corrosion of hip and lower limb, except ankle and foot

275

1.51

1.71

1.3

2.0

1.59

1.43

g/l

0.51

241

Graves disease, strict definition

147

1197

1.24

1.71

1.7

1.8

1.42

1.52

g/l

0.71

124

1032

Peroneal tendinitis

164

1.67

1.70

1.5

2.0

1.39

g/l

0.01

142

Unspecified lump in breast

252

2159

1.17

1.70

1.5

1.6

1.46

1.59

g/l

1.45

218

1825

Personality and behavioural disorders due to brain disease, damage and dysfunction

196

1.61

1.68

2.5

1.8

1.55

1.46

g/l

0.21

176

Benign neoplasm: Tonsil

150

1.71

1.67

1.3

2.1

1.42

1.49

g/l

0.18

130

Injury of muscle and tendon at lower leg level

273

2358

1.16

1.67

1.8

1.7

1.62

1.53

g/l

0.90

238

2029

Embedded and impacted teeth

370

2687

1.14

1.67

2.3

2.1

1.28

1.30

g/l

0.14

326

2349

Congenital hypothyroidism without goiter

2.32

1.67

1.6

2.0

1.13

1.41

g/l

0.52

Hypersomnia

150

1.70

1.66

1.4

2.0

1.94

1.40

g/l

1.52

128

Sixth [abducent] nerve palsy

522

1.36

1.66

1.7

1.9

1.66

1.50

g/l

0.57

465

Chronic suppurative otitis media

125

1005

1.25

1.66

1.8

1.50

1.48

g/l

0.08

109

876

Other specified/unspecified deforming dorsopathies

181

1.63

1.66

1.6

1.9

1.63

1.47

g/l

0.32

157

Assault by sharp object

166

1.65

1.64

1.4

2.0

1.52

1.38

g/l

0.29

151

Injury of eye and orbit

238

2038

1.17

1.63

1.6

1.8

1.42

1.49

g/l

0.66

206

1753

Disorders of lacrimal system and orbit in diseases classified elsewhere

287

1.48

1.62

1.6

1.7

1.40

1.44

g/l

0.14

249

Conductive hearing loss, unspecified

148

1217

1.23

1.60

1.7

1.8

1.64

1.53

g/l

0.69

134

1061

Other and unspecified injuries of abdomen, lower back and pelvis

183

1.62

1.60

1.9

2.3

1.27

1.41

g/l

0.40

163

Dislocation, sprain and strain of joints and ligaments of knee

1083

9292

1.08

1.59

1.8

1.49

1.48

g/l

0.02

926

8006

Alzheimer disease, including avohilmo

875

6663

0.92

1.58

1.5

1.6

1.62

1.57

g/l

0.79

692

5643

Lyme disease

468

5204

0.90

1.58

1.7

1.36

1.56

g/l

5.73

387

4472

Other disorders of amniotic fluid and membranes

139

1109

1.23

1.57

1.9

1.26

1.35

g/l

0.62

122

949

Acute appendicitis, with complications

373

3307

1.13

1.57

2.0

1.7

1.59

1.54

g/l

0.40

319

2829

Foreign body or object entering through skin

103

816

1.27

1.57

1.5

1.9

1.49

1.52

g/l

0.11

716

Anti-inflammatory and antirheumatic products, non-steroids

713

3275

1.10

1.55

1.8

2.0

1.51

1.42

g/l

1.63

617

2794

Alzheimer’s disease, strict definition

575

5207

0.90

1.55

1.5

1.6

1.61

1.55

g/l

0.76

445

4414

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

323

1.44

1.55

1.5

2.2

1.62

1.44

g/l

0.74

287

Suggestive for eosinophilic asthma

177

1488

1.20

1.54

1.5

1.7

1.71

1.52

g/l

1.93

149

1280

Uterine polyps

152

1259

1.21

1.54

1.7

1.38

1.56

g/l

1.73

129

1069

Other degenerative diseases of the basal ganglia

317

1.45

1.53

1.3

2.1

1.47

1.53

g/l

0.20

280

Carcinoma in situ, bladder

644

1.31

1.53

1.6

1.9

1.68

1.51

g/l

1.00

553

Injury of muscle and tendon at ankle and foot level

266

1.49

1.53

1.4

2.2

1.33

1.48

g/l

0.34

226

Hyperkinetic disorders

141

1134

1.22

1.53

1.8

2.2

1.25

1.20

g/l

0.34

119

997

Maternal care for cervical incompetence

434

1.37

1.53

1.8

2.0

1.23

1.50

g/l

1.52

387

Carcinoma in situ of other and unspecified sites

706

1.30

1.53

1.6

1.8

1.73

1.51

g/l

1.41

602

Dyshidrosis [pompholyx]

146

1.67

1.53

1.6

2.0

1.68

1.38

g/l

0.67

126

Pain and other conditions associated with female genital organs and menstrual cycle

273

2182

1.15

1.52

1.9

1.46

1.40

g/l

0.47

230

1879

Bruxism

154

1.65

1.52

1.8

2.4

1.64

1.36

g/l

0.67

133

Moderate mental retardation

2.06

1.51

1.4

1.9

1.43

1.29

g/l

0.25

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

2.35

1.51

2.1

1.4

1.24

1.40

g/l

—

Temporomandibular joint disorders, including avohilmo

706

6391

1.09

1.51

1.6

1.9

1.43

1.44

g/l

0.12

609

5516

Crossbite

634

1.29

1.51

1.4

2.2

1.39

1.34

g/l

0.18

555

Injury of muscle and tendon at wrist and hand level

240

2073

1.16

1.50

1.6

1.8

1.54

g/l

0.01

217

1792

Alzheimer disease

756

6000

0.92

1.50

1.5

1.6

1.60

1.57

g/l

0.35

589

5085

Spirochaetal infections, other/unspecified

474

5250

0.90

1.50

1.7

1.37

1.56

g/l

5.68

393

4512

Cervicobrachial syndrome

372

3311

1.13

1.48

1.7

1.48

1.54

g/l

0.59

312

2825

Normal-pressure hydrocephalus

956

0.76

1.48

1.4

1.7

1.57

1.53

g/l

0.17

815

Maternal care related to the fetus and amniotic cavity and possible delivery problems

554

2945

1.11

1.48

2.0

1.9

1.24

1.47

g/l

7.87

472

2549

Hyperkinetic disorders (excl. ADHD)

138

1.67

1.48

1.4

2.3

1.17

1.24

g/l

0.14

126

Impacted teeth

253

1951

1.16

1.47

2.5

2.2

1.24

1.26

g/l

0.14

225

1723

Hypersensitivity pneumonitis due to organic dust

228

1.52

1.47

1.5

2.2

1.73

1.47

g/l

0.56

203

Mixed disorders of conduct and emotions, excluding more controls

163

1.61

1.47

1.8

2.3

1.49

1.13

g/l

0.63

142

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

102

1.79

1.47

1.9

2.4

1.43

1.32

g/l

0.20

Exposure to smoke, fire and flames

319

1.43

1.46

1.3

2.0

1.47

1.53

g/l

0.16

281

Other specified transport accidents

2.09

1.46

1.4

1.9

1.21

1.39

g/l

0.33

Spirochaetal infections, other/unspecified

159

1332

1.20

1.46

1.7

1.8

1.43

1.53

g/l

0.72

131

1158

Nontoxic multinodular goitre

375

3349

1.13

1.44

1.6

1.64

1.60

g/l

0.41

320

2859

Other specified and unspecified disorders of choroid

2.17

1.43

3.1

2.0

1.52

1.62

g/l

0.13

Open bite

448

1.35

1.42

1.7

2.2

1.25

1.32

g/l

0.19

399

Pregnancy with abortive outcome

1185

5792

1.07

1.40

1.8

1.52

1.50

g/l

0.41

1013

4964

Retained placenta and membranes, without haemorrhage

157

1318

1.20

1.40

1.8

1.7

1.42

1.57

g/l

1.19

136

1133

Hypermobility syndrome

432

1.35

1.40

1.6

2.0

1.26

1.37

g/l

0.44

378

Intermittent heterotropia

606

1.29

1.40

1.8

2.0

1.35

1.37

g/l

0.06

532

Hyperprolactinaemia

297

1.43

1.38

1.7

2.1

1.38

1.39

g/l

0.03

258

Graves ophthalmopathy

281

1.44

1.38

1.6

1.8

1.43

1.47

g/l

0.15

244

Excessive earwax

1246

11451

1.06

1.37

1.6

1.7

1.50

1.56

g/l

1.45

1047

9767

Pollen allergy

243

2089

1.15

1.37

1.8

2.0

1.30

1.38

g/l

0.80

209

1797

Abnormal findings in secretions and smears from cervix uteri vagina vulva

720

5020

1.09

1.36

2.0

1.8

1.39

1.46

g/l

0.99

623

4332

Perichondritis of external ear

266

1.46

1.35

1.6

1.9

1.53

1.63

g/l

0.20

237

128

1.66

1.34

3.5

2.0

1.34

1.12

g/l

0.40

116

Tonsillectomy and adenotomy

748

5624

0.92

1.34

2.2

1.9

1.37

1.40

g/l

0.35

648

4860

Other and/or unspecified nontoxic goitre

145

1216

1.20

1.34

1.5

1.7

1.55

1.60

g/l

0.34

132

1044

Graves ophthalmopathy, strict

250

1.46

1.33

1.6

1.8

1.40

1.53

g/l

0.51

215

Other and unspecified intracranial injuries

420

1.35

1.33

1.9

2.0

1.84

1.52

g/l

1.83

372

Contracture of muscle

2.16

1.33

1.1

1.7

1.29

1.52

g/l

—

Sacrococcygeal disorders, not elsewhere classified

317

1.40

1.32

2.0

2.1

1.42

1.49

g/l

0.24

270

Schizoid personality disorder

193

1.53

1.31

1.3

2.4

1.91

1.44

g/l

1.33

169

Male infertility

446

1.33

1.31

1.7

1.8

1.32

1.49

g/l

0.91

383

Injury of nerves at wrist and hand level

464

1.33

1.31

2.1

1.59

1.47

g/l

0.37

396

Disturbance of activity and attention

130

1058

1.21

1.31

1.8

2.2

1.28

1.18

g/l

0.67

110

926

Vertigo of central origin

243

1.47

1.31

1.2

2.0

1.74

1.52

g/l

0.87

212

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

802

1.25

1.30

1.9

1.7

1.40

1.58

g/l

1.15

698

Malignant neoplasm of corpus uteri

141

1184

1.20

1.29

1.8

1.6

1.65

1.61

g/l

0.15

108

1013

L02BA Anti-estrogens

201

2320

0.86

1.29

1.5

1.6

1.74

1.60

g/l

0.94

166

1965

Scabies

198

1710

1.16

1.28

1.7

1.8

1.49

1.44

g/l

0.34

157

1493

Tuberculosis

140

1177

1.20

1.28

1.5

1.6

1.47

1.54

g/l

0.42

120

991

Hereditary corneal dystrophies

511

1.31

1.27

1.4

1.8

1.47

1.54

g/l

0.30

440

Benign neoplasm of male genital organs

355

1.38

1.27

1.3

1.9

1.73

1.52

g/l

0.77

313

Heterophoria

119

985

1.22

1.27

1.7

1.9

1.44

1.47

g/l

0.13

104

869

Benign neoplasm: Lip

313

1.40

1.25

1.4

1.9

1.39

1.50

g/l

0.43

273

Other and unspecified hypertrophic disorders of skin

1.95

1.25

1.9

2.8

1.09

1.34

g/l

0.59

Female infertility, tubal origin

425

1.33

1.23

2.1

1.8

1.44

1.45

g/l

0.03

366

Pathological resorption of teeth

452

1.32

1.23

1.5

2.1

1.49

1.52

g/l

0.08

397

Medial epicondylitis

417

1.33

1.22

1.5

1.8

1.49

1.60

g/l

0.40

357

Other specified and unspecified disorders of conjunctiva

117

1.66

1.20

2.7

1.9

1.60

1.56

g/l

0.07

103

Congenital malformations of genital organs

115

949

1.21

1.20

1.7

1.9

1.33

1.39

g/l

0.29

100

828

Generalized epilepsy, mode (most common among epilepsy diagnosis)

315

1.38

1.20

1.7

2.2

1.27

1.38

g/l

0.26

282

Benign neoplasm: salivary glands, exclude unknown (D119)

167

1435

1.17

1.19

1.5

1.8

1.66

1.54

g/l

0.84

139

1236

Cerebral amyloid angiopathy

1.88

1.19

1.4

1.7

1.49

1.66

g/l

0.25

Deep bite

151

1126

1.18

1.19

1.8

1.9

1.23

1.44

g/l

2.64

128

981

Polycystic ovarian syndrome

489

1.30

1.18

2.7

2.2

1.34

1.16

g/l

0.89

427

Lichen planus, including avohilmo

351

3166

1.11

1.18

1.6

1.7

1.47

1.58

g/l

1.54

302

2711

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

240

1.44

1.18

1.3

1.7

1.89

1.50

g/l

1.03

205

Benign neoplasm: Skin of lower limb, including hip

368

1.35

1.18

1.3

1.9

1.46

1.49

g/l

0.07

322

Other conjunctival vascular disorders and cysts

317

1.37

1.17

1.6

1.8

1.63

1.52

g/l

0.32

285

Hypertrophy of breast

174

2010

0.86

1.16

1.7

1.53

g/l

0.01

152

1708

Muscle strain

378

1.34

1.15

2.3

1.9

1.84

1.55

g/l

0.87

323

Allergic colitis

166

1.52

1.15

2.7

2.4

1.03

1.16

g/l

0.31

148

Benign neoplasm of major salivary glands

186

1617

1.16

1.15

1.6

1.7

1.67

1.54

g/l

1.07

157

1388

Other spirochaetal diseases

483

5260

0.92

1.15

1.7

1.37

1.56

g/l

5.64

400

4521

Hypermetropia

108

896

1.21

1.14

1.3

1.8

1.47

g/l

0.01

778

Allergic rhinitis

450

4069

1.10

1.14

1.7

1.9

1.40

1.43

g/l

0.26

383

3514

Malignant neoplasm of bronchus and lung

383

2885

1.11

1.14

1.5

1.94

1.54

g/l

9.32

323

2444

Femoral hernia, unilateral

397

1.33

1.13

1.4

1.9

1.58

1.62

g/l

0.07

350

Inguinal hernia, unilateral

397

1.33

1.13

1.4

1.9

1.58

1.62

g/l

0.07

350

Inguinal of femoral hernia, unilateral

397

1.33

1.13

1.4

1.9

1.58

1.62

g/l

0.07

350

Benign neoplasm: Skin, unspecified

547

1.27

1.13

1.6

1.9

1.57

1.53

g/l

0.14

479

Allergic contact dermatitis

198

1731

1.15

1.12

1.7

1.8

1.55

1.54

g/l

0.05

174

1491

L02BB Anti-androgens

245

2176

1.13

1.12

1.4

1.6

1.76

1.53

g/l

2.38

206

1835

Explosion of other materials

2.33

1.12

4.0

2.5

1.55

1.62

g/l

—

Endometriosis of rectovaginal septum and vagina

1052

0.81

1.12

1.4

1.7

1.56

1.55

g/l

0.04

894

Use of other anti-dementia drugs

644

5736

0.93

1.12

1.5

1.6

1.60

1.56

g/l

0.42

486

4854

Use of memantine

644

5736

0.93

1.12

1.5

1.6

1.60

1.56

g/l

0.42

486

4854

Sequelae of tuberculosis

320

1.36

1.12

1.9

1.7

1.37

1.52

g/l

0.45

284

Unspecific neurodegenerative disorder

1029

7450

0.94

1.12

1.4

1.6

1.59

1.57

g/l

0.35

814

6335

Deep endometriosis

103

1237

0.83

1.11

1.6

1.8

1.46

1.50

g/l

0.18

1058

Postprocedural disorders of nervous system

727

1.23

1.11

1.7

2.0

1.40

g/l

0.00

642

Endocrine disorders, other/unspecified

218

1.44

1.11

1.8

2.1

1.47

g/l

0.01

194

Non-allergic asthma

152

1305

1.17

1.10

1.7

1.8

1.51

1.50

g/l

0.03

134

1134

Other abnormal products of conception

382

2293

1.10

2.0

1.28

1.34

g/l

0.78

342

1995

Acute appendicitis

1383

12300

1.05

1.10

1.7

1.8

1.52

1.51

g/l

0.28

1193

10553

Asthma mixed form (mode)

593

1.26

1.10

1.4

1.6

1.57

1.47

g/l

0.42

502

Infections of genitourinary tract in pregnancy

120

1012

1.19

1.08

1.8

1.9

1.44

1.47

g/l

0.15

105

871

Vasomotor and allergic rhinitis

624

5692

1.08

1.7

1.8

1.41

1.46

g/l

0.77

529

4900

Foreign body in respiratory tract

685

1.24

1.08

1.6

2.0

1.61

1.46

g/l

0.64

601

Other spirochaetal diseases

491

5325

0.92

1.08

1.7

1.37

1.56

g/l

5.69

405

4579

Malignant neoplasm of heart, mediastinum and pleura

178

1.49

1.08

1.1

1.7

1.96

1.50

g/l

1.14

151

Bicipital tendinitis

650

1.24

1.07

2.0

1.7

1.50

1.57

g/l

0.27

559

Delivery

657

3726

0.93

1.07

1.7

1.8

1.44

1.58

g/l

3.48

571

3188

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

525

1.27

1.06

1.7

1.8

1.36

1.55

g/l

0.91

453

Other acute disseminated demyelination

1.69

1.05

2.0

2.3

1.37

1.34

g/l

0.07

LSIL lesion of the cervix uteri

129

1098

1.18

1.05

1.8

1.9

1.38

1.40

g/l

0.09

114

947

Benign neoplasm of breast

188

1648

1.15

1.05

2.0

1.7

1.58

1.57

g/l

0.02

159

1400

Other and unspecified mononeuropathies of lower limb

367

1.32

1.05

1.7

1.8

1.71

1.58

g/l

0.38

321

Idiopathic peripheral autonomic neuropathy

1.98

1.04

2.4

1.6

1.58

1.51

g/l

—

Injury of muscle and tendon at hip and thigh level

161

1397

1.16

1.04

1.8

1.62

1.53

g/l

0.50

145

1193

Malignant neoplasm of breast, ER-negative, including Hilmo

335

2894

1.11

1.04

1.6

1.62

g/l

0.01

271

2454

Acute poliomyelitis

163

1.50

1.03

1.5

2.3

1.69

1.50

g/l

0.41

145

Lesion of medial popliteal nerve

1.93

1.02

1.3

2.4

1.54

1.53

g/l

—

Otorrhoea

2.07

1.02

1.9

2.0

1.46

1.59

g/l

—

Burn and corrosion confined to eye and adnexa

239

1.39

1.02

1.3

2.3

1.55

1.45

g/l

0.19

210

Benign neoplasm: Pituitary gland, craniopharyngeal duct

709

1.22

1.01

1.5

1.9

1.45

1.49

g/l

0.14

615

Peritonsillar abscess

327

2968

1.10

1.01

1.8

1.54

1.45

g/l

0.90

284

2560

Atopic conjunctivitis

476

1.27

1.00

2.0

1.9

1.40

1.47

g/l

0.25

425

Stenosis and insufficiency of lacrimal passages

171

1497

1.15

0.99

1.4

1.8

1.47

1.53

g/l

0.44

143

1277

Toxic effect of carbon monoxide

232

1.40

0.99

1.8

2.1

1.51

1.46

g/l

0.10

205

Cluster headache, strict, including avohilmo

521

1.26

0.99

1.4

1.9

1.42

1.47

g/l

0.19

453

Diseases of appendix

1502

12950

1.05

0.99

1.7

1.8

1.53

1.51

g/l

0.39

1291

11099

Apocrine sweat disorders, other sweat gland disorders

1.85

0.98

1.3

3.1

1.81

1.44

g/l

—

Toxic effect of corrosive substances

1.90

0.98

1.3

2.1

1.45

1.30

g/l

—

Propionic acid derivatives

697

3275

1.07

0.98

1.8

2.0

1.51

1.42

g/l

1.49

605

2794

Viral conjunctivitis

380

1.30

0.97

1.9

2.1

1.55

1.46

g/l

0.28

337

Respiratory tuberculosis

115

980

1.18

0.97

1.5

1.7

1.46

1.56

g/l

0.62

100

831

Other congenital malformations of circulatory system

311

1.33

0.96

1.6

2.1

1.19

1.49

g/l

1.35

272

Respiratory tuberculosis, confirmed and not-confirmed

115

981

1.18

0.96

1.5

1.7

1.46

1.56

g/l

0.62

100

832

Contact with and exposure to communicable diseases

351

3821

0.91

0.96

2.1

1.9

1.29

1.36

g/l

0.81

289

3329

Drug-induced headache, not elsewhere classified

1.80

0.96

1.4

2.2

1.02

1.33

g/l

—

Scissor bite

197

1.42

0.96

4.0

2.2

1.04

1.26

g/l

0.67

179

Obstructed labour due to maternal pelvic abnormality

155

1774

0.87

0.96

1.9

1.7

1.67

1.61

g/l

0.33

136

1530

Contact with other sharp object(s)

787

1.20

0.95

1.8

2.0

1.31

1.43

g/l

0.77

685

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

1041

0.83

0.95

1.7

1.8

1.59

1.53

g/l

0.23

905

Malignant neoplasm of oesophagus

365

1.30

0.94

1.2

1.6

1.66

1.50

g/l

0.77

318

Melanocytic naevi of other and unspecified parts of face

771

1.20

0.93

2.8

1.8

1.23

1.53

g/l

2.79

676

Retinal breaks without detachment

294

2670

1.11

0.93

1.7

1.48

1.59

g/l

1.20

248

2276

Appendicitis, broad definition

1484

12859

1.05

0.93

1.7

1.8

1.53

1.51

g/l

0.40

1276

11024

Alzheimer’s disease (Late onset)

548

4939

0.93

0.92

1.5

1.6

1.61

1.55

g/l

0.73

425

4188

Non-small cell lung cancer

201

1775

1.13

0.92

1.5

1.98

1.52

g/l

6.76

172

1507

Kissing spine

2.17

0.92

1.3

1.9

1.69

1.40

g/l

—

Convergence insufficiency and excess

110

1.56

0.91

1.1

1.9

1.38

1.29

g/l

0.10

Spermatocele

165

1453

1.14

0.91

1.5

1.6

1.47

1.54

g/l

0.39

140

1244

Fall on and from ladder

153

1341

1.15

0.91

2.1

1.7

1.43

1.53

g/l

0.80

128

1163

Prolapse and hernia of ovary and fallopian tube

668

1.21

0.90

1.4

1.7

1.66

1.61

g/l

0.17

545

Phakomatoses, not elsewhere classified

120

1.52

0.86

1.3

2.3

1.40

1.37

g/l

0.08

105

Mouth breathing

759

7166

1.06

0.86

1.5

1.7

1.52

1.54

g/l

0.19

666

6139

Benign neoplasm: Parotid gland

145

1272

1.15

0.86

1.6

1.8

1.64

1.54

g/l

0.66

119

1109

Emotional disorders and disorders of social functioning with onset specific to childhood

416

1.26

0.86

2.6

2.3

1.20

1.10

g/l

0.41

368

Burn and corrosion of shoulder and upper limb, except wrist and hand

248

1.34

0.85

1.6

2.0

1.52

1.45

g/l

0.16

222

Dementia in other diseases classified elsewhere

100

855

1.18

0.84

1.5

1.8

1.47

1.51

g/l

0.16

731

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

135

1181

1.15

0.83

1.5

1.8

1.35

1.57

g/l

1.88

111

1028

Mixed disorders of conduct and emotions

188

1.39

0.83

1.8

2.5

1.49

1.18

g/l

0.53

171

Oesophagitis, drug-induced

1.94

0.83

1.2

2.1

1.94

1.64

g/l

—

Hydrocephalus

120

1378

0.87

0.83

1.4

1.7

1.58

1.51

g/l

0.34

101

1178

Malignant neoplasm of breast, HER-negative

300

2696

1.10

0.82

1.7

1.6

1.60

1.63

g/l

0.18

245

2277

Contraceptive management

484

3638

0.93

0.82

2.1

1.8

1.32

1.55

g/l

6.09

418

3132

Meningitis, viral

1.74

0.82

1.3

2.8

1.05

1.36

g/l

—

Periodontal disease, other/unspecified

329

1.29

0.81

1.3

2.0

1.50

1.53

g/l

0.06

285

250

1.33

0.81

1.9

2.0

1.60

1.54

g/l

0.11

218

Calcific tendinitis of shoulder

701

1.19

0.80

1.6

1.7

1.73

1.61

g/l

0.50

601

Melanoma in situ of trunk

251

1.34

0.80

1.9

1.8

1.46

1.52

g/l

0.15

219

Vasomotor rhinitis (mode)

118

1026

1.16

0.80

1.5

1.9

1.47

1.52

g/l

0.25

884

Dislocation, sprain and strain of joints and ligaments of elbow

738

1.18

0.80

1.6

1.9

1.44

1.43

g/l

0.01

645

Disorders of male genital organs in diseases classified elsewhere

1.66

0.80

1.3

1.5

1.40

1.60

g/l

0.50

Crowding of teeth, including avohilmo

678

1.17

0.79

2.8

2.2

1.07

1.25

g/l

2.08

600

Gluteal tendinitis

456

1.24

0.79

1.5

1.9

1.54

1.57

g/l

0.11

393

Use of levodopa decarboxylase inhibitor

319

2939

1.09

0.79

1.5

1.7

1.55

1.56

g/l

0.07

271

2515

Cluster headache, wide,, including avohilmo

565

1.21

0.79

1.4

1.9

1.39

1.48

g/l

0.39

489

Certain zoonotic bacterial diseases

234

1.34

0.79

1.8

2.1

1.34

1.46

g/l

0.24

208

Undescended testicle

1.57

0.78

1.6

1.9

1.03

1.29

g/l

0.79

Serous carcinoma of ovary, including Hilmo

385

1.26

0.78

1.6

1.88

1.60

g/l

0.72

333

Postprocedural disorders of eye and adnexa, not elsewhere classified

1.76

0.78

2.2

2.7

1.38

1.36

g/l

—

Malignant neoplasm of brain, including Hilmo

612

1.20

0.78

1.9

1.7

1.74

1.47

g/l

1.35

522

Acute appendicitis, no complications

1010

9605

1.05

0.77

1.6

1.8

1.50

1.49

g/l

0.13

874

8263

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

209

1.36

0.77

1.3

1.9

1.45

1.61

g/l

0.46

182

Foreign body entering into or through eye or natural orifice

131

1152

1.14

0.77

2.0

1.8

1.46

1.51

g/l

0.22

113

997

Melanoma in situ, other sites/unspecified

1.72

0.76

2.2

2.6

1.38

1.62

g/l

—

Amblyopia ex anopsia

458

1.23

0.76

2.4

2.0

1.22

1.48

g/l

1.86

416

Dystonia

687

1.19

0.76

2.1

1.9

1.45

1.55

g/l

0.38

604

Melanoma in situ of upper limb, including shoulder

116

1.50

0.76

1.4

1.9

1.23

1.57

g/l

0.61

100

Effects of foreign body entering through natural orifice

423

3946

1.07

0.76

1.7

1.8

1.59

1.50

g/l

1.19

348

3403

Other disorders affecting eyelid function

116

1.49

0.76

1.4

1.9

1.40

1.46

g/l

0.18

103

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

333

1.27

0.76

2.0

1.6

1.81

1.59

g/l

0.67

287

Cholesteatoma of middle ear

874

0.84

0.75

2.0

1.8

1.59

1.53

g/l

0.21

762

Premature rupture of membranes

222

1439

1.11

0.75

1.7

2.0

1.20

1.37

g/l

2.59

189

1243

Triptan medication for migraine, single purchase ok

1234

8701

0.96

0.74

1.9

1.8

1.39

1.49

g/l

3.86

1055

7490

Migraine, single triptan purchase ok & required. ICD-code if available is included

1234

8701

0.96

0.74

1.9

1.8

1.39

1.49

g/l

3.86

1055

7490

Femoral hernia

699

1.18

0.74

1.4

1.8

1.48

1.57

g/l

0.32

609

Injury of blood vessels at lower leg level

1.71

0.74

1.3

1.9

1.61

1.46

g/l

—

Alcoholic cardiomyopathy

1.62

0.73

1.5

1.35

1.46

g/l

0.23

Amoebiasis

1.63

0.73

1.4

1.7

2.16

1.52

g/l

—

Other specified disorders of external ear

627

1.19

0.72

1.6

1.9

1.53

g/l

0.00

542

Other complications of labour and delivery, not elsewhere classified

111

889

1.15

0.72

2.0

2.1

1.13

1.20

g/l

0.42

777

Anomalies of dental arch relationship, including avohilmo

269

2226

1.09

0.72

1.8

1.9

1.38

1.45

g/l

0.58

226

1932

Oral lichen planus

354

1.25

0.71

2.3

2.0

1.36

1.56

g/l

0.82

309

Pituitary-dependent Cushing's disease

1.75

0.71

1.7

2.6

2.11

1.56

g/l

—

Malignant neoplasm of hypopharynx, including Hilmo

1.59

0.70

1.6

1.4

1.42

1.58

g/l

0.28

Increased muscle tone

1.59

0.70

1.3

2.3

1.49

1.47

g/l

0.02

Congenital malformations of the musculoskeletal system, not elsewhere classified

135

1.42

0.69

2.3

2.5

1.64

1.30

g/l

0.70

117

Other and unspecified degenerative diseases of nervous system

465

1.22

0.69

1.3

1.7

1.63

1.57

g/l

0.17

401

Undescended testis, unilateral

1.61

0.69

1.8

2.0

0.99

1.28

g/l

0.76

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

605

0.82

0.68

1.4

2.0

1.51

1.55

g/l

0.13

526

Adenocarcinomas of cervix

1.66

0.68

2.1

2.3

1.21

1.51

g/l

—

conjunctival degenerations and deposits

294

1.27

0.67

2.4

1.7

1.53

1.56

g/l

0.08

260

Pedal cyclist injured in other and unspecified transport accidents

180

1630

1.11

0.67

1.6

1.8

1.48

1.51

g/l

0.17

151

1409

Benign neoplasm: Pancreas

458

1.21

0.67

1.9

1.8

1.41

1.53

g/l

0.48

397

Other vitreous opacities

588

1.18

0.65

1.4

1.8

1.40

1.53

g/l

0.53

509

Oher contracture of tendon (sheath)

1.67

0.63

1.3

2.0

1.19

1.36

g/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

524

0.82

0.63

1.8

1.35

1.62

g/l

0.85

465

Other obstructed labour

738

1.16

0.63

1.8

1.36

1.58

g/l

1.28

643

Primary open-angle glaucoma, strict

561

5895

0.95

0.63

1.5

1.6

1.58

1.59

g/l

0.05

451

5002

Pleural plaque without asbestos

759

1.16

0.62

1.6

1.8

1.65

1.51

g/l

0.79

654

Embolism and thrombosis of abdominal aorta

1.71

0.62

1.0

1.5

1.89

1.67

g/l

—

Malignant neoplasm of hypopharynx

1.63

0.62

1.1

1.4

1.60

1.44

g/l

—

Other appendicitis

129

1154

1.12

0.62

1.7

1.8

1.59

1.56

g/l

0.11

110

1001

Benign neoplasm of thyroid gland

423

0.80

0.61

2.2

1.8

1.53

1.50

g/l

0.04

366

Lichen ruber planus, wide definition including periferal and oral lichen planus

398

3742

1.07

0.61

1.7

1.6

1.48

1.58

g/l

1.32

341

3209

Other bursitis of knee

165

1.35

0.61

1.5

1.8

1.52

1.47

g/l

0.08

141

Schizotypal disorder

209

1.30

0.61

1.6

2.2

1.68

1.41

g/l

0.74

184

Exposure to noise

0.00

0.60

0.0

1.4

—

1.44

—

Childhood allergy (age < 16)

163

1218

1.10

0.59

2.7

2.3

1.14

1.13

g/l

0.03

143

1086

Long labour

258

2045

1.08

0.59

2.2

1.9

1.33

1.42

g/l

0.72

230

1778

Adenomyosis (Endometriosis of uterus)

209

1922

1.09

0.59

1.6

1.7

1.48

1.58

g/l

0.78

172

1621

Malignant neoplasm of eye, brain and central nervous system

511

1.18

0.58

1.8

1.7

1.51

1.47

g/l

0.12

444

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

319

1.23

0.58

1.8

2.0

1.35

1.53

g/l

0.72

286

Parkinson's disease, including avohilmo

357

3357

1.07

0.57

1.5

1.7

1.57

1.56

g/l

0.06

297

2865

Undefined dementia

248

2459

0.93

0.56

1.5

1.6

1.71

1.53

g/l

2.00

201

2034

Foreign body in ear

212

1.28

0.56

1.8

2.2

1.77

1.41

g/l

0.92

188

Mucinous and mucinous cystic tumor

1.64

0.56

2.2

1.8

2.38

1.61

g/l

—

Foreign body on external eye

202

2191

0.92

0.56

1.6

1.8

1.62

1.50

g/l

1.02

171

1893

Spinal enthesopathy

448

1.19

0.56

1.4

1.6

1.44

1.56

g/l

0.38

372

Pregnancy, childbirth and the puerperium

572

2842

1.05

0.55

1.8

1.7

1.50

1.56

g/l

0.65

486

2408

Hyperprolactinaemia, drug-induced

1.52

0.55

1.3

3.0

1.29

1.53

g/l

—

Benign neoplasm of other and unspecified female genital organs

533

1.17

0.55

1.7

1.8

1.63

1.58

g/l

0.12

461

Abrasion of teeth

570

5436

1.05

0.55

1.7

1.49

1.55

g/l

0.81

485

4658

Medical abortion

1090

5708

1.04

0.54

1.9

1.8

1.55

1.50

g/l

1.10

933

4893

Carcinoma in situ of breast, other/unspecified

181

0.71

0.53

1.8

2.1

1.49

1.61

g/l

—

159

Benign neoplasm: Brain, unspecified

1.54

0.53

1.2

2.2

1.62

1.57

g/l

—

Pedestrian injured in collision with pedal cycle

406

1.19

0.52

1.9

2.1

1.37

1.55

g/l

0.63

360

Desensitization to allergens

489

1.17

0.52

1.8

2.0

1.30

1.38

g/l

0.37

439

Other disorders of prostate

649

1.15

0.52

1.4

1.6

1.56

1.54

g/l

0.05

545

Endometriosis of ovary

242

2199

1.08

0.52

1.9

1.7

1.39

1.53

g/l

1.49

207

1870

Any dementia

1029

6908

1.04

0.51

1.5

1.6

1.60

1.57

g/l

0.48

823

5871

Other and unspecified disorders of vitreous body

833

7914

1.04

0.51

1.7

1.47

1.60

g/l

3.71

719

6741

Vertical strabismus

416

1.18

0.51

1.7

2.0

1.29

1.48

g/l

0.79

373

Dentofacial anomalies [including malocclusion]

1124

9319

0.97

0.51

1.8

1.42

1.48

g/l

1.25

961

8032

Hypertrophy of breast in women and men

237

2543

0.93

0.51

1.7

1.51

1.53

g/l

0.09

208

2168

Noise effects on inner ear

660

0.86

0.51

1.4

1.8

1.44

1.54

g/l

0.39

572

Glaucoma, exfoliation

219

2353

0.93

0.51

1.8

1.6

1.49

1.54

g/l

0.33

186

1983

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.52

0.50

1.4

1.8

1.67

1.65

g/l

—

Retinoschisis and retinal cysts

390

1.19

0.50

1.4

1.8

1.52

1.58

g/l

0.16

338

Pterygium

508

0.84

0.50

1.4

1.8

1.35

1.54

g/l

0.86

445

Calcific tendinitis

110

1.38

0.49

1.7

1.6

1.40

1.57

g/l

0.31

Multiple system atrophy (rare forms of Parkinsonism)

1.56

0.49

1.4

2.1

1.44

1.73

g/l

—

Postpartum haemorrhage due to retained placenta

132

1202

1.10

0.49

2.3

2.1

0.97

1.27

g/l

5.68

113

1053

Hydatidiform mole

110

0.63

0.48

4.0

2.1

0.88

1.37

g/l

—

Malignant neoplasm of lip

102

1.39

0.48

1.4

1.9

1.69

1.63

g/l

0.08

Plantar fascial fibromatosis

139

1272

1.10

0.47

1.6

1.8

1.53

1.58

g/l

0.26

121

1083

Contact with machinery

171

1848

0.92

0.47

1.5

1.8

1.51

g/l

0.04

148

1594

Primary open-angle glaucoma

706

7083

0.96

0.47

1.6

1.55

1.59

g/l

0.57

574

6014

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

120

1.35

0.47

3.0

2.5

1.45

1.55

g/l

0.14

102

Chromomycosis and phaeomycotic abscess

1.45

0.46

2.9

2.0

1.14

1.40

g/l

—

Traumatic amputation of wrist and hand

675

0.87

0.46

1.6

1.9

1.59

1.55

g/l

0.11

584

Non-small cell lung cancer, squamous

749

0.88

0.46

1.4

1.5

1.95

1.50

g/l

3.13

623

Benign neoplasm: Cerebral meninges

162

1496

1.09

0.46

1.8

1.7

1.54

1.58

g/l

0.20

141

1277

Carcinoma in situ of cervix uteri

106

959

1.11

0.46

1.9

2.0

1.44

1.34

g/l

0.46

838

Other ill-defined and unspecified causes of mortality

168

1555

1.08

0.46

1.4

1.6

1.63

1.55

g/l

0.52

139

1316

Allergic contact dermatitis due to drugs in contact with skin

283

1.21

0.45

1.6

2.0

1.62

1.51

g/l

0.28

247

Disorder of the sleep-wake schedule

183

1.27

0.45

2.1

1.63

1.37

g/l

0.57

151

Neuroendocrine tumor and carcinoma of lung

1.41

0.45

1.3

1.6

1.70

1.65

g/l

0.06

Amoebiasis

1.41

0.45

1.3

2.0

1.97

1.36

g/l

1.50

Labour and delivery complicated by umbilical cord complications

422

1.17

0.45

2.0

1.9

1.64

1.50

g/l

0.31

367

Prophylactic surgery

1.38

0.44

1.0

2.1

1.99

1.19

g/l

—

Divergent concomitant strabismus

104

943

1.11

0.44

1.6

1.8

1.53

1.52

g/l

0.04

829

Severe bullous disorders, KELA reimbursement

1.66

0.44

1.4

2.0

1.07

1.93

g/l

—

Abnormalities of forces of labour

857

1.11

0.44

1.7

1.8

1.34

1.47

g/l

0.83

741

Injury of nerves at hip and thigh level

1.48

0.44

4.1

2.2

1.56

1.66

g/l

—

Calculus of lower urinary tract

113

1031

1.10

0.43

1.5

1.7

1.51

1.52

g/l

0.08

877

Cyst of Bartholin Gland

368

1.17

0.43

1.3

2.1

1.11

1.50

g/l

2.90

323

Medicines for HER+ breast cancer

566

5579

0.96

0.43

1.5

1.7

1.68

1.59

g/l

1.12

467

4754

Congenital ovarian cysts

368

1.17

0.43

1.7

2.1

1.41

1.36

g/l

0.10

321

Female genital prolapse

440

2603

0.95

0.42

1.4

1.7

1.60

1.58

g/l

0.19

377

2190

Juvenile dermatomyositis

0.00

0.42

0.0

1.5

—

1.14

—

Parkinson's disease

337

3206

1.05

0.41

1.5

1.7

1.57

g/l

0.06

278

2746

Endometriosis of fallopian tube

1.37

0.41

1.8

2.8

1.28

1.36

g/l

—

Hand

1.35

0.41

2.0

2.1

1.58

1.41

g/l

—

Ménière disease

166

1546

1.08

0.40

1.6

1.7

1.60

1.55

g/l

0.26

142

1322

Use of levodopa decarbox-comt-inhibitor

581

0.87

0.40

1.4

1.9

1.80

1.56

g/l

1.56

505

Benign neoplasm: Bones of skull and face

105

0.66

0.40

1.3

2.2

1.18

1.38

g/l

—

Spontaneous abortion

624

4358

0.96

0.39

1.9

1.8

1.35

1.47

g/l

2.42

545

3763

Use of amantadine

206

1.22

0.38

1.6

2.0

1.37

1.53

g/l

0.53

179

Benign neoplasm of meninges

180

1687

1.07

0.37

1.7

1.57

g/l

0.01

157

1427

Glaucoma-related operations

115

1060

1.09

0.37

1.6

1.8

1.55

g/l

0.00

912

Mandibular retrognathia

629

0.89

0.37

1.4

2.2

1.21

1.41

g/l

1.30

560

Occlusion and stenosis of arteries, not leading to stroke

216

1.21

0.37

1.7

1.8

1.80

1.53

g/l

0.69

188

Aggressive periodontitis

272

1.18

0.36

1.9

2.2

1.57

1.54

g/l

0.05

235

Benign neoplasm of brain and other parts of central nervous system

103

946

1.09

0.36

1.6

1.9

1.60

1.53

g/l

0.29

821

Benign neoplasm: Retina

0.63

0.36

1.4

2.1

0.88

1.59

g/l

—

Glaucoma suspect

769

7469

1.03

0.35

1.6

1.52

1.59

g/l

1.32

649

6363

Struck by thrown, projected or falling objec

670

1.11

0.35

1.8

1.9

1.58

1.50

g/l

0.30

577

Ill-defined and unknown causes of mortality

184

1732

1.07

0.35

1.4

1.6

1.64

1.55

g/l

0.66

151

1468

Benign lipomatous neoplasm of other sites/unspecified

160

1499

1.07

0.35

1.9

1.7

1.57

1.56

g/l

0.07

133

1288

Supervision of normal pregnancy

195

1047

1.06

0.35

1.8

1.24

1.49

g/l

3.69

170

906

Persons encountering health services in circumstances related to reproduction

871

5705

1.03

0.34

2.0

1.8

1.37

1.55

g/l

6.49

738

4895

Triptan medication for migraine, min. 3 purchases

777

6101

0.97

0.34

1.7

1.9

1.42

1.43

g/l

0.21

652

5300

Unspecified dementia

247

2336

0.95

0.34

1.5

1.6

1.70

1.52

g/l

2.04

200

1968

Brachial plexus disorders

1033

0.92

0.34

1.6

1.9

1.37

1.54

g/l

1.20

894

Parkinson's disease, strict definition

315

3014

1.05

0.33

1.5

1.7

1.54

1.57

g/l

0.25

259

2584

Nasal polyp

357

3425

1.04

0.33

1.6

1.7

1.58

1.53

g/l

0.49

300

2953

Benign neoplasm: Floor of mouth

1.32

0.33

1.3

2.1

1.44

1.56

g/l

—

Caught, crushed, jammed or pinched in or between objects

627

1.10

0.32

1.6

2.0

1.39

1.48

g/l

0.37

541

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

1.34

0.31

4.1

2.8

0.82

1.60

g/l

—

Presbyopia

781

1.09

0.31

1.9

1.7

1.60

1.57

g/l

0.08

680

Benign neoplasm: Choroid

996

0.92

0.31

1.5

1.8

1.59

1.54

g/l

0.21

862

Lichen sclerosus et atrophicus

149

1400

1.07

0.31

1.6

1.7

1.73

1.59

g/l

0.78

119

1193

Pleural plaque with presence of asbestos

180

1703

1.06

0.31

1.7

1.41

1.54

g/l

1.35

150

1446

Mumps

283

0.84

0.31

1.3

1.8

1.46

1.55

g/l

0.19

248

Dementia, including avohilmo

1187

7987

1.02

0.31

1.4

1.6

1.60

1.58

g/l

0.22

947

6809

Other specified and unspecified disorders of eyelid

175

1.21

0.30

1.7

1.9

1.21

1.51

g/l

0.90

157

Delivery, wide proxy

584

3196

0.97

0.29

1.9

1.7

1.42

1.58

g/l

3.55

500

2726

Macular hole

110

1026

1.08

0.29

1.6

1.8

1.42

1.57

g/l

1.13

882

Mandibular hypoplasia

1.23

0.29

1.6

2.8

0.85

1.32

g/l

—

Nontoxic goitre/thyroid nodule

545

5291

1.03

0.29

1.6

1.62

1.58

g/l

0.48

470

4480

Endovascular or surgical operations to intracerebral aneurysms

872

1.08

0.29

2.0

1.8

1.68

1.56

g/l

0.53

758

Other and unspecified disease of Bartholin gland

346

1.13

0.28

1.5

2.0

1.73

1.55

g/l

0.51

299

Other facial nerve disorders

353

0.87

0.27

2.5

1.9

1.77

1.51

g/l

0.79

308

Non-small cell lung cancer, adenocarcinoma, helper endpoint

125

1177

1.07

0.26

1.6

1.7

1.91

1.52

g/l

3.04

107

1004

Other superficial injuries of ankle and foot

1.20

0.26

1.9

2.0

1.28

1.49

g/l

—

Contact with blunt object, undetermined intent

1.31

0.26

2.0

2.4

1.34

1.40

g/l

—

Early lumbar disc prolapse operation

1018

0.93

0.26

1.7

1.8

1.53

1.40

g/l

0.59

880

Dementia due to Parkinson's disease

467

0.89

0.26

1.6

1.9

1.36

1.53

g/l

0.74

409

Alzheimer’s disease (Atypical or mixed), excluding more controls

188

1426

1.05

0.26

1.7

1.59

1.58

g/l

0.08

144

1214

Benign neoplasm of bone and articular cartilage

102

1089

0.93

0.26

1.8

1.45

1.54

g/l

0.59

953

Endometriosis ASRM stages 3,4

303

3143

0.96

0.25

1.8

1.7

1.42

1.52

g/l

1.10

255

2679

Other disorders of male genital organs

540

1.10

0.25

1.6

1.7

1.48

1.51

g/l

0.07

463

Other mosquito-borne viral fevers

1.22

0.25

1.3

1.9

1.47

1.54

g/l

—

Lower leg

0.73

0.24

1.2

2.3

1.55

1.43

g/l

—

Malignant neoplasm of pancreas, including Hilmo

145

1377

1.06

0.24

1.5

1.66

1.53

g/l

0.91

126

1180

Benign neoplasm of other and unspecified sites

446

1.10

0.24

1.6

1.9

1.46

1.49

g/l

0.08

390

Obstructed labour due to malposition and malpresentation of fetus

216

1931

1.04

0.24

2.0

1.9

1.19

1.40

g/l

3.20

189

1676

Multiple delivery

929

1.07

0.24

2.2

1.8

1.22

1.54

g/l

3.03

796

Adrenomedullary hyperfunction

1.33

0.23

2.4

2.0

1.48

1.62

g/l

—

Injury of muscle and tendon at forearm level

218

1.15

0.23

1.6

2.0

1.55

1.47

g/l

0.19

195

Other noninflammatory disorders of cervix uteri

688

1.08

0.23

1.6

1.7

1.63

1.62

g/l

0.01

580

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.25

0.23

1.4

2.3

1.72

1.56

g/l

0.36

Inflammatory disease of cervix uteri

815

0.93

0.23

1.4

1.8

1.58

1.59

g/l

0.02

702

Simple and mucopurulent chronic bronchitis

670

1.08

0.22

1.8

1.7

1.53

1.51

g/l

0.09

577

Accident to powered aircraft causing injury to occupant

0.00

0.22

0.0

3.6

—

1.24

—

Carcinoma in situ of breast, intraductal

104

1102

0.94

0.22

1.5

1.7

1.71

1.61

g/l

0.37

946

164

1.17

0.22

2.5

2.3

0.72

1.07

g/l

1.73

139

Other benign neoplasm of uterus: Other parts/unspecified

720

0.93

0.22

1.3

1.7

1.48

1.61

g/l

0.61

616

Other lesions of median nerve

401

1.10

0.22

2.1

1.7

1.61

g/l

0.01

346

Retained (old) intraocular foreign body

0.00

0.21

0.0

3.2

—

1.57

—

Toxic effect of pesticides

0.00

0.21

0.0

2.8

—

1.69

—

Complications of labour and delivery

910

4968

1.02

0.21

1.9

1.8

1.36

1.53

g/l

6.08

779

4273

Lumbosacral plexus disorders

1.26

0.20

1.3

1.9

2.10

1.67

g/l

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.20

0.0

3.2

—

1.74

—

Other adrenocortical overactivity

1.23

0.20

3.8

2.3

1.72

1.33

g/l

—

Complications following abortion and ectopic and molar pregnancy

413

1.09

0.20

1.8

1.65

1.57

g/l

0.18

363

Delayed puberty

1.20

0.20

4.7

2.6

0.97

1.04

g/l

—

Vestibular neuronitis

147

1407

1.05

0.20

1.7

1.8

1.46

1.55

g/l

0.63

126

1213

Nontoxic single thyroid nodule

107

1016

1.06

0.19

1.8

1.7

1.55

g/l

0.01

873

Dementia

1108

7508

1.02

0.19

1.5

1.7

1.60

1.58

g/l

0.28

886

6391

Congenital malformations of eye, ear, face and neck

746

0.94

0.19

2.6

2.0

1.41

1.38

g/l

0.07

656

898

1.06

0.18

1.3

1.8

1.43

1.54

g/l

0.46

738

Benign neoplasm of eye and adnexa

174

1677

1.04

0.18

1.5

1.7

1.68

1.55

g/l

0.92

145

1439

Other benign neoplasms of connective and other soft tissue

151

1451

1.04

0.18

1.7

1.8

1.45

1.55

g/l

0.75

125

1257

Dementia due to Parkinsons disease, excluding more controls

387

1.09

0.18

1.6

1.7

1.36

1.46

g/l

0.40

328

Spasmodic torticollis

358

1.09

0.17

2.6

2.0

1.18

1.51

g/l

1.69

313

Communicating hydrocephalus

291

1.10

0.17

1.3

2.0

1.47

1.54

g/l

0.16

259

Viral infections of central nervous system, not elsewhere classified/unspecified

110

1.19

0.17

1.2

2.2

1.28

1.43

g/l

0.43

Accidental poisoning by and exposure to other gases and vapours

1.12

0.17

4.4

2.6

1.34

1.58

g/l

—

Puerperal sepsis

144

1497

0.96

0.17

1.7

1.64

1.59

g/l

0.25

129

1287

Erosion and ectropion of cervix uteri

369

1.09

0.16

1.5

1.8

1.69

g/l

0.00

317

Benign neoplasm: Other/unspecified site

196

1.13

0.16

1.8

2.1

1.78

1.63

g/l

0.29

169

Degenerative conditions of globe

1.12

0.16

3.8

1.6

1.81

1.50

g/l

—

Systemic atrophies primarily affecting the central nervous system

677

0.94

0.15

1.7

1.9

1.45

1.52

g/l

0.29

593

Otosclerosis

113

1177

0.96

0.15

1.6

1.8

1.67

1.57

g/l

0.49

1013

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1007

7869

1.01

0.15

1.9

1.8

1.43

1.48

g/l

0.99

861

6777

Malignant neoplasm of brain

381

1.08

0.15

1.7

1.57

1.48

g/l

0.26

336

FESS (DNB20)

172

1774

0.97

0.14

1.9

1.8

1.70

1.53

g/l

1.35

148

1528

Vascular dementia (undefined)

852

1.05

0.14

1.2

1.6

1.80

1.54

g/l

2.15

714

Mesial bite

1.20

0.14

1.0

2.9

1.97

1.22

g/l

—

Occupational exposure to risk-factors

510

0.94

0.13

2.0

1.35

1.49

g/l

0.49

438

Degenerative diseases of the nervous system

889

6605

0.99

0.12

1.5

1.6

1.60

1.58

g/l

0.42

702

5597

Polypectomy (DHB20)

104

1079

0.96

0.12

1.6

1.8

1.75

1.53

g/l

1.67

929

Motorcycle rider injured in other and unspecified transport accidents

649

1.05

0.12

2.0

1.9

1.47

1.50

g/l

0.14

556

Lesion of sciatic nerve

781

0.96

0.11

1.9

1.8

1.55

g/l

0.00

664

Adenocarcinoma of pancreas

383

0.94

0.11

1.3

1.6

1.57

1.53

g/l

0.10

334

Chondromalacia

331

0.93

0.10

1.3

1.9

1.56

1.51

g/l

0.11

289

Foreign object accidentally left in body during surgical and medical care

1.17

0.10

7.0

2.6

1.42

1.50

g/l

—

Use of rasagiline

443

0.95

0.10

1.3

1.9

1.57

1.58

g/l

0.04

386

Disorders of acoustic nerve

398

1.06

0.10

1.6

1.9

1.61

1.60

g/l

0.04

348

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.12

0.09

1.8

2.2

1.31

1.61

g/l

—

Endometriosis of pelvic peritoneum

194

1813

1.02

0.08

1.9

1.8

1.38

1.48

g/l

0.75

167

1547

Benign neoplasm: Scapula and long bones of upper limb

113

0.88

0.08

1.5

1.9

1.53

1.44

g/l

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.80

0.08

1.6

1.5

1.61

1.35

g/l

—

Other disorders of breast

165

1617

1.02

0.08

1.8

1.7

1.62

1.54

g/l

0.39

139

1381

Other and unspecified atrophic disorders of skin

1.06

0.08

4.0

2.9

0.89

1.45

g/l

—

L02BG Aromatase inhibitors

480

4844

0.99

0.08

1.5

1.7

1.70

1.61

g/l

0.93

396

4138

Benign leiomyoma with endometriosis

227

2307

0.98

0.08

1.5

1.6

1.60

1.61

g/l

0.04

185

1969

Left side

0.80

0.08

1.5

2.8

1.03

1.44

g/l

—

Other benign neoplasms of uterus

886

1.03

0.07

1.8

1.7

1.63

1.56

g/l

0.28

755

Loose body in joint

296

0.94

0.07

1.3

2.0

1.76

1.57

g/l

0.26

251

Congenital malformations of ovaries, fallopian tubes and broad ligaments

501

1.04

0.07

1.9

2.0

1.44

1.43

g/l

0.02

436

Injury of muscle and tendon at shoulder and upper arm level

695

7005

0.99

0.07

2.0

1.7

1.60

1.56

g/l

0.44

610

6016

Dental pulpitis, including avohilmo

1706

11123

0.99

0.07

1.7

1.8

1.47

1.49

g/l

0.31

1457

9628

Intussusception

216

1.07

0.07

1.5

2.0

1.61

1.51

g/l

0.13

185

Other obstetric trauma

393

1.04

0.07

1.8

2.0

1.33

1.34

g/l

0.03

340

Disorders of breast

761

6859

1.01

0.06

1.7

1.8

1.51

1.52

g/l

0.16

653

5867

Contact with nonpowered hand tool

592

1.03

0.06

1.9

2.0

1.62

1.54

g/l

0.27

513

Unspecified chronic bronchitis

563

1.03

0.05

1.7

1.60

1.55

g/l

0.12

476

Maternal care for known or suspected disproportion

287

1.05

0.05

1.8

1.7

1.18

1.38

g/l

0.59

243

Peripheral retinal degeneration

414

0.97

0.05

1.4

1.8

1.43

1.59

g/l

0.54

359

Pneumoconiosis due to asbestos and other mineral fibres

434

0.97

0.05

1.6

1.7

1.62

1.46

g/l

0.59

369

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

208

2057

1.01

0.04

1.6

1.7

1.51

1.55

g/l

0.22

173

1765

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

506

1.03

0.04

1.6

1.7

1.45

1.57

g/l

0.42

436

Benign neoplasm: Rectum/anal canal icd-9

150

1.07

0.04

2.1

2.0

1.65

1.58

g/l

—

131

Pedal cyclist injured in transport accident

348

3453

1.01

0.04

1.6

1.8

1.44

1.50

g/l

0.50

290

2967

Normotensive glaucoma

170

1680

1.01

0.04

1.5

1.7

1.49

1.54

g/l

0.25

142

1452

Adenocarcinoma and ductal carcinoma of pancreas

493

0.97

0.04

1.2

1.6

1.62

1.55

g/l

0.22

422

Lateral epicondylitis

166

1679

0.99

0.04

1.6

1.7

1.63

1.54

g/l

0.61

149

1439

Benign neoplasm: Cranial nerves

408

1.03

0.04

1.6

1.8

1.70

1.55

g/l

0.47

359

Ethmoidectomy

183

1848

0.99

0.03

1.9

1.8

1.69

1.53

g/l

1.27

158

1594

Pedal cyclist injured in noncollision transport accidents

160

1588

1.01

0.02

1.5

1.8

1.43

1.50

g/l

0.37

129

1379

Postprocedural disorders of ear and mastoid process, not elsewhere classified

117

0.94

0.02

3.8

2.1

1.46

1.55

g/l

—

102

Other and unspecified spinal muscular atrophies

127

0.94

0.01

1.3

1.7

1.76

1.48

g/l

0.48

113

Single delivery by forceps and vacuum extractor

139

843

0.99

0.01

1.6

2.1

1.15

1.36

g/l

1.93

124

720

Respiratory tuberculosis, not confirmed

712

1.01

0.01

1.5

1.7

1.44

1.55

g/l

0.54

606

Early lumbar disc prolapse, operated

902

1.01

0.01

1.7

1.8

1.55

1.40

g/l

0.66

777

Benign mammary dysplasia

211

2119

1.00

0.01

1.7

1.6

1.53

1.59

g/l

0.45

181

1799

Varus deformity, not elsewhere classified

124

1.05

0.00

5.3

2.0

1.47

1.42

g/l

0.08

109

Inflammation of lacrimal passages (chronic)

216

0.97

0.00

1.2

1.8

1.43

1.55

g/l

0.27

189

Endometriosis ASRM stages 1,2

200

1993

1.00

0.00

1.9

1.8

1.39

1.48

g/l

0.71

173

1711

Oral lichen planus, including avohilmo , including avohilmo

894

1.01

0.00

2.2

1.8

1.53

1.58

g/l

0.20

779

Benign lipomatous neoplasm

532

5321

1.00

0.00

1.7

1.50

1.55

g/l

0.67

443

4547

Ectopic pregnancy

199

1994

1.00

0.00

1.7

1.8

1.47

1.48

g/l

0.08

163

1712

Use of selegiline

815

0.99

0.00

1.6

1.8

1.61

1.54

g/l

0.24

700

Lesion of plantar nerve

851

1.00

0.00

1.5

1.7

1.79

1.61

g/l

0.79

724

Malignant neoplasm of pancreas

110

1099

1.00

0.00

1.5

1.6

1.65

1.52

g/l

0.77

933

Burn and corrosion of head and neck

242

0.99

0.00

1.6

1.9

1.72

1.44

g/l

0.75

208

Chalazion

167

1674

1.00

0.00

2.0

1.8

1.54

1.50

g/l

0.22

140

1432

Primary angle-closure glaucoma

778

1.00

0.00

1.3

1.8

1.50

1.53

g/l

0.13

671

Dermatitis due to ingested food

252

0.99

0.00

1.6

2.1

1.24

1.14

g/l

0.16

226

Viral infections of central nervous system, not elsewhere classified/unspecified

148

1.01

0.00

1.3

2.0

1.44

1.49

g/l

0.10

128

Use of ropinirole

605

0.99

0.00

1.6

1.9

1.37

1.56

g/l

0.86

530

Fusion of the labia

0.00

0.0

5.6

—

1.10

—

Arteriovenous malformation of peripheral vessels

0.94

0.00

1.6

2.5

0.70

1.34

g/l

—

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

0.0

1.7

—

0.83

—

Intrauterine hypoxia

0.00

0.0

2.4

—

1.04

—

Other specified air transport accidents

0.00

0.0

5.4

—

1.19

—

Pediculosis and phthiriasis

0.84

0.00

1.8

1.5

1.11

1.46

g/l

—

Disorders of branched-chain amino-acid metabolism, other/unspecified

0.00

0.0

1.0

—

1.60

—

Granuloma faciale [eosinophilic granuloma of skin]

0.00

0.0

2.4

—

1.62

—

Microcephaly

0.00

0.0

4.5

—

0.99

—

Exposure to vibration

0.00

0.0

2.4

—

1.46

—

Neurofibromatosis, type 1

0.89

0.00

1.2

1.9

1.36

1.53

g/l

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.93

0.00

1.3

2.4

1.63

1.52

g/l

—

Carcinoma in situ of breast, lobular

0.89

-0.00

1.1

2.3

1.89

1.58

g/l

—

Melanocytic naevi of ear and external auricular canal

0.92

-0.00

1.3

1.8

1.10

1.57

g/l

—

Myxoedema coma

0.00

-0.00

0.0

4.2

—

1.41

—

Bacterial vaccines

0.00

-0.00

0.0

1.2

—

2.24

—

Spotted fever [tick-borne rickettsioses]

0.00

-0.00

0.0

5.3

—

1.55

—

Birth injury to skeleton

0.00

-0.00

0.0

4.2

—

0.93

—

Follicular adenocarcinoma of thyroid gland

0.94

-0.00

3.3

1.4

1.72

1.52

g/l

—

Defects in post-translational modification of lysosomal enzymes

0.00

-0.00

0.0

5.5

—

1.03

—

Fusion of the labia

0.00

-0.00

0.0

4.3

—

1.16

—

Carcinoma in situ of other/unspecified digestive organs

0.00

-0.00

0.0

1.1

—

1.48

—

Benign neoplasm: Mesothelial tissue of peritoneum

0.00

-0.00

0.0

1.9

—

1.56

—

Congenital absence of the uterus

0.00

-0.00

0.0

1.7

—

1.61

—

Neuropathic heredofamilial amyloidosis

0.00

-0.00

0.0

1.0

—

1.17

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

1.02

-0.00

1.7

0.72

1.49

g/l

—

Cholinergic urticaria

1.02

-0.00

1.6

2.1

1.16

1.41

g/l

—

Carcinoma in situ of breast

0.91

-0.00

1.6

2.1

1.54

1.60

g/l

—

Miliaria crystallina

0.00

-0.00

0.0

1.2

—

1.30

—

Right side

0.97

-0.00

1.3

2.6

0.97

1.60

g/l

—

Typhus fever

0.00

-0.00

0.0

2.0

—

0.86

—

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs

0.00

-0.00

0.0

1.3

—

1.81

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

-0.00

0.0

1.7

—

1.63

—

Malignant neoplasm of trachea

0.00

-0.00

0.0

5.4

—

1.48

—

Progressive external ophthalmoplegia

0.00

-0.00

0.0

1.0

—

1.17

—

Other conditions of integument specific to fetus and newborn

0.00

-0.00

0.0

1.1

—

0.81

—

Benign neoplasm: Endocrine pancreas

0.95

-0.00

1.3

2.1

1.69

1.51

g/l

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Haptoglobin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS